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“I asked the Great Sage ‘How can I solve the secret of life?’  He
replied, ‘The secret of life lies in the structure of proteins, and X-
ray crystallography is the only way to solve it’.  The ‘Sage’ was
John Desmond Bernal (…) who had been the first to discover that
protein crystals give detailed X-ray diffraction patterns (…).”
Max Perutz in “How the Secret of Life Was Discovered”
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Chapter I.
Introduction
2I.1. Objectives of this work
Eukaryotic cells rely heavily on the compartmentalization of their cytoplasm; it is the
only way they can perform multiple, sometimes almost contrary, reactions at the same time.
This solution comes at a cost: the eukaryotic cell has to ensure that the transport of material is
done in the correct way, that the vesicular traffic does not lead to problems.  To this end, a
whole subfamily of Ras–related small GTPases, termed Ypt in yeast and Rab in higher
eukaryotes has emerged; in the yeast genome, it accounts for a third of the small GTPases.
Current data shows us that Ypt proteins play a major role in the catalysis/specificity of
membrane traffic.  Unfortunately, it does not (yet) tell us exactly in which substeps these
proteins are implicated.  Also, we do not know much about how the specificity is achieved
and which are the molecular mechanisms that control the very complex endomembraneous
system within the cell.  Neither do we know what makes these Ypt proteins, structurally so
much alike, the key players in a specificity process which requires the differentiation between
different compartments.  Another question which was unanswered at the beginning of this
work was how big are the structural differences between the GTP- and the GDP- bound forms
of the members of the family and if defining the “switch” regions based solely on the homology
with Ras was a correct decision or not.
This work was done with the points outlined above in mind and with the hope of
gaining some insight into the molecular basis of this specificity.  To answer these questions,
crystallographic analysis was combined with extensive kinetic characterization of different Ypt
members.
The crystallographic analysis was performed on Ypt7p.  This protein was truncated, in
order to facilitate its crystallization, crystallized in complex with a non-hydrolyzable GTP
analogue and its structure solved.  Based on the semi-refined model, a second, more severe,
truncation was performed.  This second construct could be crystallized both in complex with
GDP and a non-hydrolyzable GTP analogue and very high resolution structures were
determined.  Analysis of the models obtained, in comparison with other Rab / Ypt structures
3emerged meanwhile, helped us to increase our knowledge on the specificity structural
determinants and the structural changes that occur after the hydrolysis of GTP to GDP.
The purpose of the kinetic analysis was to gain a better understanding of the way
prenylation is controlled.  To this end, pre steady state kinetics methods, as well as equilibrium
titrations were employed.  By making use of a large array of techniques, the characterization of
the interaction between the escort protein Mrs6p and a variety of members of the
Saccharomyces cerevisiae Ypt family was achieved.  The results obtained helped us to suggest a
mechanism by which cells differentiate between the more and the less important members of
the family.
In a trial to understand at molecular level the interaction between the Mrs6p and Ypt
proteins, and since the complex did not seem amenable to crystallization, I tried to employ a
new method of characterizing the interaction interface, using proton/deuteron exchange and
mass spectrometry.  Although it did not give information at high resolution and accuracy, the
approach permitted pinpointing some regions involved in the interaction.
The experiments described in this work were performed between July 1998 and
September 2001 in the Max-Planck-Institute Dortmund, Germany.
4I.2. Ypt / Rab Proteins — Ras-like proteins involved in
membrane fusion control
Eukariotic cells contain multiple lipidic membrane-bound compartments that are
essential for their functioning.  Exactly this compartmentalization gave them the evolutionary
advantage over the prokaryotic systems.  Each compartment is endowed with a specific proteic
and lipidic composition and has a certain, well-defined role.  A resulting problem is that the
compartments, by themselves, are impermeable for the majority of macromolecules in the cell,
such as proteins, glucides and ions and yet, such macromolecules have to be transported
between compartments.  This transport is achieved by what is termed “transport vesicles”,
which bud from the donor compartment, travel through the cytoplasm and fuse with the
acceptor compartment, delivering there both their contents (“cargo”) and lipid membrane
components (Palade, 1975).
The budding process itself involves loading the vesicles with their cargo (Kirchhausen et
al., 1997) and the assembly of coat protein complexes (COP I and II, chlatrin etc.) (Wieland
& Harter, 1999; Wendland et al., 1998).  After that, the vesicle is transported, with the help
of cytoskeletal structures, to the destination (Sheetz, 1999), where it fuses with the target
membrane in a process catalyzed by a very complex machinery, involving the Rab/Ypt small
GTPases and the SNARE family proteins, to name just a few of them (Wickner & Haas, 2000;
Jahn & Sudhof, 1999).
Cell’s sustainable survival depends on the fidelity of cargo vesicles fusion with the right
target membrane.  First, because the surface aria of the different compartments (or that of the
plasma membrane) has to be kept constant, despite the vesicular traffic (which comprises
membrane transport as well as cargo) in which they are involved; moreover, there is the risk of
non-specific fusion, a risk which has to be avoided in order to guarantee the survival of the
cell.
According to the current view, the role of assuring a control on the specificity of the
fusion event is assigned to small GTPases from the Rab / Ypt family (Wickner & Haas, 2000;
Lazar et al., 1997; Gotte et al., 2000) (yeast proteins are termed Ypt, with the exception of
Sec4p, while their counterparts from higher organisms are termed Rab).
5GTPases are considered to be the cell’s molecular switches (Bourne et al., 1990); they
shuttle between two states, a GTP–bound, active, and a GDP–bound, inactive; the timer of
the switch is represented by the rate the GTPase is able to hydrolyze its substrate (alone or
with the catalytic help of a GTPase Activating Protein, termed generic GAP).  Currently,
there are more than 700 genes known for small (≈ 21..23kDa), monomeric GTPases of the
Ras superfamily; the yeast Saccharomyces cerevisiae contains 30 open reading frames (ORFs)
coding such small GTPases (Garcia-Ranea & Valencia, 1998).  Out of them, four belong to
the Ras family, six to Rho, two belong to Ran, seven to the Arf/Sar family and eleven, i.e.
more than a third, to the Ypt/Sec4 family. This alone gives a hint on the importance of the
Ypt family. The general characteristics of a Ras-related protein are: a GTP-binding domain
and (in most of the cases) a prenylation signal at the C-terminus.  For the special case of
Rab/Ypt proteins, there is not an obvious consensus C-terminal prenylation signal; instead,
there are different motifs, like xxxCC, xxCCx, xCCxx, CCxxx or xxCxC.  Moreover, these
proteins exhibit a hypervariable C-terminal tail, which is believed to contain the information
for subcellular localization.
I.2.1. Generic structure of a Ras-like protein and highlights on
Ypt proteins
Generally speaking, all Ras-related GTPases (and Ypt proteins as well) have a very
similar fold, owing to their high sequence homology (see Figure I-1 for a sequence alignment).
They consist of a six-stranded beta sheet, surrounded by five alpha helices.  Two important
secondary structure elements are the helices α2, part of the so-called “switch II region”, and
the C-terminal helix, α5, at the end of which isoprenoid groups are attached.  Also, three
loops, L1, L2 and L4 play important roles in GTP binding, hydrolysis and interaction with













































































































































Figure I-1: Structural alignment of Saccharomyces cerevisiae Ypt proteins.  Consensus motifs described
below are marked on the bottom row of the alignment.  It is worth noting that, except Ypt11p,
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Figure I-2: The overall fold of H-Ras p21.  The secondary structure elements of the protein are
gradient-colored from dark-blue at the N-terminus to red at the C-terminus, the only
exceptions being the loop L2 (Switch I) and the Switch II region (L4 and helix α2),
depicted in pink.
Two major motifs define Ras-related protein and Ypt proteins are no exception to this
rule as well.  One is the nucleotide binding site and its associated “switch” regions, whereas
the other one is the lipidation signal at the C-terminus.  Specific for the Rab / Ypt proteins is
the hyper-variability of their C-terminus, feature with important functional implications.
These features will be described in the following subchapters.
I.2.1.a. The nucleotide binding site
comprises six conserved, small motifs. The main principle is that the binding pocket for the
base should provide both hydrophobic and H-bonding interactions for the purine base and H-
bonding and electrostatic interactions for the charged part (the phosphate moiety).  Three
motifs are involved in the binding of the phosphate groups and the Mg2+ ion (hence their P/M
9name) while the remaining three are involved in the binding of the purine base (the G motifs)
(Valencia et al., 1991).
Motif PM1 (GxxxxGKS/T) is part of loop L1, called the P-loop (where P stands for
phosphate-binding).  The name is justified by the observation that this sequence is present in
many purine-nucleotide triphosphate (ATP/GTP) binding proteins (nucleoside and
nucleoside monophosphate kinases, ribosomal elongation factors, the β subunit of ATP
synthases, myosin heavy chains, phosphoglycerate kinases and, last but not at least, the
members of Ras family of small GTPases). However, it should be noted that this motif is not
found in all ATP/GTP binding proteins, and, if used alone in a database mining, might
sometimes “fish” false hits (Saraste et al., 1990). The P-loop is also known as “the G-rich”
loop, since, in H-Ras, for example, it contains four glycines in eight residues.  What are the
features of this loop?  First, the loop wraps around the β and γ phosphates with the main chain
amide nitrogen atoms pointing “inside”; thus it helps to balance the high negative charge of
the phosphate groups.  The same role is played by the conserved lysine, which is in contact
with the β and the γ phosphates; in the GDP state, the lysine coordinates only the β
phosphate.  Second, the serine or threonine binds the Mg2+ ion which, in turn, is coordinated
by the phosphates β and γ.
Motifs PM2 (T) and PM3 (DxxGQ/TE, WDTAGQE in all Ypt family members)
involve a conserved threonine, aspartate and glycine (underlined) that bind the γ phosphate
of the GTP.  Threonine  35 —if we refer to the well-known H-Ras p21 structure (Pai et al.,
1989; Schlichting et al., 1990; Pai et al., 1990; Milburn et al., 1990)— or T40 —in Ypt7p
numbering— and  glycine 60 (G67 in Ypt7p) bind the γ-phosphate via their backbone
nitrogen, while aspartate 57 (D64 in Ypt7p) is part of the second coordination sphere of the
Mg2+ ion.  These residues are responsible for the conformational changes which occur after
the hydrolysis of GTP to GDP: since they cannot bind the β phosphate, the whole loop which
contains the threonine (L2) as well as the one which contains the WDATGQE motif (L4 plus
α2) undergoes large rearrangements.  In Ypt7p, the threonine and the glycine move after the
GTP hydrolysis about 10Å from their original positions (see also Figure I-3).  These
rearrangements make the GTPase competent for interaction with other molecules.  Since
loops L2 and L4 plus helix α2 transmit to the outer world the state of the GTPase (switched
on or off), they are known also as the “Switch I” and “Switch II” regions.  Moreover, for
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reasons discussed below (see I.2.1.b), “switch I” is known also as the “effector loop”, while
“switch II” is also known as the “catalytic loop”.
Figure I-3: Comparison of the hydrogen bonding pattern for the GTP and GDP states of Ypt7p.  The
parts that do not move significantly upon GTP hydrolysis are colored light gray.  The nucleotide (here
only the three phosphates and the sugar base visible) is green.  “Switch I” region is depicted in dark
blue for the GTP state, while it is light-blue in the GDP state.  “Switch II” is red for GTP and yellow
for the GDP state.  Residues T40 and G67, responsible for anchoring the loops to the γ-phosphate, are
represented in “ball and stick”, with the H-bonds to the γ-phosphate indicated.  Some parts of the
loops  (including residues T40 and G67) could not be traced in the electron density for the GDP case.
Motif G1 (F/Y) contains a phenylalanine or a tyrosine (in the Rab/Ypt family only the
Rab7 and Ypt7p have a tyrosine) positioned perpendicular to the plane of the base.  Strong
interactions between the π electrons of the base and the aromatic aminoacid stabilize the
contact with the purine base (see Figure I-4).
Motif G2 (NKxD) provides both hydrophobic and ionic interactions with the base.
Two nitrogens from the base, N2 and, respectively, N1, are bound by the aspartate 119 (D129
in Ypt7p), with both its OD1 and OD2.  This residue is very important, since it is one of the
key elements involved in the high specificity of these proteins towards the guanosine base.
Mutating this aspartate to asparagine (DN mutation) switches the specificity of the GTPase
from guanosine to xanthosine (Hwang & Miller, 1987; Hoffenberg et al., 1995; Schmidt et al.,
1996).  This altered specificity has proved to be a very useful way of controlling the activity of
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a small G protein in a complex context, especially for in vivo experiments, where there are so
many GTP-binding proteins involved and the activity of only one should be perturbed (Rybin
et al., 1996).
The same motif also provides a lysine which packs against the base by hydrophobic
interactions and is H-bonding the O4’ of the sugar ring with its terminal nitrogen.
Motif G3 (F/YxExSAK/L) does not contribute so much to the binding of the
nucleotide.  The serine H-bonds the O6 of the base (more weakly in the case of Ras than in
the case of Ypt7p) while the lysine packs “above” the base, stabilizing it by hydrophobic
interactions.
Figure I-4: The contacts between the base and the G1/G2/G3 motifs in H-Ras p21.  Residue
numbering according to H-Ras p21, coordinates derived from PDB entry 5P21.
The motifs PM1, PM3 and G2 were identified as early as 1987  (Dever et al., 1987) as
being the signature for all the GTP-binding proteins; they were named the “GTP binding
domain” and had the consensus sequences: GxxxxGKT/S, DxxG and, respectively NKxD.
I.2.1.b. The switch regions
It is now generally accepted that all the G proteins shuttle between two states, a GDP-
bound and a GTP-bound form. The balance between the time spent in the GDP and in the
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GTP state is mainly dictated by the interaction of the protein with the GTPase activating
proteins (GAPs) and the Guanine nucleotide Exchange Factors (GEFs), combined with the
intrinsic GTPase activity.  The GTP-bound is always the active state, while the GDP-bound is
the inactive state.  This is why the G proteins are considered to be “molecular switches”
(Bourne et al., 1991).
Following the determination of the X-ray structures of the elongation factor EF-Tu
(also a GTPase domain closely related to Ras) in the GDP form (Jurnak, 1985) and the ones
of p21 H-Ras in GDP form (de Vos et al., 1988) and, later, in the GTP form  (Pai et al., 1989;
Milburn et al., 1990), it became clear that there are two main regions undergoing
rearrangements as a consequence of GTP hydrolysis, namely the loops L2 and L4 and the
helix α2.  These regions have been named “switch I” (L2) and “switch II”(L4+α2).
In switch I the main element sensing the nucleotide state is the threonine residue from
the PM2 motif, which binds the γ phosphate and the Mg2+ ion.  Upon GTP conversion to
GDP, this residue is not anymore part of the γ phosphate and Mg2+ coordination sphere and as
a result the whole loop is displaced, in Ypt7p by more than 9Å (this work), which is a shift
almost three times larger than that observed in Ras.  In the triphosphate form, switch I is also
stabilized in its conformation due to hydrophobic packing against Switch II.  Since it was
proven that, in the case of Ras, effectors interact with this loop, it was also named “effector
loop”.  The structure of Rab3a bound to its effector molecule Rabphilin3 (Ostermeier &
Brunger, 1999) shows, however, that the switch I region is only one of the many regions
implicated in the complex formation, together with switch II and other regions (see the
paragraph on “Rab3a-Rabphilin3 crystal structure” on page 17).
Switch II contains the “catalytic loop” L4 and the helix α2.  The DTAGQE motif binds
the γ phosphate via the glycine backbone nitrogen.  Upon GTP hydrolysis, this loop also
change its position dramatically and becomes highly unstructured; this is demonstrated by the
very poor electron density and the high crystallographic thermal factors for its atoms.  The
glutamine residue (Q61 in p21 Ras) was shown to play a very important role in the catalysis,
which led to the naming of loop L4 as “catalytic loop”.
I.2.1.c. The C-terminus
Generally speaking, the C-terminus of almost all Ras-related GTPases (with the
exception of Arf and Ran families) contains a prenylation signal to which an isoprenoid will be
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attached; this posttranslational modification is essential for their reversible attachment to a
biological membrane.   Two features are special for the Rab / Ypt proteins: their C-terminus
contains (with very few exceptions) two prenylated cysteine residues instead of the usual one
(Seabra et al., 1992).  Moreover, a part of the C-terminus is responsible for the specific
localization of the protein in the cell (Chavrier et al., 1991).
The geranylgeranyl transferase type II adds, via a thioether linkage, a geranylgeranyl
(C20 isoprenoid) moiety on each of these two cysteine residues (Rossi et al., 1991; Ferro-
Novick et al., 1991).  These two strongly hydrophobic groups are responsible for the reversible
manner in which Ypt proteins are able to associate with the membrane.
A particularity of Rab proteins is the existence of a “hypervariable C-terminal region”
which determines to which compartment the Rab protein will localize (Chavrier et al., 1991;
Stenmark et al., 1994).  It was shown that the last 34 residues (but not the last 13 or fewer)
contained the targeting signal for Rab5.  Similar results were observed with the yeast proteins
Sec4p and Ypt1p: exchanging the last 40 residues of these two proteins showed that the
localization was dictated by this part of the tail (Dunn et al., 1993; Brennwald & Novick,
1993). However, the last 20-24 residues of Rab7 are flexible in solution (Neu et al., 1997); the
same holds true for crystals of Ypt51p, where at least the terminal 20 residues  are not visible
in the electron density (Esters et al., 2000), as well as the last 22 residues in Ypt7p (this work),
so this behavior cannot be explained by a certain structuring of the tail.
I.2.1.d. Variability among Rab / Ypt proteins
The striking feature of Rab / Ypt proteins is the fact that they have a high homology
and, in spite of it, control a number of diverse processes.  The experiments described in the
paragraph I.2.1.c proved that the hyper-variable C-terminus is important for the localization of
the proteins. However, in both cases, the tail was dictating only the localization of the protein,
but not the function.  The same studies, along with others, have attempted to define the
regions of the proteins able to render the chimeric proteins functional.   Three approaches
were employed: construction of molecular chimeras  and in vivo assessment of their effects,
identification of consensus sequences by sequence analysis and interpretation of  the data
obtained from the structure determination of a Rab-Rab effector complex.
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Construction of molecular chimeras:
In order to analyze the functional determinants of Ypt / Rab proteins, more complex
chimeras were constructed, containing not only the C-terminus of Ypt1p grafted onto Sec4p,
but also other different structural domains.  The results showed that grafting loops L2
(“effector loop”) and L7 together with helix α2 (part of the “switch II” region) of Ypt1p onto
Sec4p rendered a protein able to behave like Ypt1p, both in terms of localization and function.
Unexpectedly, the chimera between β3+α2+L5+L6+α3+L7 (the segment between the
PM3 and G2 motifs) of Ypt1p and what was left from Sec4p was able to function as both
Ypt1p and Sec4p, albeit with low efficiency.  This evidence suggested, however, that the
specificity determinants for each protein are not exactly the same.
In order to gain a better understanding of “what makes a Rab a Rab”, Zerial and
colleagues constructed several finer sampled chimeras between canine Rab5 and human Rab6
(Stenmark et al., 1994).  Based on sequence alignments of many Rabs (Valencia et al., 1991),
they first assessed the role of the N- and C-termini.  Similar to the yeast system, the C-
terminus alone was able to code for the correct localization, but not for functionality in the
new context. Inserting the Rab5 α2 helix, part of the “switch II” region in the Rab6 led to an
unexpected result: the chimera was not anymore attached to the membrane, but it was
soluble.  This suggests that Rab5 α2 might not be compatible with Rab6 α3; to test this
hypothesis, a new chimera, containing the Rab5 α2/L5 and α3/L7 on the Rab6 frame (always
with the Rab5 tail) resulted in a correctly localized protein, still missing the new functionality.
The functionality could be partly (≈ 50%) restored only after adding also a part of the N
terminus, namely the first 20 residues of Rab5 instead of the first 13 of Rab6.
The conclusion that could be drawn from these experiments was that there are many
specificity determinants on the surface of any Rab / Ypt protein and, also, that they are not
localized to a certain surface of the molecule, but on two “faces” of the protein: the N- and C-
termini, together with the L7 on one side and mainly the α2 and α3 helices on the other.
Sequence analysis of the Rab family
Taking advantage of the increasing number of proteins deposited in the public
databases (more than 700 Ras-related GTPases) Seabra and co-workers (Pereira-Leal &
Seabra, 2000) performed a multiple sequence alignment on a representative of each Rab
subfamily.  Their main goal was to identify sequences which would be specific “tags” for all the
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Rabs.  This was not only because of the (still) lack of understanding of what defines a
Rab / Ypt protein, but, as well, because different proteins of the family were submitted with
“non-standard” names, so that there was a lack of nomenclature.  Also, once identified a Rab
consensus sequence, this might be used to search the database with the hope of finding new,
as of yet not identified, members of the family.
The model set comprised 50 mammalian Rab GTPases.  As expected, six regions
aligned to almost 100% identity: the three phosphate-binding and the three guanine-binding
motifs.  However, five other regions could be identified, very conserved among Rabs and able
to distinguish Rabs from Ras/Rho and Arf.
These five regions were denominated “Rab family motifs” and were labeled RabF1 to
RabF5.  RabF1 was localized in the switch I region (see Figure I-5). The other four family
determinants were found to cluster in, or close to, the switch II region; RabF2 was localized in
the sheet β3, RabF3 and RabF4 reside in the loop L4/α2 and RabF5 is in the β4.  Based on
these consensus sequences, a search in the databases identified 52 different Rabs, so two new.
This extensive alignment exercise delivered yet another conclusion: examining the
phylogenetic tree, several clusters of “related” Rabs could be identified.  The sequence analysis
revealed four Rab subfamily determinants, termed RabSF1 to RabSF4.  They are characterized
by very high aminoacid identities for the members of the same subfamily (between 80 and
90%), in high contrast with the sequence identity at the level of the whole Rab family (around
20-30%).  Exception is RabSF4, for which the identity is 58% in the subfamily and only 14%
in the whole family.  These very low figures can be explained taking in account the fact that
this subfamily determinant maps to the C-terminus of the proteins, in the so-called hyper-
variable domain.  RabSF1 was identified at the very N-terminus of the proteins.  The other two
subfamily motifs map to the α helices 1 and 3.
These results help to provide a more molecular explanation of the experiments
performed by the groups of Zerial (Stenmark et al., 1994) and Novick (Brennwald & Novick,
1993).  In these experiments, the N- terminus, the α2/L5, α3/L7 and C-terminus were
swapped between Rab5 and Rab6, in order to obtain a semi-functional chimeric protein.
These regions are, by the definitions mentioned above, the RabSF1, RabF3 and RabF4,
RabSF3 and, respectively, RabSF4.
It is, however, worth mentioning that the last two “consensus” sequences (for RabSF3
and RabSF4) cannot be easily mapped onto the members of the Ypt family, the yeast
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counterparts.  However, the Dunn (Dunn et al., 1993) and Novick (Brennwald & Novick,
1993) experiments with Ypt1p/Sec4p chimeras showed that swapping the regions
corresponding to RabSF2 and RabSF3 were necessary and sufficient to generate an active
chimeric protein and that the C-terminal tail region of Ypt1p, termed the HV region in the
Novick experiments, (and corresponding to RabSF4) was the solely necessary to drive Sec4p
(a plasma membrane–associated protein) to the Golgi membranes, where Ypt1p resides
normally.
Figure I-5: Alignment of profile HMM model sequences (manually adjusted to accommodate
structural considerations). The uppercase/lower case coding represents the results of the
profile Hidden Markov Model method, in which uppercase characters were found at
p>0.5. Residues found to be Rab specific are highlighted in red. When a position is
conserved in other families, the corresponding position is also highlighted in red. Green




The “final proof” concerning the structural specificity determinants was provided by
the group of Axel Brunger which solved by X-ray diffraction the structure of the Rab3A:GTP-
Rabphilin3 complex (Ostermeier & Brunger, 1999) (with a Rab3A mutant, Q81L, locked in
the GTP state and only the effector domain of rabphilin-3A). Rabphilin3 is an “effector
molecule” which binds Rab3A in the GTP state; not much is yet known about Rabphilin3
function downstream of Rab3A, but it is known that it is implicated in neurotransmiter
release.
The structure of the complex explained many of the results described previously.
Rabphilin3 binds Rab3A at two interfaces, roughly of the same size (1300Å2 and, respectively,
1500Å2).  Most of the interactions are of hydrophobic nature, but some of them are also based
on charge complementarity.
For interface A, Rab3A participates with the switch I and II regions, while Rabphilin3
participates with helix α1 and the C-terminus.  The interface B is composed of Rabphilin3 C-
terminal end of α2 helix and a motif next to it (SGAWFF), which binds the Rab3A N-
terminus, C-terminus and the loops L5 and L7.  These loops seem to be stabilized as a
consequence of their interaction with Rabphilin, since in the structure of Rab3A alone
(Dumas et al., 1999) they exhibit a very weak electron density, indicative of flexible, non-
structured regions.  It should be mentioned that during the Rab3A-Rabphilin crystallization
trials, an “engineered” version of Rab3A proved to be the best candidate; this version is
lacking the first 18 aminoacid residues at the N-terminus, as well as the last three residues.
However, the structure is still biologically relevant, since a ∆N18 version of Rab3A was able to
bind Rabphilin3, while a ∆N21 version had no affinity at all for Rabphilin.
Corroborated with data on binding partners for other Rabs, the X-ray structure
suggested that the N-terminus of Rab proteins, together with loops L5 and L7 and part of the
C-terminal helix α5, form a “Rab Complementarity Determining Region” or, shortly, Rab
CDR.  It is noteworthy that the Rab CDRs for other Rab proteins have a sequence different
from that of Rab3a and that these other Rabs cannot bind to Rabphilin3.
The data presented here strongly suggest that the Rab family determinants are present
in some well defined regions and that the interactions with the effectors are based on two
distinct mechanisms: the conserved switch regions are used mainly to transmit the GTP- or
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GDP-bound state of the GTPase, while specific sequences in the hyper-variable N- and C-
termini, as well as in loops L5 and L7, facilitate the interaction with a cognate partner, thus
preventing other effectors from binding.
I.2.2. The prenylation machinery
Protein prenylation is a type of posttranslational modification consisting in the
covalent attachment of an isoprenoid (be it farnesyl –C15– or geranylgeranyl –C20–) via a
thioether linkage to cysteine residues, usually near the C-terminus of the protein.  These
prenylated proteins play very important roles in signal transduction or intracellular traffic
(Casey & Seabra, 1996), accounting for up to 2% of the cell proteins (Glomset & Farnsworth,
1994).  The lipidic substrate is, in both cases, an ester with a pyrophosphate; hence, they are














Figure I-6: Farnesyl- and geranylgeranyl  pyrophosphates
There are three types of protein:prenyl transferases (here thereafter named, for
simplicity, just prenyl transferases), grouped in two major classes: the CaaX prenyl transferases
and the Rab geranylgeranyl  transferase (Rab GGTase or, even shorter, GGTaseII ).
I.2.2.a. CaaX prenyl transferases
This family includes farnesyl transferase (FTase) and geranylgeranyl transferase type I
(GGTase I). Both enzymes recognize the C-terminal consensus sequence CaaX of the protein
to be modified.  The difference in specificity between FTase and GGTase I arises from the
residue in the fourth position of the consensus sequence, namely the X.  While FTase has as
substrate peptides ending in Ser, Met, Ala or Gln, GGTase I recognizes peptides ending in
Leu.
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Farnesyl transferase was the first prenyl transferase to be identified and characterized
(Reiss et al., 1990), mainly in connection with the posttranslational modification of Ras-p21.
The enzyme was shown to have specificity towards a tetrapeptide containing the prenylation
signal Cys-aaX, where a signifies an aliphatic residue and X signifies a variety of residues.  It
was shown that the protein consists of two subunits, named initially α and β and weighting,
respectively, 48kDa and 43kDa. The same study demonstrated that a peptide as short as four
aminoacids was a good substrate for the enzyme.  Different experiments showed that the β
subunit was the one to which the proteic substrate was binding to, suggesting the α subunit to
be the prenyl phosphate carrier (Reiss et al., 1991).  In time, different other studies and, more
important, the X-ray structure (Park et al., 1997) showed that the β subunit is the one binding
both the lipid and the substrate. Among the proteins modified by this enzyme are the members
of the Ras superfamily, nuclear lamins A and B, the γ subunit of transducin, rhodopsin kinase
(Zhang & Casey, 1996; Glomset & Farnsworth, 1994).
Geranylgeranyl transferase type I was, later, shown to consist also from two subunits,
again termed α and β.  Remarkably, the α subunit is shared between FTase and GGTase I
(Seabra et al., 1991).  This called for a small change in the names of the subunits, which are
now known as αF/GGI and βF or βGGI.  Known substrates for the GGTase I are the members of
the Rac / Rho family, most of the γ subunits of heterotrimeric G proteins (Casey & Seabra,
1996).
I.2.2.b. Rab geranylgeranyl  transferase
Many substrates of GGTase I and FTase have enhanced mechanisms in order to help
them correctly localize after the prenylation.  Some of them, like Ras proteins (with the
notable exception of K-(B)Ras), undergo another posttranslational modification, which is
palmitoylation of cysteine residues upstream from the C-terminus.  Others, like members of
the Rho family, have stretches of polybasic aminoacid residues, able to electrostatically
interact with the negatively charged phospholipids in the biological membranes.  It appears
that just having one C15 or C20 lipid attached to the C-terminus is not enough to keep the
protein anchored to the membrane — although there are some exceptions (Rab8 and Rab13
have just one C-terminal cysteine (Zahraoui et al., 1994)).  Rab proteins seem to solve the
problem in another way: they have two cysteines to be geranylgeranylated, instead of only one.
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This special modification is conferred by another prenyl transferase, geranylgeranyl
transferase II.
Unlike Ras / Rho / Rac, which exhibit the CaaX box as a signal for the prenylation,
there is considerable heterogeneity in the C-terminal sequence of the Rab / Ypt proteins and
there is no real consensus sequence for double geranylgeranylation. This might be one of the
reasons for which GGTase II is not able to recognize/bind alone its proteic substrate and the
prenylation of Rab / Ypt proteins needs an additional factor, a so-called “escort protein”. This
polypeptide is known as “Rab Escort Protein” (REP) in higher eukaryotes (Seabra et al., 1992)
and under the more cryptic name of Mrs6p in yeast (Jiang & Ferro-Novick, 1994).  Mrs6p is a
66kDa soluble protein which appears to have multiple tasks.  First, it binds/recognizes Ypt
proteins and presents them to the transferase; secondly, once the Ypt proteins are modified by
the addition of the hydrophobic moieties, it might shield the prenyl groups from the aqueous
environment of the cytosol, hence preventing protein aggregation/ precipitation prior to its
delivery to the donor-membrane; finally, Mrs6p is able to escort newly prenylated Ypt proteins
to the target-membrane and deliver them there.  However, new evidence suggests that Rep is
not completely indispensable for delivery to the correct membrane.  A recent study
(Overmeyer et al., 2001) employed a Rab1B mutant (Y78D) that was unable to bind to Rep or
GDI.  Replacing the C-terminal GGCC residues of Rab1B(Y78D) with a  CLLL motif
permitted the protein to be prenylated by GGTase I, but not by GGTase II, in vitro as well as in
vivo.  Surprisingly, this double mutant was proven to be correctly delivered to the ER and
Golgi compartments, like its wildtype counterpart.  Use of a dominant-negative mutant
showed that the protein was fully functional and able to inhibit the ER to Golgi transport,
demonstrating that the different prenylation did not have a major impact on its functionality.
Rab Geranylgeranyl transferase (or geranylgeranyl transferase II, or, even shorter,
GGTaseII) is a heterodimeric protein; in yeast, the genes BET2 and BET4 (initially called
MAD2) code for the two subunits, each about 35kDa in mass.  The mammalian enzyme is
composed of an α and a β subunit; these subunits (about  65 and, respectively, 42kDa)
resemble the corresponding subunits from the farnesyl transferase and the GGTase I.
Indeed, the X-ray structure of rat GGTase II (Zhang et al., 2000) shows that it has a
fold similar with FTase.  The α subunit is formed of 15 α-helices organized in a crescent-
shaped, right-handed superhelix.  The root mean square deviation (rmsd) between
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corresponding Cα atoms in the α subunits of FTase and GGTase II is 2.1Å, at an aminoacid
identity of only 22%.  The β subunit has an α-α barrel fold composed of 12 helices; the center
of the barrel forms a funnel-shaped pocket lined out with mostly aromatic residues, obviously
the prenyl binding site.  The bottom of the pocket is defined by a turn near the C-terminus.
Compared with the β subunit of FTase, the rmsd is even smaller: 1.4Å for 280 superimposable
Cα.  However, there are, also differences between these two proteins.  The GGTase II
contains two extra domains, both located in the α subunit: an Ig-like and a leucine-rich
repeat.  It can be speculated that these extra domains are the ones implicated in the
recognition of the REP-Rab complex.
Studies by Seabra (Desnoyers & Seabra, 1998) showed, before the publishing of the X-
ray structure, that, surprisingly, there is a single prenyl binding site in the GGTaseII.  This is
somehow counterintuitive, since Rab proteins are known to be doubly prenylated (Seabra et
al., 1992).  This finding suggested (together with the crystallographic structure of rat GGTase
II) that the two prenyl groups are transferred in a successive manner onto the two C-terminal
cysteines.  The next question which arises is whether the two rounds are tightly coupled or
not, namely whether the prenylated intermediate product is released from the complex or not.
Recent evidence (Thomä NH, ms. in preparation) suggests that it is more likely that the
prenylated intermediate does not leave the prenylation complex; hence, just some
rearrangements take place at the active site, in order to shift the second cysteine in the active
site and to give the possibility of reloading the enzyme with GGpp.  This might also be a good
reason for needing a third component for the prenylation machinery (apart from the
transferase itself and its proteic substrate); this third component —the escort protein— would
stabilize the interaction between the transferase and the small GTPase during the
rearrangement.  At this moment, it is not clear which is the cellular source of GGpp for the
prenylation reaction: soluble, membrane-bound or the GGpp synthetase (Zhang et al., 2000).
In any case, the C-terminal tail of the Rab / Ypt  protein has to move away from the active site,
in order to leave access for the GGpp to the hydrophobic pocket.  This means that the binding
of the C-terminal tail of the substrate has to be more flexible and less tight than in the case of
the CaaX prenyl transferases; in turn, this leads to the conclusion that the escort protein has
the task of ensuring that, during this rearrangement process, the semi-prenylated Rab does not
leave the prenylation machinery.
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I.2.3. The cycles of a Ypt protein and its interacting partners
Rab/Ypt proteins are involved in different cycles.  First of all, they cycle between a
GTP-bound state and a GDP-bound state; in addition, they cycle between a membrane-bound
and a “soluble” (cytosolic) form.  Moreover, the membrane-bound form can be subdivided in
vesicle- and target membrane-bound states.
I.2.3.a. GTP vs. GDP state
As the GTP switch hypothesis states (Bourne et al., 1990),  Ypt proteins cycle between
a GTP state, in which they are “active” and able to fulfill their role, and a GDP state, in which
they are “switched off” to prevent undesired membrane-fusion events.  However, since Ypt
proteins are slow GTPases, with rates of about 0.005min-1  (Wagner et al., 1987), they need
the help of a GTPase activating protein, GAP.
I.2.3.b. Membrane-bound vs. soluble
The GTP/GDP cycle is associated with another cycle: the shuffling of the protein from
the  membrane  to the cytosol and back on the membrane.  After being synthesized in the
cytosol, Ypt proteins interact with the geranylgeranyl transferase and a Rab escort protein
(Mrs6p in yeast, REP in higher eukaryotes) and are posttranslationally prenylated (Casey &
Seabra, 1996).  After this step, Mrs6p delivers the protein to the donor membrane.  Following
vesicle budding and fusion, the Ypt protein ends up on the target membrane, hydrolyzes the
GTP to GDP, and can be extracted by a protein termed GDI (for GDP dissociation inhibitor)
and delivered back to the donor-membrane.
I.2.3.c. Donor –  vs. acceptor –  membrane bound
As mentioned earlier, the Ypt GTPases are, after their prenylation, delivered to the
donor membrane.  From there, they travel, bound to the cargo vesicle, to the receptor
membrane.  When the cargo vesicle finds the proper target membrane, Ypt proteins help in
the docking stage (Ungermann et al., 2000; Ungermann et al., 1998) (see below) and,
following membrane fusion, end up on the target membrane.  However, since they cannot
supervise correct fusion while attached to the target membrane, they have to be extracted and
recycled to the donor membrane.
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I.2.3.d. Schematic overview
The three cycles presented above might be schematically represented as in Figure I-7:
Figure I-7: Overlapping the GTP/GDP-bound, target/vesicle and membrane-bound and soluble
cycles of a Ypt protein.  ® = putative Ypt receptor (After  (Gotte et al., 2000))
It will be noted from the scheme above that there is overlap between the three cycles.
Starting with the newly-prenylated Ypt protein (which is, only in the first round, escorted by
Mrs6p, not Gdi1p) in a soluble form, the protein is then inserted in the appropriate membrane
upon recognizing/being recognized by a putative membrane receptor.  Once inserted into the
membrane, the GDP molecule has to be exchanged for a GTP molecule in order to yield an
active, “ready to fuse” Ypt protein.  This is accomplished with the help of a guanine-
nucleotide exchange factor (GEF,  (Jones et al., 1995)).  A known GEF for Ypt proteins is the
one for Sec4p, termed Sec2p.  As its name suggests, this protein was found (like its substrate)
while screening for mutants which affect the secretory pathway; the SEC2 gene is also
essential, as is the case with SEC4.
Once in the GTP form, the Ypt protein is activated and can participate in the fusion
process.  However, after it plays its role, the Ypt has to be “switched off”; to this end, since the
intrinsic GTPase rate is extremely low, the involvement of a GTPase activating protein
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appears necessary.  The first GTPase stimulating activity was discovered for Ypt6p in the
group of Dieter Gallwitz (Strom et al., 1993) and termed Gyp6p— GTPase activating protein
(GAP) for Ypt proteins.  Later on, GYP7 and GYP1 genes were identified and cloned
(Vollmer & Gallwitz, 1995).  These Gyps accelerate the slow GTPase rates (10-4..10-3s-1) by a
factor of ca. 105  (Albert et al., 1999)
Although not essential for the cell’s viability (Rybin et al., 1996; Eitzen et al., 2000),
the Ypt cycle between compartments is completed once the protein is returned to the starting
membrane.  Responsible for extracting the Ypt proteins from the target membrane and
reinserting them in the donor membrane is a protein termed Gdi1p (first known as Sec19p).
As the name suggests, the protein was found to block release of GDP from the inactive Ypt
protein;  however, its main feature is the capability of extracting only the GDP form of the
protein from the membrane (Wu et al., 1996).
I.3. The fusion process and main proteins implicated
Membrane fusion can be defined as the merger of two (phospho)lipidic bilayers present
in an aqueous medium.  In the case of artificial lipid bilayers, fusion can proceed by itself,
without the help of any “catalyst”; on the other hand, this implies that there is neither
specificity nor the chance of preventing fusion of vesicles which should not fuse.
Biological membrane fusion is a far more complex process, requiring a large number of
proteins.  However, the three major players known at the moment are the Rab/Ypt proteins,
Sec1/Munc18 homologues (SM proteins) and proteins of  the SNARE family.  If the latter
give the force necessary for the fusion to proceed, the Rabs are thought to be the ones to
provide the specificity.  For intracellular fusion events, there are two model systems studied:
one is the yeast vacuole and the other is the mammalian synapse.
The use of vacuole system relies on the power of yeast genetics, enabling manipulation
of the proteins that are expressed in vivo and monitoring the results; moreover, there is an in
vitro assay for fusion that can be easily monitored (Ungermann et al., 1998).  The system is
based on two yeast strains; one strain is deficient in vacuolar lumenal proteases, while the
other one has the alkaline phosphatase gene deleted.  Hence, one cell will have a vacuole
containing pro-alkaline phosphatase, while the other one lacks the phosphatase, but has the
proteases required to process the proenzyme.  Upon fusion of vacuoles from both strains, the
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proenzyme is converted very fast to the fully active enzyme; the extent of the reaction can be
easily monitored.
The advantage of the mammalian synapse system is its ability to combine biochemistry,
(mouse) genetics and electrophysiology (which allows the real-time measurement of the
progress of the fusion reaction, thing not possible in the yeast system).  No matter how
different these two systems are, the conclusions one gets from investigating them are almost
the same, suggesting that common mechanisms are used for fusion in organisms as different as
fungi and superior mammals.  However, since the order of the events is different in synapse as
opposed to the vacuole system, I will refer here mainly to the yeast system.
The fusion process can be divided in three major steps: priming, docking and fusion.
Priming consists of different reactions rendering the vesicles “ready for fusion”.  During
docking, the primed vesicles attach to each other; this is followed by opening and extending a
fusion pore — the fusion itself.  The schematic drawing in Figure I-8 should help in following
these steps.
SNAREs are membrane proteins with high propensity for forming coiled-coil structures.
Although weakly conserved on the sequence level, they share a so-called “SNARE motif” of
about 60 aminoacid residues; these SNARE motifs mediate the assembly of SNAREs in the so-
called “core complex” during fusion.  This comprises an extremely stable coiled-coil structure
built from four α-helices. If all the members of the core complex are anchored to the same
membrane, the complex is called cis, while, if one member is on a different membrane, the
complex is called trans.  The term SNARE stands for soluble NSF attachment protein
receptor, where NSF is the abbreviation for N-ethylmaleimide-sensitive factor; this factor,
actually a protein, was proven to be an ATPase that, in conjunction with SNAP proteins,
breaks the coiled-coil structure of cis SNARE pair during the priming step.  According to the
SNARE hypothesis (Sollner et al., 1993), the assembly of the “core complex”, which consists of
SNARE molecules placed on both vesicle and target membrane (hence v- and t- SNAREs),
provides the necessary energy for bringing the lipid bilayers close enough so that the fusion
can occur.  However, SNAREs by themselves are not sufficient to provide specificity (Gotte &
von Mollard, 1998) and SNARE pairing is far from being either the only or the last step in
vesicle fusion (Price et al., 2000).
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Figure I-8: Schematic representation of the fusion events.  For the sake of simplicity, only Ypt and
the SNARE proteins were represented.  The coiled coil represented in the “SNARE
pairing” step is based on actual X-ray structure (with the exception of the yellow,
membrane-inserted fragments) and is reproduced from (Sutton et al., 1998).
Sec1/Munc18 proteins are a class of proteins about which very little is known.  It
appears that they interact with the Q-type of SNAREs (SNAREs bearing, in the middle of the
region responsible for the forming of the coiled-coil, a glutamine residue, as opposed to R-
SNAREs, bearing an arginine), also known as syntaxins.  Despite the fact that mutations in
yeast homologues of Sec1/Munc18 led to a complete block in fusion, apparently providing an
effect to be easily monitored, it is not yet clear how they act.  The fact that syntaxins cannot
simultaneously bind Sec1/Munc18 proteins and other SNAREs suggests that these proteins
might prevent premature formation of the core complexes in cis, giving them a chance of
forming trans, productive, complexes.
Ypt proteins are shown by different lines of evidence to be responsible for the specificity
of the fusion process (Lazar et al., 1997).  According to the current model (Ungermann et al.,
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1998), the docking event can be divided into the substeps of tethering, which is Ypt-dependent
and reversible and trans-SNARE pairing, which is irreversible. Tethering can be reversed by
simply diluting the vacuoles used in the fusion assay and continues even in excess of Sec18p
and Sec17p which (by the use of ATP) continuously disassemble the newly-formed trans
SNARE pairs, before these can accomplish their role.  It seems also that the GTP form (i.e.
“on”) of Ypt is necessary till the moment of SNARE pairing; after this step, the Ypt protein
can be switched “off” by either GTP  GDP hydrolysis or even physically removing it from the
membrane (in the GDP form) with the help of Gdi.  However, currently there are no clues
concerning the identity of the “Rab receptor” with which Rab proteins are supposed to
interact in the tethering step nor evidence on the exact molecular role played by the Ypt
proteins during the fusion.
I.4. The members of the Rab/Ypt Family in yeast
Results of different studies performed in vivo on yeast (mainly generation of
temperature-sensitive mutants) has led to the idea that the Ypt proteins can be divided in two
major categories: those which are essential for cell survival and those which are not.  The first
class contains Ypt1p, Sec4p and both Ypt31p and Ypt32p, while in the second class fall
Ypt51/52/53p, Ypt6p, Ypt7p, Ypt10p and Ypt11p.  (See also Figure I-9 for schematic
localization of each Ypt protein in the cell).
I.4.1. Ypt1p
The first Ypt/Rab to be discovered and classified as a GTPase was exactly Ypt1p
(initially termed Yp2p) (Gallwitz et al., 1983). Discovered during the analysis of the
surroundings of the actin gene, it was proven that its deletion is lethal for the yeast cell.
Further analysis showed Ypt1p to be involved in vesicular transport (hence the name
Yeast Protein Transport), more exactly in the step linking ER to Golgi. Blocking YPT1
expression or use of ypt1 temperature-sensitive mutants (Bacon et al., 1989; Jedd et al., 1995)
leads to severe trafficking defects between the endoplasmic reticulum and the Golgi apparatus.
This was proven both by EM studies, showing ER-derived transport vesicles of about 50nm in
diameter, as well as by realizing that the vesicles are mainly populated with proteins which are
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core-glycosylated, suggesting that they underwent only ER glycosylation but not maturation in
the Golgi cisternae.
Moreover, it seems that Ypt1p is also involved in intra-Golgi traffic, mainly cis- to
medial- compartments (Jedd et al., 1995) defining it as being essential for the first two steps of
the yeast secretory pathway.  However, since Ypt31/32p are also involved in intra Golgi traffic
(see below), it is understandable that overexpression of Ypt31/32p can partly rescue the
dominant lethal YPT1 mutations (Yoo et al., 1999).
Figure I-9: Schematic representation of a yeast cell and the trafficking steps controlled by different
Ypt proteins.  ER–endoplasmic reticulum; cGN–cis Golgi Network; mG–medial Golgi;
tGN–trans Golgi Network; eE–early endosome; lE–late endosome.  Secretory pathway is
marked in red, endocytic pathway is marked in green (from  (Lazar et al., 1997)).
I.4.2. Sec4p
Sec4p was discovered in a genetic screen for disorders in the secretory pathway
(Novick et al., 1980).  Five minutes after shifting the sec4-8 temperature-sensitive mutant (the
best characterized) from the permissive temperature to the non-permissive temperature, the
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cells start displaying a blockade of the transport of the invertase, corroborated with the
accumulation of vesicles as large as 100nm in diameter, filled with completely processed
secretory proteins.
Localization studies showed Sec4p to be distributed in three compartments: a large
pool was membrane-bound and associated with the plasma membrane, and smaller pools were
found to be either “soluble” or associated with secretory vesicles; sec4 temperature-sensitive
mutants were found to have the main Sec4p pool located on the secretory vesicles at non-
permissive temperature (Goud et al., 1988).  These two lines of evidence show that Sec4p is
involved in the last stage of the secretory pathway, namely Golgi to plasma membrane.
I.4.3. Ypt31p and Ypt32p
Search for Saccharomyces cerevisiae homologues of Schizosaccharomyces cerevisiae YPT3
gene yielded (with the help of a low-stringency hybridization protocol) two open reading
frames; by virtue of their significant sequence identity (81% at protein level), and conforming
to already-agreed rules  (Kahn et al., 1992), the newly-found proteins were termed Ypt31p and
Ypt32p (Benli et al., 1996).
Although disruption of either of them does not affect Saccharomyces cerevisiae,
disruption of both is lethal.  However, a more detailed study shows that depletion of Ypt31p
(which is believed to be the more abundant isoform) leads to accumulation of highly
glycosylated proteins in the cell, good proof that the intra-Golgi trafficking pathway is
hindered.  This is supported further by the finding that the majority of Ypt31p is found in
subcellular fractions enriched in Golgi marker-enzymes.  It is, however, not known in which
part of the intra-Golgi trafficking pathway these proteins are implicated: retrograde or
anterograde.
I.4.4. Ypt51p, Ypt52p and Ypt53p
These three isoforms were proven to be responsible for the endocytic delivery of the α
mating factor and the lucifer yellow CH (two endocytic markers) from the external medium to
the vacuole — yeast’s equivalent of the mammalian lysosome (Singer-Kruger et al., 1994).
There is evidence linking the delivery of Golgi-derived vesicles to the vacuole. Mutations in
the Ypt5 “family” also generate other defects, like problems in vacuolar protein maturation,
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partial missorting of vacuolar hydrolases, alterations in the morphology and acidification of the
vacuole.
Moreover, Ypt51p was previously discovered as Vps21p, where vps stands for “vacuolar
protein sorting [defects]”.  However, even triple-deletion mutants (Ypt51p, Ypt52p, Ypt53p)
are viable (under laboratory conditions), although the phenotype is markedly affected.
I.4.5. Ypt7p
The most striking phenotype achieved upon disrupting the YPT7 gene is the
fragmentation of the vacuole (Wichmann et al., 1992).  Cell-fractionation assays (Haas et al.,
1995a) localized the majority of Ypt7p on the membrane of the vacuole.
This vacuole fragmentation, in turn, leads, biochemically speaking, to a block of
maturation of some vacuolar enzymes, for example carboxypeptidase Y and alkaline
phosphatase, as well as problems in the degradation of the internalized α mating pheromone
(Wichmann et al., 1992).  This and other data suggest that Ypt7p is involved in late
endosome-to-vacuole transport as well as in the homotypic vacuole fusion  (Haas et al.,
1995b). This process is important for a phenomenon know as “vacuole inheritance”.  During
the division of Saccharomyces cerevisiae, many organelles —and the vacuole is among them—
become highly fragmented and a part of them is passed over to the daughter-cell.  At the end
of the division process, the organelles reassemble in both daughter– and mother– cell.  This is
the moment when homotypic vacuole fusion takes place: two small vacuoles have to fuse, in
order to generate a larger one and so on, till there is just one vacuole left in the cytoplasm, its
size being around 1/4 of that of the cell.
Using a vacuole in vitro fusion assay{Haas, Conradt, et al. 1994 229 /id}, Ypt7p was
shown to be required on both membranes (Haas et al., 1995b) and the distinct steps involved
in the Ypt7p-mediated vacuole fusion are partly resolved.  Currently available evidence shows
that fusion occurs in the ordered subreactions of priming, docking and fusion, docking being
further subdivided into two steps: the tethering and the SNARE  pairing  (Ungermann et al.,
1998). Newer results (Price et al., 2000) show that Ypt7p is the anchoring site for a 38S
complex that is involved in vacuole docking.  The main players in this complex are two
proteins named Vam2p/Vps41p  and Vam6p/Vps39p (in brief Vam2/6p) which are initially
bound to the cis SNAREs, as a part of a 65S complex.  After priming, catalyzed by Sec18p
(NSF) and Sec17p (α-SNAP), the 65S complex partly dissociates, forming a smaller, 38S,
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complex which has the ability to associate with Ypt7p, in a nucleotide-sensitive manner, i.e. it
binds to Ypt7p•GTP but not to Ypt7p•GDP.
This would mean that the 38S complex meets all the requirements of a Ypt effector,
adding it to the family of multiprotein effectors such as TRAPP (cis-Golgi transport protein
particle) (Sacher et al., 1998) and the exocyst  (Bowser et al., 1992; Kee et al., 1997). Further
experiments suggested that the Vam2/6p complex is present at the docking site and hence the
role of Ypt7p would be to keep this complex associated with the vacuolar membrane during
the tethering process, helping trans-SNARE pairing.
I.4.6. Ypt6p
Ypt6p null mutants manifest themselves also by a fragmented vacuole.  Other
ultrastructural modifications consist of the accumulation of vesicles of around 50nm diameter,
as well as some membrane-bounded structures 150…300nm in diameter (Tsukada & Gallwitz,
1996).  Other authors (Hengst et al., 1995) report immuno-fluorescence staining around the
Golgi apparatus.  It might therefore be conceivable for Ypt6p to function in a step involving
retrieval of the proteins in a late Golgi stage, perhaps the trans-Golgi network.
I.4.7. Ypt10p and Ypt11p
These two proteins were found in silico, after the sequencing of the yeast genome,
based on sequence-homology with other Ras-like GTPases (Maurer et al., 1995; Doignon et al.,
1993).  None of them could be assigned a role in the intra-cellular traffic scheme, since there
is no obvious phenotypic effect upon deleting/inactivating their corresponding genes.
Ypt11p is the most peculiar, being about 50% bigger than the other proteins (it
contains 355 aminoacids, in contrast to 200..220 for all the other Ypt proteins; see also the
alignment depicted in Figure I-1 on page 7); it is possible that Ypt10p and Ypt11p are products






Reagents for general use in the laboratory were purchased from Riedel-de-Haën
(Seelze, Germany). Enzymes for molecular biology experiments were purchased from
Pharmacia and New England Biolabs. Kits for molecular biology were purchased from Qiagen
(Hilden, Germany) or Macherei Nagel (Düren, Germany).
Acrylamide for SDS-PAGE was purchased from Applichem (Darmstadt, Germany).
Acetonitrile for HPLC was from JT Baker and was of HPLC grade.
Reagents for crystallography were purchased either from Fluka (Seelze, Germany) and
the pre-made screens (factorial or grid-screens) from Hampton Research (Laguna Niguel, CA,
USA).  PEG 3350 was, however, from Sigma (Taufkirchen, Germany).
MantGDP and mantGppNHp were sinthetized in MPI Dortmund by Andrea Beste.
Compounds for fluorescently labelling the proteins (N-(Iodoacetaminoethyl)-1-naphthyl-
amine-5-sulfonic acid (1,5 I-A-EDANS) and tetramethylrhodamine-5-iodoacetamide dihydro-
iodide (5-TMRIA)) were obtained from Molecular Probes Europe (Leiden, The Netherlands).
MALDI matrices (sinapinic acid (3,5-Dimethoxy-4-hydroxy cinnamic acid) for
proteins and CHCA (α-cyano-4-hydroxycinnamic acid) for peptides) were from Sigma.
CHCA was recristallized from ethanol in house.
II.2. Materials
PCR reactions were performed using a PE 9700 thermocycler from Applied Biosystems
(Weiterstadt, Germany), while sequencing was performed using the BigDye™kit from the
same company; the sequencing products were analyzed by a ABI Prism 373XL machine, also
from Applied Biosystems, run by a core facility.
Protein purification was usually performed on Waters 650 system (Millipore, Eschborn,
Germany), using Pharmacia columns for Ni2+ affinity purification, as well as for gel filtration.
Ni2+ resin was also obtained from Qiagen.  The ion-exchange protocols were optimized using a
BioCad Perfusion Chromatography workstation (PerSeptive Biosystems, Weiterstadt,
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Germany) and Poros resins, from the same supplier.  The same Poros resin was used in the
scaled-up protocol.
Proteins were concentrated in devices (Microcon, Centricon and Centriprep) from
Millipore (Eschborn, Germany).  Other system for concentrating or dializing the proteins was
the “ultrathimble” from Schleicher&Schuell (Essen, Germany).
The HPLC columns were supplied either by Bischoff (Leonberg, Germany) or by
Phenomenex (Aschaffenburg, Germany).  The HPLC system used for isocratic conditions was
from Latek (Eppelheim, Germany) with a Shimadzu data recorder and integrator, while for
gradient methods Beckman System Gold (Krefeld, Germany) or Waters 600s HPLC
(Millipore, Eschborn, Germany) were used.
Linbro 24-well crystallization trays, as well as all the other equipment for crystal
handling were from Hampton Research (Laguna Niguel, CA, USA).  The in-house X-ray data
collection was composed from an Enraf-Nonius 591 rotating anode (Delft, The Nederlands)
with mirror optics and a MAR345 (X-ray Research GmbH, Norderstedt, Germany) image
plate detector.  Crystals were cryocolled using Oxford Cyrosystems 600 Series (Oxford, UK).
Long time base fluorescence spectra were aquired on a AMINCO SLM 8100 spectro-
photometer (Silver Spring, MD, USA), while stopped flow experiments were performed in a
High Tech Scientific SF61 apparatus (Salisbury, UK).  Primary data analisys was performed
with the help of the sowftare provided with the machine.  Secondary data analysis was
performed with the program Grafit 3.0 (Erithacus Software, Surrey, UK).  Competitive
titration data interpretation and global fitting were performed with Scientist 2.0 (Micromath,
Salt Lake City, UT, USA).
The MALDI-TOF apparatus used for mass spectrometry analysis was Voyager DE Pro
(PerSeptive Biosystems, Weiterstadt, Germany).  Data was first evaluated in the Data
Explorer v3.5 software provided with the machine.  The centroid calculations were done in a
custom Excel (Microsoft, Redmond, VA, USA) worksheet.
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II.3. Bacterial strains used
Strains used for cloning:
XL1-Blue RecA1, endA1, gyrA96, thi, hsdR17(rK–, mK–), supE44, relA1,
lac, [F’, proAB+, lacIqZ∆M15, ::Tn10(Tetr)
DH5α Φ80dlacZ∆M15, recA1, endA1, gyrA96, thi-1, hsdR17(rK–,
mK
–), supE44, relA1, deoR, ∆(lacZYA-argF)U169
Strains used for expression:
BL21(DE3) E. coli F– ompT, hsdSB, (rB– mB–) dcm, Tetr gal, dcm, λ(DE3)
BL21-CodonPlus(DE3)-RIL: E. coli B F– ompT, hsdSB, (rB– mB–) dcm, Tetr gal, dcm,
λ(DE3), Hte, [argU ileY leuW Camr]
II.4. Protocols
II.4.1. Growth and storage of bacterial stocks
Bacteria were tipically grown at 37˚C (some expression protocols required lower
temperatures), with antibiotics, where appropriate.  Typical antibiotics concentrations used
were 100µg/ml ampicillin, 35µg/ml chloramphenicol, 30µg/ml kanamycin.  Media were
sterilized by autoclaving at 121˚C for 20 minutes.  Thermolabile compounds (such as
antibiotics) were added as sterile-filtered solutions.
For stock preparation, a log-phase culture (OD600≈0.7) was 1:1 diluted with a solution
of 40% (v/v) sterile glycerol in an Eppendorf tube and snap-frozen in liquid nitrogen.  The
Eppendorf tube was kept at –80˚C.  When needed, the tube was removed from the freezer,
scratched at the surface with a Pt loop and placed again in the freezer, care being taken not to




Cloning was performed as described in  (Sambrook et al., 1989).  Restriction digestion
of DNA was performed in concordance with the instructions supplied with the restriction
enzyme.  Usually, about 0.5..1µg of DNA was digested with about 10U (supplier’s definition)
of restriction enzyme(s).  Resulting restriction fragments were separated in agarose gels.
Gel electrophoresis of DNA fragments was performed either in agarose or in low
melting point agarose (for gel extraction) 0.75..1% with ethidium bromide (0.1µg/ml); the gels
were run submerged in TAE buffer at 10V/cm.  The desired bands were extracted from gel
using kits from Qiagen.
For ligation, the relative amounts of vector and insert were estimated from the
intensity of the bands as seen under UV light after staining with ethidium bromide and a 5
fold excess of insert over plasmid was used.
II.4.2.b. Preparation of electrocompetent bacteria
• Make an O/N culture
• Dilute 1/100 (v/v) the preculture in 500ml of fresh LB- <antibiotic>
• Incubate till OD595≈0,7
• Pellet the cells (≈1500-2000x g, 15’)
• Wash in 500 ml MilliQ water, sterile, cold
• Pellet
• Wash in 500 ml MilliQ water, sterile, cold
• Pellet
• Wash with 20 ml of 10% (v/v) glycerol
• Pellet
• Resuspend in 2 ml 10% glycerol
• Aliquot as 50µl; snap-freeze and store at -80ºC
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II.4.2.c. Electroporation transformation
For electroporation transformation, ≈50µl of electrocompetent bacteria were added in
an ice-cooled cuvette.  DNA was added (in a volume not exceeding 10µl and about 10ng
DNA) and a 1.8kV pulse was applied, using a BioRad E.coli pulser.  Subsequently, the cells
were resuspended in 1ml of warm LB media and incubated with shaking (200rpm) at 30˚C for
1hour; after this time, the cells were plated on Petri plates with LB-Agar supplemented with
the appropriate antibiotic(s).
II.4.2.d. Preparation of DMSO-competent bacteria
• Grow a 5ml inoculus o/n in LB at 37°C
• Next day innoculate 100ml SOB with the o/n inoculus and grow it to OD600=0.6 at 30°C
• Chill cells 10-20 minutes on ice
• Spin cells down at 4°C (10-15min at 4000x g)
• Gently resuspend in 25ml TB and incubate 10 minutes on ice
• Spin gently at 4°C (15min at 3500 x g)
• Resuspend in 4.65ml TB and add 0.35ml DMSO
• Aliquote as 50-100µl and shock-freeze
Solutions:
SOB: LB + 10mM MgSO4 + 10mM MgCl2
10x TB: 2.38g HEPES + 18.6g KCl + 15ml 1M CaCl2; add to pH 6.7 with KOH and add
10.88g MnCl2·4H2O.  Add water to 100ml. Filter sterile
II.4.2.e. Transformation in DMSO-competent bacteria
• Thaw DMSO competent cells on ice.
• Add 100ng of circular plasmid to 50µl cells.
• Incubate 5-10minutes on ice.
• Heat shock 60seconds at 42°C
• Resuspend in 1ml LB and grow in the shaker 20-60minutes
• Plate on plates with the appropriate antibiotic
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II.4.2.f. Sequencing of DNA using the BigDye terminator kit
• Prepare a sequencing mix as follows:
BigDye Premix 8,0µl
DNA Template 0,5µl (500ng)
Primer 0,5µl (3-10pmol)
Dist. water ad 20,0µl
• Run 25 cycles as follows: 15" at 96 °C, 10" at 50 °C (or appropiate Tm), 3' at 60 °C
• Purification:
add 1µl Dextran blue (colour and pp of DNA)+ 2µl AcONa 3M, pH 4,6 + 50µl 100%
EtOH (ice cold both)
Incubate 20’ on ice
20’ at max speed in a cool centrifuge (12-14.000 x g)
Wash 2-3 times w/ 75% EtOH (get rid of ddNTPs, salt)
Dry (SpeedVac)
• Send it to the in house sequencing facility.
II.4.2.g. PCR-screening of colonies
• Pick colonies using a sterile toothpick.   Thoroughly rub the toothpick against the bottom
of a PCR Eppendorf vial, after that against a small area of an LB-Antib. agar plate.
• Set up the following PCR mix:
For ONE colne
Taq 10x Buffer 1.25µl
dNTPs 0.25µl
Primer 1 (32pmol/µl) 0.16µl
Primer 2 (32pmol/µl) 0.16µl
DW ad 12,5ul 10.56µl
Taq Polimerase 0.12µl
Total volume 12.50µl
(multiply by no. of clones+1, make the mix and distribute 12,5µl in each
Eppendorf)
• Run the PCR protocol:3’ at 96°C, 25× (20" at 96°C, 30" at 50°C (or appropiate melting
temperature), 40" at 72°C),∞ at 4°C
• Load the PCR products on the gel
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II.4.3. Protein methods
II.4.3.a. Expression and purification of wildtype and mutants/truncants of
Ypt7p
• Transform pET11aYPT7 in E.coli BL21(DE3)cells.  Select on LB-Amp 125mg/l plates.
• Grow an O/N preculture (25ml), spin the cells down, wash with fresh media and inoculate
it into 5l of LB-Amp. Grow to OD600 ≈0.8 at 37°C.
• Induce with 0,4mM IPTG (final concentration) and continue growth at 37°C for 5 hours.
• Spin down the cells.  Resuspend in lysis buffer.  Run twice through the fluidizer.  Clear
the lysate by ultracentrifugation (min. 30min @100.000xg). Filter through ZapCaps or similar.
• Load on a Q-Sepharose column (column volume ≤400ml) preequilibrated with buffer
IExA; wash the column with the same buffer.  Elute with linear gradient of 50..450mM NaCl
in 6.5CV.  YPT7 will elute around 150-200 mM NaCl.
• Do an SDS-PAGE to identify the fractions which contain YPT7.  Pool them and add
ammonium sulphate till 70% saturation (0,472g/ml).  Pellet 20-30min @ 10.000xg in Falcon
tubes.  Resuspend in gel-filtration buffer.
• Run gel-filtration on a Superdex G75 column preequilibrated with gel-filtration buffer.
Flow rate ≤0,75ml/min. Identify fractions containing YPT7 by SDS-PAGE.  Concentrate and
snap-freeze.
Solutions used:
Lysis buffer: 20mM TRIS pH 8.0, 10mM MgCl2, 1mM NaN3, 1mM PMSF, 1% Triton
X100, 5mM DTE
IExA: 20mM TRIS pH 8.0, 50mM NaCl, 5mM DTE
IExB: 20mM TRIS pH 8.0, 500mM NaCl, 5mM DTE
Gel-filtration buffer: 20mM TRIS pH 8.0, 150mM NaCl, 10mM MgCl2, 5mM DTE,
25µM GDP
II.4.3.b. Expression and purification of Ypt31p
• Transform pET3aYPT31 in E.coli BL21(DE3) cells.  Select on LB-Amp 125mg/l plates.
• Grow an O/N preculture (25ml), spin the cells down, wash with fresh media and inoculate
it into 2l of LB-Amp. Grow to OD600≈0.8 at 37°C.
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• Induce with 0,4mM IPTG (final concentration) and continue growth at 37°C for 5 hours.
• Spin down the cells.  Resuspend in lysis buffer.  Run twice through the fluidizer.
• Centrifuge at 100.000 x g, filter the supernatant through a ZapCap.
• Load on a Poros HQ column (10ml or more) preequilibrated with buffer 95%IexA +
5%IexB (100mM NaCl); wash the column with the same buffer till stable baseline.  Elute with
a gradient of 100 to 500mM NaCl in 20 column volumes (5%IExB to 25%IExB).  YPT31 will
elute around 250-300mM NaCl.
• Do a SDS-PAGE to identify the fractions that contain YPT31.  Pool them and add
ammonium sulfate till >80% saturation (0,6 g/ml).  Pellet 20-30min @ 10.000xg in Falcon
tubes.  Resuspend in minimal volume of gel-filtration buffer.
• Run gel-filtration on a Superdex G75 column preequilibrated with gel-filtration buffer
(elution volume is approx. 150-160ml for a 26/60 column).  Flow rate ≤0,75ml/min, collect
2ml fractions. Identify fractions containing YPT31 by SDS-PAGE. Concentrate and
snap-freeze.
Solutions used:
Lysis buffer: 20mM TRIS pH 8.5, 2mM MgCl2, 20mM NaCl, 1mM NaN3, 1mM PMSF,
2mM βME
IExA: 20mM TRIS pH 9.0, 2mM βME, at least 1l
IExB: 20mM TRIS pH 9.0, 2M NaCl, 2mM βME
Gel-filtration buffer: 20mM TRIS pH 8.0, 40mM NaCl, 5mM MgCl2, 5mM DTE,
25µM GDP
II.4.3.c. Expression and purification of yeast GGTaseII
• Transform BL21 (DE3) with plasmids pGATEVmod/Bet2 (#187) and pBCUC-MAD2
(#59) (either in two steps or in one step).
• Pick one colony, let it grow in 50ml LB-Amp125+Kn35 O/N at 37°C.  In the morning
pellet the cells, resuspend in fresh media, repellet and resuspend in 5ml and inoculate in 5-10l
(100-200µl/1l).
• Grow @37°C till OD600≈0.7-0.8
• Reduce temperature to 20°C and induce with 100µM IPTG.  Grow them over night.
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• Pellet and lyse the cells (with the fluidizer) in “Bug Buffer” with 1mM PMSF, 2mM
β−mercapto ethanol.
• Spin them down 45' at 30.000 rpm in a Beckman Ti45 rotor.
• Filter the SN through a ZapCap and load the flow-through on a 20ml Hi-Trap Ni column
preequilibrated with Bug Buffer with 9mM Imidazole.
• Wash the column with “Bug Buffer” + 9mM imidazole until you get back to baseline
(approx 150ml) at a flow rate of 3ml/min.
• Elute in a gradient of 9mM to 300mM imidazole in “BugBuffer” in 120ml at 3ml/min.
Collect 1.5ml fractions.
• Run SDS-PAGE and identify the fractions of interest (approx. 200mM imidazole).
• Cleave the HIS-tag with TEV protease: to the pooled fractions of protein, add EDTA to
0.2mM (TEV is inhibited by M2+ ions) and add TEV protease to 1:20 mol/mol (approx 0.9mg
TEV for 60mg protein).  Incubate O/N at 4°C.
• In the morning, add MgCl2 to 2mM in the mixture (to block EDTA that would chelate
Ni2+ from the column).  Load the cleavage mixture on Ni2+ column equilibrated with “Bug
Buffer”.  Collect the flow-through.
• Concentrate the flow-through: use a CentriPrep MWCO 30kDa (clear base) and spin it to
1500 x g.
• Gelfiltration: equilibrate a G200 26/60 preparative column with gel filtration buffer.
Load the concentrated protein (≤ 4ml) and run it at a flow rate of 0.75-1.0ml/min.
• Identify the peaks by SDS-PAGE (the second one is Bet2 alone).  Concentrate the protein
to around 8mg/ml or above, aliquote and snap-freeze it.
Solutions used:
“Bug Buffer”: 50mM NaPi pH8, 300mM NaCl
Gel filtration buffer: 25mM HEPES Na, 25-50mM NaCl, 5mM DTT
II.4.3.d. Expression and Purification of untagged Mrs6p
• Transform pET30b(+)—MRS6 into BL21(DE3) cells and select on LB-Kan (50mg/l)
plates.
• Grow a preculture (50ml), spin the cells down, wash with fresh media and inoculate it into
5l of LB-Kan. Grow to OD600≈0.7.
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• Place on ice and induce with 0.1mM IPTG (final conc.).  Grow 6h at 18°C.
• Harvest cells by centrifugation and wash once in PBS.   Resuspend the cells in
“BugBuffer”. Brake cells with fluidizer twice.   Add a new portion of PMSF. Clear lysate at
40.000 x g 1h at 4°C in a Ti45 rotor.
• Add solid ammonium sulphate to 25% saturation. Centrifuge at 12.000rpm 20-30min 4°C
in a Beckman JA12 rotor. Discard the pellet. To the supernatant add solid ammonium
sulphate to 40% saturation. Centrifuge again.  Resuspend the pellet in 100ml of 50mM TRIS
HCl pH 7.2, 10mM β mercapto-ethanol.   Centrifuge again as above (to eliminate insoluble
material).
• Subject supernatant to anion exchange chromatography on 20ml PorosHQ column,
equilibrated with buffer IExA. Flow rate is 5ml/min.  Wash the column with buffer IExA
containing 50mM NaCl.
• Elute protein with following gradient: (buffer IExA plus) 50 to 400mM NaCl in 10CV and
5CV of 500mM NaCl.  Collect 5ml fractions.   Run SDS-PAGE to identify fractions.
• Dyalize O/N against buffer IExB.
• Load the protein on a PorosHS 10ml column equilibrated with buffer IExB at the flow rate
of 5ml/min.   Collect flow-through.   Run SDS-PAGE to identify fractions.
• Precipitate with ammonium sulphate to 40% saturation. Centrifuge at 12.000rpm 20-
30min 4°C in a Beckman JA12 rotor. Resuspend in 5ml of gel-filtration buffer. Centrifuge as
above to eliminate the insoluble material.
• Load on a Superdex G200 26/60 column preequilibrated with gel-filtration buffer.  Flow-
rate: 1ml/min.  Run SDS-PAGE.
• Concentrate and snap-freeze.
Solutions used:
“BugBuffer”: 50mM NaH2PO4/Na2HPO4 pH 8.0, 0.3M NaCl, 1mM PMSF, 10mM β
mercapto-ethanol
Buffer IExA: 50mM TRIS HCl pH 7.2, 10mM β mercapto-ethanol
Buffer IExB: 25mM TRIS HCl pH 8.6, 10mM NaCl, 10mM β mercapto-ethanol
Gel-filtration buffer: 25mM HEPES pH 7.2, 25mM NaCl, 10mM DTE
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II.4.3.e. Nucleotide exchange using alkaline phosphatase
• This method is appropriate just for non-hydrolyzable nucleotide analogues.  The success of
the protocol depends on using alkaline phosphatase, calf intestinal and not E.coli, since the
latter is able to break diphosphate or triphosphate linkages.
• Equilibrate a buffer exchange column (NAP5/ NAP10/ PD10) with NE buffer by filling
the column three times.
• Load 300µl GTPase (approx 80-100nmoles) onto the column in no more than Vmax
sample.
• Add NE buffer up to the difference between Vmax sample and the sample volume; let it sit
at RT for 5 minutes.
• Elute the column with Velute buffer.
• Collect the protein and add 2…4 times molar excess of non-hydrolyzable nucleotide
analogue.
• Run a sample on HPLC to check the molar ratio.
• Add 5U of alkaline phosphatase for each mg of protein.
• Incubate at RT for about 40 minutes.
• Check the hydrolysis extent by HPLC.  If everything is ok:
• Load another buffer exchange column, preequilibrated with NE buffer with the protein
solution.  Repeat steps 3 and 4 but this time collect fractions (3-4 droplets).  Check each
fraction by Bradford.
• Repeat steps 5 to 9 if this is the case (try to have more 95% nucleotide exchanged).
• Add MgCl2 to 10mM, in order to stabilize the protein.  Run the mixture through a column
equilibrated with final buffer.  Keep sample volume smaller than Vmax sample.
• If necessary, add final buffer up to the difference between Vmax sample and the sample
volume; let it sit at RT for 5 minutes.
• Elute the column with Velute buffer.
• Concentrate, measure the protein concentration (both Bradford and nucleotide




• Gradient of 0 to 65% HPLC-B in 13 minutes on a C18 column 250×4.6mm
equilibrated with HPLC-A, flow rate is 1.5ml/min.  Go back to 0%HPLC-B in 2 min
and hold it for 10min.  Detection at 254nm.
Isocratic mode
• Flow rate 1…1.5ml/min on an isocratic machine with IsoA buffer.  Also on C18
column.  Detection at 254nm.
Solutions used:
NE buffer: 50mM HEPES 7.2, 3mM DTE, 5mM EDTA
Final buffer: 50mM HEPES 7.2, 3mM DTE, 5mM MgCl2
HPLC-A: 50mM KH2PO4/K2HPO4, pH 6.5
HPLC-B: 50% HPLC-A 50% CH3CN
IsoA: 10mM tetra-n-butyl ammonium bromide, 100mM KPi pH 6.5, 8%CH3CN.
Degas all buffers prior to use!!
II.4.3.f. Nucleotide exchange using EDTA
• This method is usable for any nucleotide substitution; it relies on the ability of EDTA and
SO42- ion to decrease the affinity of the G protein for the nucleotide.
• Equilibrate three columns (NAP 5) with buffer A.
• Load 300µl GTPase (approx 80-100nmoles) onto the column in no more than 500µl.
• Add buffer A to make up the difference between 500µl and the sample volume; let it sit at
RT for 5 minutes.
• Eluate the column with 1ml buffer A.
• Collect the protein and add 10× molar excess of desired nucleotide and EDTA to 10mM
final concentration.
• Incubate at RT for 40 minutes.
• Reload the column and re-add nucleotide and EDTA.
• Repeat steps 6 & 7.
• Run through a buffer-exchange column equilibrated with buffer B.
• Remove the excess of nucleotide by passing through a NAP5 column pre-equilibrated with
buffer B.
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• Concentrate, measure the protein concentration (both Bradford and nucleotide
concentration) and snap-freeze it.
HPLC ANALYSIS
CH3CN gradient
• Gradient of 0 to 65% HPLC-B in 13 minutes on a C18 column 250×4.6mm
equilibrated with HPLC-A, flow rate is 1.5ml/min.  Go back to 0%HPLC-B in 2 min
and hold it for 10min.  Detection at 254nm.
Isocratic mode
• Flow rate 1.5ml/min on an isocratic machine with IsoA buffer. Detection at 254nm.
Solutions used:
Buffer A: 50mM HEPES 7.2, 3mM DTE, 5mM EDTA
Buffer B: 50mM HEPES 7.2, 3mM DTE, 2mM MgCl2
HPLC-A: 50mM KPi pH 6.5
HPLC-B: 50% HPLC-A 50% CH3CN
IsoA: 10mM tetra-n-butyl ammonium bromide, 100mM KPi pH 6.5, 8%CH3CN.






Many biochemical experiments reveal different properties of the proteins being
studied: specificity, ability to interact in a certain manner with some partners but not with
other etc.  These observations determine the start of a wealth of other biochemical
experiments trying to pinpoint areas or even residues important for the observed functions.
But the best and most convincing evidence can, usually, come from actually seeing how the
structure of the protein looks.  Eventually, in combination with structural analysis of different
mutants, this can provide ultimate answers to questions regarding the specificity and the
reaction mechanism.
Currently there are two main ways of determining the atomic structure of a protein:
X-ray diffraction and nuclear magnetic resonance (NMR) spectroscopy.  The main advantage
of NMR is that it uses molecules in solution, so it is not limited to those proteins that
crystallize well.  This is a great advantage over the X-ray method, in which the sample has to
be in the form of a crystal, sometimes extremely difficult to obtain, sized at least
50×50×50µm3.  On the other hand, the usual methods limit the NMR to solving structures
of proteins that are smaller than ca. 40kDa.  Protein crystallography, on the contrary, does not
have any size limitations: very large proteic complexes such as virus capsids (Tsao et al., 1991),
RNA polymerase (Cramer et al., 2001), the photosystem I (Jordan et al., 2001) and even
ribosomes (Ban et al., 2000; Wimberly et al., 2000), to name just the biggest and most
impressive, were crystallized and their structures solved at atomic resolution.
Two of the “small G protein” family members were crystallized fairly early, the
ribosomal elongation factor EF-Tu  (Jurnak, 1985; Berchtold et al., 1993) elongation factor
and the oncogenic product H-Ras p21 (de Vos et al., 1988; Pai et al., 1989; Schlichting et al.,
1990).  This led to a better understanding of the processes underlying their capacity to act as
“molecular switches” and to speculate about the way they hydrolyze GTP to GDP, although
the fine details of the mechanism are even now not perfectly understood.  Some of the
problems can be addressed using molecular modeling might be a good tool, but this approach
is still very much dependent on the correctness of the sequence alignment and it cannot
accurately model neither insertions in loops nor N- and C-terminal extensions.  All the
currently known 700  members of the “small G proteins” family share a fairly high sequence
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homology, but there are small differences in their structures.  Exactly these differences enable
them to perform different functions through interactions with different partners, in a word,
confer them specificity.
The Ypt family consists, in the yeast Saccharomyces cerevisiae, of eleven members
(Gotte et al., 2000), controlling all the vesicular transport pathways in the cell.  What is so
striking in the family, and is even more pronounced compared to other proteins, is the
specificity of the members.  Every single member of the family interacts with certain common
proteins (the constituents of the prenylation machinery and Gdi1p), whereas they remain
extremely specific in the interaction with other proteins.  For example, TRAPP interacts
specifically with Ypt1p (Wang et al., 2000), and not with other partners.  Other proteins (such
as the GTPase activating proteins, Gyp) have a broader specificity spectrum, still
distinguishing between different members of the family.  For example, Gyp7p is able to
stimulate the GTPase activity of Ypt7p, as well as the activity of Ypt31/32p and Ypt1p (albeit
to a lower extent), but it does not interact with Sec4p or Ypt6p.  These variations arise in
both the GTP- as well as the GDP- bond states of the proteins.
Despite different sequence analyses, some of them very sophisticated (Pereira-Leal &
Seabra, 2000), the significant differences outlined above cannot be explained simply based on
sequence differences between the members of the subfamily.  This stresses the need for high-
resolution structural information on a number of the members of the family.
Ypt7p is a member of the Ypt family (see also Section I.4.5) involved in the fusion
machinery implicated in late endosome-to-vacuole transport and homotypic vacuole fusion.
Together with Ypt51p and Ypt52p and Ypt53p, it is involved in the endocytic pathway, but
YPT7 mutants behave differently from the YPT5X mutants, showing that they have different
roles and that interacting partners can distinguish them reasonably well.  Also, these
interacting partners are able to recognize and bind Ypt7p in one of the two states: GTP- or
GDP-bound; this is the case for Gdi1p, which can bind significantly better the GDP form, or
the case for Gyp7p, Gyp1p and effectors which bind more strongly the GTP form.  It is clear
that the structural modifications arising from GTPGDP hydrolysis have deep consequences.
At the time this work was started, there was no Rab / Ypt structure available and there were
only speculations on what changes the GTPGDP transitions would involve, suppositions
based mainly on the high similarity with H-Ras p21.  One of the purposes of this work was to
crystallize Ypt7p, if possible in both forms (complexed with GDP and a non-hydrolyzable GTP
49
analogue) and to characterize it, together with the structural changes which accompany the
GTPGDP transition.
III.2. Crystallization and model building for Ypt7p∆C10
III.2.1. Design of Ypt7p for crystallization studies
For crystallization of Ypt7p, it was decided that a C-terminal truncation would be
advantageous.  This decision was based on previous results with H-Ras and structural studies
performed on canine Rab7, the homologue of Ypt7p.
Crystallization attempts on H-Ras were successful only after a C-terminal truncation
was performed (Ras p211-166); it was shown that this truncation by 23 aminoacids does not
influence neither the G domain structure nor its biochemical properties (John et al., 1989).   A
second indication came from investigations performed on Rab7.  It was shown by NMR
studies that the last 25 residues of Rab7 are not structured in solution (Neu et al., 1997). The
study by Neu et al. showed that: i) approximately the last 25 residues at the C-terminus were
flexible and ii) nucleotide binding and hydrolysis kinetics were not affected by the truncations.
Point i) suggests a potential hindrance to crystallization, while point ii) guarantees that the
crystal structure will not reflect artifacts induced in the active site or important loops by the
truncation at the  C-terminus.  On the other hand, crystallization studies (Brachvogel et al.,
1997) showed that a 10 residue C-terminal truncation of Rab7 yielded better-quality crystals
than a 25 residue C-terminal truncation.  Based mainly on the Rab7 results and the high
homology between it and Ypt7p (62% identity, 75% strongly similar), the decision was taken
to shorten the C-terminus of Ypt7p by 10 residues.
In order to obtain this Ypt7p truncation, PCR with degenerated primers was performed
on the original plasmid pET11a YPT7 (kindly provided by Dr. Dieter Gallwitz, Göttingen).
The 5’ primer was the standard T7 promoter primer (Novagen catalogue no. 69348-3) and the
3’ primer had the sequence 5’-ATTTTCGGATCCTTAGCGAATA-3’, containing a BamH I
restriction site (bold) and a STOP codon (underlined). Both the amplicon and the
pET11aYPT7 vector were cut with Nde I (recognition site of which contains the START
codon for YPT7) and BamH I  and ligated together.  The vector obtained in this manner was
called pET11a YPT7∆C10.  The protein encoded by this vector will be referred to as
50
Ypt7p∆C10 and was purified by a two step protocol, involving ion exchange and gel filtration
(see the protocol described in section II.4.3.a, at page 39 for details).
III.2.2. Crystallization of Ypt7p∆C10 and improvement of the
crystals
As structural results with other GTPases have already shown, in the GTP form, the
loops L2 and L4 are kept in place by interactions between their amide hydrogen and the γ
phosphate of the GTP.  In the GDP case, these loops become extremely flexible, thus
hindering the crystallization.  Because of this, and since one of the purposes of this work was
to find out differences between the GTP- and GDP- bound states, a pool of Ypt7p∆C10 was
loaded with the non-hydrolyzable GTP analogue GppNHp (5P-guanosyl-β-γ-imido-
triphosphate).  This analogue, utilized also for the crystallization of p21 Ras, has a
stereochemistry very similar to that of GTP and can still participate in H-bonding contacts
with its β-γ NH, as opposed to GppCH2p.  The protocol used for nucleotide exchange (see
Section II.4.3.e) is based on the phosphatase activity of calf intestinal phosphatase, which can
convert GTP and GDP to GMP and then guanosine, while not being able to hydrolyze the
pNHp linkage efficiently.
Using multifactorial crystallization screens (Jancarik & Kim, 1991) crystals of
Ypt7p∆C10•GppNHp appeared under the following conditions: 0.1M TRIS pH 8.0, 2M
(NH4)2HPO4, 20˚C.  Crystals obtained under these conditions were still too small for
diffraction experiments, so optimization was necessary even for the first tests.  A remark has to
be made: in incomplete factorial screens (like the Jancarik and Kim), there is no
“optimization” of the conditions based on the chemical knowledge.  In this particular case,
one has to note that the pH of the reservoir (and of the crystallization drop) is dictated not by
the 0.1M TRIS, but by the 2M (NH4)2HPO4 and that small pH modifications have to be done
by altering the pH of the ammonium phosphate solution.  Two approaches were used for
improving the quality of the crystals in a first phase: variation of the pH and salt
concentration on the one hand and seeding on the other.  Seeding (in this case microseeding)
is performed with the purpose of lowering the activation energy for forming crystals.
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Figure III-1: One of the first crystals of Ypt7p∆C10•GppNHp.  Colors are different due to polarization
filters.  Crystals are about 100-120µm on the longest dimension.
In a vapor diffusion crystallographic setup, a droplet is prepared by mixing (usually equal
volumes of) protein sample and precipitant.  The droplet is suspended over a reservoir
containing the same solution of the precipitant.  Hence, at the start of the experiment, the
precipitant concentration in the droplet is just ½ of the concentration in the reservoir
(protein concentration is rarely above 1mM, which means roughly 20mg/ml for Ypt7p, while
precipitant concentration is in the molar range for any salt used).  Because the system will
tend to equilibrate, water vapors from the droplet will diffuse towards the reservoir.  However,
since the reservoir volume is about 300-500 times bigger than that of the droplet, the effect
will be slow shrinkage of the droplet and thus slow concentration of protein and precipitant.
Figure III-2: Schematic representation of a vapor diffusion setup in “hanging drop” geometry.
The crystals obtained (see Figure III-1) showed dendritic growth (a tree-like disorder at
the growing end), usually a sign of disorder caused by a too fast growth.  In the case when the
precipitant used is salt, equilibration is completed to more than 90% in about 25 hours (Mikol
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et al., 1990).  On the other hand, the rate-limiting step in crystallization is the appearance of a
critical nucleus; this nucleus can appear only in suprasaturated states, relatively far from
equilibrium.  By seeding, the critical nucleus is provided “from the exterior” and crystallization
can start earlier in time, at a state of lower supersaturation.  In turn, this means that the
crystallization process will be slower (the driving force for the crystallization will be smaller),
resulting in a higher chance of forming well-ordered crystals.  A second advantage of seeding
is that by doing serial seedings one can try to control the number of crystals which will appear
in a droplet.  The fewer crystals, the bigger they will have the chance to grow, since all the
proteic material available for crystallization will be used to grow fewer crystals.  This mixed
approach worked (although not extremely well), yielding crystals of type shown in Figure III-3.
They were bigger, but still manifested the same dendritic growth defect.  On a very intense
beamline, like the microfocus beamline ID13 at EMBL/ESRF Grenoble, their regular “stem”
was able to diffract up to a Bragg d spacing of 2.1Å.
Figure III-3: Crystal of Ypt7p∆C10•GppNHp.  Conditions, in this case, were:
2.2M (NH4)2HPO4, 0.1M TRIS, pH 8.5, 18˚C.  The stem is about
80×80×150µm3.
Considering that it would be helpful to obtain Ypt7p∆C10•GppNHp crystals of better
quality and bigger size, I tried a different approach.  The crystals seem to be extremely
sensitive to temperature.  Although it is not uncommon for proteic crystals to be affected by
changes in the temperature (which drives changes in the solubility of the protein, not always
in a predictable direction), the sensitivity of Ypt7p∆C10•GppNHp crystals was extreme:
variations of 5˚C were able to trigger their complete dissolution.  This unusual sensitivity was
exploited in the following way: setups were prepared as usual at 20˚C with a reservoir solution
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consisting of 1.9M (NH4)2HPO4, 0.1M TRIS, pH 9.0, 2mM L-Cys, left to equilibrate and
crystals to form.  Once crystals appeared (with the already-known defects), the setup tray was
moved to a 15˚C incubator, with a temperature buffer (dummy plates) to prevent
condensation and rapid temperature changes.  After 48 hours, all the crystals were completely
dissolved.  Then, the plate was shifted back to 20˚C, with the same temperature buffer, so
that the change in temperature will take place over days, and left completely still for several
days.  This approach yielded crystals measuring about 125×125×1250µm3 with no visible
defects (Figure III-4).  Unfortunately, bigger is not always better.  The diffraction pattern of
these crystals showed increased mosaicity, due most probably to handling problems.  Crystals
of this size present two major difficulties: they tend to bend relatively easily when collected in
a cryo-loop and freezing such a large crystal fast enough that only amorphous ice is formed
becomes a problem.
Figure III-4: Crystal of Ypt7p∆C10•GppNHp obtained by temperature-induced
“recrystallization”.  One mark on the scale corresponds to 25µm.
The data set collected at the beamline ID13 (see data collection statistics in Table III-1)
could be indexed in the space group P6.  However, systematic absent reflections suggested
that the real space group also contains a screw axis.
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Area detector MAR CCD
Wavelength 0.782Å
Space group; cell dimensions P61; a = b = 76.689Å, c = 117.962Å




Intensities (I/σ)b 13.12 (3.58)
B. Refinement statistics
Resolution limit 2.2Å
Number of unique reflections 19769




 (after the last
refinement round in P61)
0.2721 / 0.2976
Rms bond lengths (Å) 0.006451
Rms bond angle (deg.) 1.20121




Solvent (30 water molecules) 42.68/4.45
a Rmerge = , I is the observed intensity and is the average intensity
calculated from multiple observations of symmetry related reflections;  [Reported  for all reflections
with signal/noise >= -3.0, all res. range]
b The value in parentheses is calculated for the highest resolution shell collected (2.2-2.1Å); [all values
are reported for reflections with signal/noise >= –3.0]
c The value in parentheses is calculated for the highest resolution shell used in refinement (2.3–2.2Å);
d Rcryst = , where Fo and Fc are, respectively, observed and calculated
amplitudes;
e Rfree is an Rcryst calculated using 10% of the processed data (1977 reflections), chosen randomly, kept
constant and omitted from all subsequent structure refinement steps.
 −× III /100 I
 − hkl oco FFF /
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III.2.3. Phasing, model building and the problems
The Matthews coefficient (Matthews, 1968) suggested a solvent content consistent
with the existence of two molecules per asymmetric unit.  In concordance with this, after
extensive molecular replacement trials, a solution was found by searching for two molecules.
Phasing was achieved using molecular replacement as implemented in the program AMoRe
(Navaza J, 1994), using Ras p21 and the recently solved Ypt51p structure (Esters et al., 2000),
PDB entry code 1EK0, as models.  The successful solution could be obtained using the Ypt51p
structure with all the atoms (not just a polyalanine model).  The space group proved to be P61.
Building of the Ypt7p∆C10 molecule was achieved by alternate cycles of manual
rebuilding against σ-weighted electron density maps in the program O (Jones T.A. et al.,
1991) and positional and B factor refinement in the CNS package (Brunger et al., 1998).
However, a problem announced itself from the beginning and after six rounds of
rebuilding/refinement proved to be a crucial one.  Due to unfortunate crystal contacts, two
adjacent molecules were facing each other, with their “switch” loops strongly interacting.  As
a consequence, the residues 34 to 40 and 65 to 77 could not be traced in the electron density
map.  This meant that the most important features of the protein could not be seen and, even
if seen, interpretation might be flawed because of the crystal packing artifact.
Figure III-5: Clashes between two molecules of Ypt7p∆C10•GppNHp.  Two molecules of
Ypt7p∆C26•GppNHp (see below) were positioned similar to the crystal packing for the
Ypt7p∆C10•GppNHp form.  Regions marked yellow could not be seen in the electron
density for the ∆C10 case.  It can be easily noted that Lys38 of one molecule clashes with
residues 68-71 of the other.
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Furthermore, for residues 183-187 only the main-chain trace could be interpreted and
residues 188-198 were not visible at all. Electrospray ionization mass spectrometry (ESI-MS)
analysis revealed that solely the first amino acid (Met1) was lost, probably due to usual
posttranslational modification, but no further degradation of the protein occurred.
After the sixth round of rebuilding, the crystallographic R factor (showing the degree
of concordance between the crystallographic model and the experimental data) and the Rfree
factor, an unbiased Rcryst , were still very high (27% and, respectively, 30%) for a fairly high
resolution data set and there was no prospect of major improvement.  The only solution
seemed to take a few steps back before making some others forward.
III.3. Crystallization and model building for Ypt7p∆C26
III.3.1. Designing the new construct
Based on the interpretation of the observed electron density and the comparison with
the recent crystal structures of Rab3a (visible residues 18-186 (Dumas et al., 1999)) and
Ypt51p (visible residues 5-175 (Esters et al., 2000)), a new construct was designed including
only residues 1-182, thus lacking the last 26 residues of Ypt7p.  This was also in accordance
with the H-Ras p211-166 construct and, more importantly, with the Metcalf experiments (Neu
et al., 1997) showing that the last 25 residues of Rab7 are flexible in solution.
In order to obtain this construct, PCR with degenerated primers was performed on
pET11a YPT7∆C10.  The 5’ primer was the T7 promoter primer, while the 3’ primer was
5’-CGGATCCTCGAGTTAAGCTTGATTCTG-3’; it contained a BamH I site (bold) and a
premature STOP codon (underlined).  The PCR amplicon was inserted into
pET11a YPT7∆C10, yielding pET11a YPT7∆C26. The protein encoded by this vector will be
referred to as Ypt7p∆C26. The integrity of the open reading frame for this construct was, like
for pET11a YPT7∆C10, checked for PCR errors by DNA sequencing (BigDye terminator kit,
PE Applied Biosystems).  After purification (which proceeded by the same protocol as the one
for Ypt7p∆C10), a sample of Ypt7∆C26 was loaded with GppNHp.
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III.3.2. Crystallization of Ypt7p∆C26•GDP and
Ypt7p∆C26•GppNHp
With this second construct of Ypt7p, we were able to obtain crystals in complex with
GppNHp as well as with GDP (the latter was not possible in the ∆C10 case), both of them in
the space group P212121.  Despite the fact that the protein and the space group were the same,
the crystals obtained for the two forms had different cell dimensions and crystal packing.
First crystals of Ypt7p∆C26•GDP were found in 20% PEG 3350, 200mM NaCl.
Further trials to improve crystal quality led to crystals able to diffract (at beamline ID14-1,
ESRF Grenoble) up to 1.3Å.  For these crystals, conditions were: 0.1M HEPES pH 7.0, 1M
LiCl, 21% PEG 6K.  For data collection, the crystals were flash-frozen in liquid nitrogen. As
cryo-protectants 10% glycerol in the reservoir solution, or perfluorinated mineral oil or
microscopy immersion oil were used.
Ypt7p∆C26•GppNHp crystals were found under conditions similar to those used for
Ypt7p∆C26•GDP, namely 1M LiCl, 20-30%PEG 6K over a wide pH range: 0.1M of citrate
pH 5.0, MES pH 6.0, HEPES pH 7.0, TRIS pH 8.0 or Bicine pH 9.0.  Attempts to fine-tune
the conditions yielded rod-shaped crystals of about 30×30×500µm3 (Figure III-6) able to
diffract to a Bragg spacing of up to 1.7Å. Conditions for these crystals were: 0.1mM Bis-Tris
Propane pH 7.0, 1M LiCl, 26% PEG 3350.
Figure III-6: Crystal of Ypt7p∆C26•GppNHp grown from 0.1mM Bis-Tris Propane pH 7.0, 1M LiCl,
26% PEG 3350.  Size is about 30×30×500µm3.
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Further optimization of the crystallization conditions led to crystals sized
80×80×100µm3 (Figure III-7) which were grown using 0.1M Bicine pH 9.0, 1M LiCl and 25%
PEG 3350; these crystals were able to diffract (at beamline ID14-1 at ESRF) to 1.57Å.  For
data collection, the crystals were flash-frozen in liquid nitrogen.  No cryo-protectant was
needed.
   
Figure III-7: Crystals of Ypt7p∆C26•GppNHp grown from 0.1M Bicine pH 9.0, 1M LiCl and 25% PEG
3350.  The one on the right is about 80×80×100µm3 and diffracted up to 1.57Å.




Area detector MAR CCD
Wavelength 0.934Å
Space group; cell dimensions P212121; a = 40.137Å b = 60.667 Å,
c = 73.537Å
Number of recorded reflections 124,357
Average redundancy 5.15
Rmerge 10.3%
Intensities (I/σ)  8.08 (2.75)
  (continued on the next page).
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Table III-2 (contd.):  Data statistics for Ypt7p∆C26•GppNHp
B. Refinement statistics
Resolution limit 1.57Å
Number of unique reflections 23450
Completeness of data (%)  96.2 (95.7)
Rcryst / Rfree 18.32/23.87
Rms bond lengths (Å) 0.008
Rms bond angle (deg.) 1.824
Mean/rms on B factors (Å2)
Backbone 17.44/9.71
Side-chain 23.71/16.58
GppNHp + Mg2+ 12.78/2.87
Solvent (284water molecules) 43.08/19.81




Area detector MAR CCD
Wavelength 0.934Å
Space group; cell dimensions P212121; a = 49.508Å b = 55.181Å,
c = 60.200Å
Number of recorded reflections 263110
Average redundancy 6.47
Rmerge 9.2 %
Intensities (I/σ)  10.81 (1.90)
B. Refinement statistics
Resolution limit 1.3Å
Number of unique reflections 40524
Completeness of data (%) 98.2(94.2)
Rcryst / Rfree 20.91 / 25.88
Rms bond lengths (Å) 0.014
Rms bond angle (deg.) 2.130
Mean/rms on B factors (Å2)
Backbone 24.08 / 14.33
Side-chain 28.98 / 16.20
GppNHp + Mg2+ 22.04 / 3.73
Solvent (225water molecules) 41.94 / 16.11
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III.3.3. Phasing and building the model
Obtaining phases for the Ypt7p∆C26 crystals (in both GDP and GppNHp forms) was
an easy task, the partly refined model of Ypt7∆C10 (without residues 182-187) being an ideal
molecular replacement model.
From the first type of Ypt7p∆C26•GppNHp crystals (the long needle morphology),
data were collected in house, using a rotating anode and CuKα radiation, to a resolution of
1.7Å; however, for phasing and initial refinement, it was used only up to 2.0Å, in order to
obtain very good data statistics.  The model obtained in this intermediate refinement step was
used with the data up to 1.57Å for the final refinement.
The same strategy was applied to both crystal forms (GDP and GppNHp).  At the
beginning, rounds of manual rebuilding were alternated with positional and individual B-
factor refinement in the program CNS.  For the more advanced stages of the refinement, I
decided to switch to the program SHELX (Sheldrick & Schneider, 1997).  The main reason
for this was its better capacity to deal with alternate conformations.  At high resolution it
might be noted that some residues are not positioned in a single place; their side chains may
have two or more alternate positions, in each of them interacting with other partners able to
satisfy the need for H-bonding, ionic interactions or hydrophobic interaction. Although
sometimes disordered residues were found even in the active site of an enzyme (Scheidig et al.,
1999), usually they do not have very important structural consequences. Nevertheless,
modeling this disorder enables the crystallographer to obtain a better model for the structure
to be solved.  Unlike CNS, SHELX has a more natural way of dealing with this problem.  Not
only is defining these residues easier, but SHELX keeps the sum of occupancies of each
individual conformer equal to 1, while giving them crystallographic thermal factors as close as
possible, which is a more correct approach.
Another reason for which SHELX was chosen is its ability to define anisotropic
thermal factors for each atom in part.  At very high resolutions (usually below 1.5Å) it can be
shown that each atom has preferential directions of movement, such that the probability of
finding the atom at a certain position can no longer be described by a sphere, but by an
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ellipsoid.  In this case, there are six thermal parameters (anisotropic displacement
components) describing the positioning of the atoms.
III.3.4. Anisotropic displacement factors: to use them or not?
The 1.57Å resolution of the GppNHp structure would, in general, be considered too
low to justify modeling of thermal anisotropy for each atom in part and even the 1.3Å
resolution of the GDP form is considered to be a borderline case.
On the other hand, using anisotropic displacement parameters might help better
interpreting the experimental data.  A first, rather pragmatic approach, would be to consider
that any protocol which leads to the lowering of the crystallographic R factor and the free R
factor (Brunger, 1992) is a valid protocol.
The crystallographic R factor is defined as
RCryst =  − hkl oco FFF /
where Fo and Fc represent, respectively, the recorded (observed) structure factor amplitudes
and the ones calculated on the basis of the model.  Basically, it is an indicator which shows
how well does the model explains the diffraction data.  Unfortunately, the R value can be
made (willingly or not) arbitrarily low, simply by increasing the number of parameters which
are used to describe the model.  The direct consequence is that a low R value is not
necessarily an indicator of a good fit and that using more parameters might artificially lower it.
For this very reason, trying to assess the opportunity of modeling anisotropic displacement
factors just by checking the R value would not have been appropriate.
To escape this bias, Brünger ported from the field of statistics the concept of the cross-
validation method, introducing the free R value (Brunger, 1992).  The Rfree is calculated
exactly in the same manner the crystallographic R is calculated.  The only difference is that it
uses about 5..10% of the data (usually 2000 reflections) which were never used, neither in the
refinement process, nor in the modeling stage.  Hence, one can, at any time, refer to the Rfree
and see how well the model predicts (as opposed to explains) the experimental data.  This is
possible because each recorded reflection is, in fact, the result of the diffractive contribution of
every atom in the crystallographic unit cell.  It can safely be said that each reflection contains
information about the content of the whole unit cell, not just a part of the molecule.  This
makes the Rfree an ideal candidate for evaluating different refinement protocols (Adams et al.,
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1997).  It has to be also noted that, in the absence of systematic errors, the Rfree should always
be higher than the conventional crystallographic R, but that a difference which is too big is a
sign of over-refinment, when the R is artificially lowered, but the Rfree cannot be.
The R and Rfree values for Ypt7∆C26•GppNHp and Ypt7∆C26•GDP were checked
before and after a SHELX run in which anisotropic displacement was modeled.  The problem
which has to be kept in mind is that during an anisotropic refinement the number of
parameters to be fitted increases from four to nine.  This means that the ratio between the
observations (reflexes) and the parameters to be fitted decreases drastically.  The results of the
two types of refinement are presented in the table below:
Aniso Ypt7∆C26•GppNHp Ypt7∆C26•GDP
R Rfree observed parameters R Rfree observed parameters
no 0.1832 0.2387 21465 6831 0.2091 0.2588 37935 5237
yes 0.1476 0.2299 21465 15351 0.1637 0.2301 37935 15975
The conclusion which might be drawn here is the following: in the case of the
GppNHp structure, the lowering of Rfree as a consequence of modeling anisotropic thermal
factors is very modest, especially when compared with the large decrease in the
crystallographic R value, showing that there are not enough observations to enable one to use
such a refinement protocol.  In the GDP case, however, the results suggests that use of atomic
thermal anisotropy may lead to a more accurate modeling of the recorded data.
III.4. Results
Ypt7p has a fold very similar to that of other small GTP-binding proteins consisting of
a six-stranded β-sheet surrounded by α-helices.  However, there are only four (and not five, as
usual) helices (see also Figure I-2 and Figure III-8). It has essentially the same main-chain trace
as other Ypt/Rab proteins, including the glycine-induced bulge at the end of the effector loop,
L2, first described by Dumas (Dumas et al., 1999). Glycine 42 (Ypt7p numbering) represents
an insertion, compared to Ras, found in all members of the Rab / Ypt family (see the discussion
about Rab Family 1 determinant, page 14 and figure Figure I-5).  This glycine forces the main
chain to “bulge” towards helix α2 (or the extended loop L4 in the case of Ypt7p, see below).
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The conformational differences between the structure of Ypt7p∆C26•GppNHp and
the structures of Rab3A•GppNHp (Dumas et al., 1999), Ypt51•GppNHp (Esters et al., 2000)
and Sec4•GppNHp (Stroupe & Brunger, 2000) are small but significant and concern the
main-chain and side-chain conformations primarily in the two switch regions, including the
effector loop L2 —between strands β2 and β3— and the catalytic loop L4, as well as loop L5
—between helix α3 and strand β5. In addition, the comparison of the Ypt7p∆C26•GppNHp
structure with the Ypt7p∆C26•GDP structure underlines the L2 and L4 loops as the major
conformational switches. These differences and the associated changes will be primarily
discussed.  In order to present and discuss these differences, the high-resolution structure of
Ypt51p•GppNH will be primarily referred to, since both proteins come from Saccharomyces
cerevisiae, are involved in the endocytic pathways of vesicular transport, and they might be
localized on the same organelle at some points in their life-cycle. Therefore, despite the fact
that they have some interacting proteins in common (the components of the prenylation
machinery, Gdi1p etc.), they have to be able to differentiate between specific binding partners.
As an example, GDP release from Ypt7p cannot be stimulated by the guanine nucleotide
exchange factor Vps9p, which is an exchange factor for Ypt51p  (Hama et al., 1999; Esters et
al., 2001).
III.4.1. Ypt7p∆C26•GppNHp
III.4.1.a. Main chain trace
The major differences in the main-chain trace occur at the N- and C-termini (residues
3-9 and 172-182), the β-turn L3 between β-sheets β2 and β3 (residues 49-59), loop L7
between α-helix α3 and β-sheet β5 (residues 110-119) and the tight turn between helix α4
and β-sheet β6 (residues 148-151, L9) (see also Figure III-8).  Also, loop L8 (between β5 and
α4) and the region between residues 69 and 82 (normally loops β3/α2 —L4— and α2/β4 —
L5, together with helix α2) show major differences when compared with other Ypt structures.
The Ypt7p loops L3 and L9 have one, and the loop L7 four residues inserted, compared to
Ypt51p (see the alignment on page 7).  These differences in the size of the loop, taken
together with the differences in the amino-acid sequence, explain very well the observed
conformational difference. These loops are in close neighborhood to the N- and C-termini,
together forming a characteristic epitope on the side opposite the nucleotide binding pocket of
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the protein. The differences are Ypt7p-specific, since the comparison between Ypt51p, Sec4p,
Rab3a and Rab5c reveal significantly fewer differences in the main-chain trace for the above-
discussed regions.  However, these proteins display significant variations in the amino-acid
sequence for this surface epitope.
Figure III-8: Ypt7p∆C26•GppNHp.  Regions showing main chain differences (RMSD > 1.0Å from
Ypt51p coordinates) compared to the structures of other Rab / Ypt family members are
depicted in red.  The extended loop L4 (usually L4/α2/L5) is yellow.
It has to be borne in mind that loops L5 and L7, together with the N terminus and the
terminal half of helix α5 were shown, in the case of Rab3A complexed with Rabphilin3
(Ostermeier & Brunger, 1999), to be major players in the complex interface, forming what was
called the “Rab Complementarity Domain” (see also the discussion about the Rab3a-
Rabphilin3 crystal structure on page17).
The electrostatic surface potential of this area is more or less neutral and does not
display significant positively or negatively charged patches. In addition, as already discussed, in
the crystallized Ypt7p construct, the last 26 residues were removed, since it is known  (Neu et
al., 1997) that about the last 25 residues of the C-terminus are flexible in solution.  Based on
this and the observed charge distribution, it seems unlikely that this surface is oriented
towards the negatively charged membrane to which all Ypt/Rab-proteins are anchored via
their geranylgeranylated C-terminus; more probably, this surface is rather accessible for
specific interacting proteins.
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The interface between the switch I and switch II region displays significant differences in
the main-chain trace as well as in the side-chain orientation compared to the described
structures of rat Rab3a, mouse Rab5c, yeast Ypt51p and yeast Sec4p. The structural plasticity
in this region was first highlighted by Merithew (Merithew et al., 2001) in mouse Rab5c. This
interface is mainly determined by the interaction of three aromatic amino acid side-chains.
Phenylalanine at position 45 and tryptophan at position 63 are absolutely conserved in all
members of the Ypt/Rab-family. The last member of this hydrophobic triad (at position 78) is
phenylalanine in Ypt7p and Rab7, whereas it is a tyrosine in all other Ypt/Rab-family
members. The side-chain of Phe78 in Ypt7p•GppNHp is oriented towards the interior of the
protein, whereas the tyrosines at the corresponding position are oriented towards the surface
of the respective Ypt/Rab-protein. As a consequence, the main-chain trace between residues
42 and 45 displays a different trace compared to all other Ypt/Rab-protein structures. The
main-chain trace is shifted around 2 Å towards the switch II region, displaying the maximum
shift at the position Ala43. Together with slightly different side-chain orientations of the
aminoacids Phe45 and Trp63, this feature is further evidence for the structural plasticity in
the RabF2/RabF3/RabF4 epitope.
A peculiar feature of Ypt7p is the extended loop L4 that starts at position Ala66 and
ends at position Gly81. In all other structures of Rab / Ypt proteins and other members of the
Ras-superfamily, this region contains a well defined α helix.  However, the region between
residues 73 to 78 of Ypt7p•GppNHp is in an extended loop conformation, and not in the
helical conformation adopted by the corresponding residues of all other small G proteins.
Figure III-9: Comparison between Ypt7p•GppNHp (blue) and Rab3A•GppNHp (transparent yellow),
showing the unusual disorganization of helix α2 in the case of Ypt7p
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There are two main reasons which suggest that this feature is not due to crystal
packing artifacts: first, there are no obvious crystal packing interactions in the P212121 crystal
form which could induce the loss of the helical structure.  The region is involved in some
minor crystal contacts, but the electron density map is very well defined.  Consistent with this,
the crystallographic thermal factors for the residues in that area are around 15Å2, even lower
than the B factors for the main chain, 17.5Å2.
Figure III-10: Electron density around residues 68 to 80 of Ypt7p•GppNHp is very well defined.  Map
contoured at 2σ.
Orientation is similar to that in Figure III-9.
Second, the respective loop could not be traced at all in the P61 crystal form (Section
III.2.3, page 55).  However, in the P61 crystal form the two switch regions of neighboring
molecules were facing and possibly disturbing each other. This suggests two hypotheses: either
the helix was partly unstructured before crystal contacts were created, and the extended loop
could fit in various positions, or the helix was actively unwound during the crystallization.
Nevertheless, it seems to be less probable that the crystallization-promoting forces would be
strong enough to actively drive the “melting” of a helix, unless it is intrinsically unstable.
Therefore, the lack of a helical structure from beginning seems to be most likely.
In order to test this hypothesis, molecular dynamics simulations were run using the
program GROMACS (Berendsen et al., 1995). GROMACS is a molecular dynamics program
that solves Newton’s equations of motion for particles (atoms) in small time steps, in cartesian
space.  The system is coupled to an external temperature bath and is pressure-controlled.  As
67
with any other molecular dynamics (MD) program, the main problem is the fact that the
simulation uses classical mechanics in order to describe the motion of atoms; in fact, it would
be impossible today to solve the quantum mechanical ones for systems as large as proteins.
Nevertheless, the use of constrains for describing bond lengths and angles proved to be a
reasonable workaround in many different MD programs.
Three test runs were with GROMACS.  For the first one, a molecular chimera was
prepared.  The L4/α2/L5 region of Rab3A (residues 81-97) was used to replace the region
between residues 68 and 84 in Ypt7p.  Rab3A was chosen because this region does not have
any insertions compared to Ypt7p.  The residues were mutated, such that the sequence was
the one of Ypt7p.  For each mutation, one of the most frequent rotamers was used, care being
taken not to generate clashes. This chimera was placed in a periodic box, keeping 5Å distance
between the molecule and the boundaries of the periodic box, solvated and equilibrated
during a short energy minimization protocol using a steepest descent algorithm and then
submitted to a MD simulation.  The time span was 4ps and snapshots were analyzed for time
steps spaced 0.5ps apart.  After the first picosecond, the α helix spanned only residues 73-77
(compared with 73-78 at the beginning of the simulation) and after two picoseconds no α
helical structure could be detected.  At some time points, residues 75-77 could be seen again
in an α helical conformation, but this did not have a long lifetime.  During the whole 4ps
simulation, helix α2 was the only one to loose its conformation, whereas all other secondary
structure elements remained well defined, only shrinking or extending by 1-2 residues during
some time periods.
In the control simulation, Rab3a was submitted to the same MD protocol.  The
conformation of loop L4 varied slightly during the MD run, but, overall helix α2 did not
disorganize, although it extended or shrank by one or maximally two residues. These MD-
simulations are in harmony with the conclusion that the observed non-helical conformation is
a genuine feature of Ypt7p and is not due to crystal packing artifacts.
From all the reasons exposed above, we do not think that the observed non-helical
conformation is due to crystal packing artifacts, but that it represents a genuine feature of
Ypt7p.  This might be a consequence of the different packing between the above-described
aromatic aminoacids Phe45, Trp63 and Phe78.  In particular, the orientation of Phe78
prevents this loop from adopting a helical backbone conformation.   However, it is improbable
that this is the only reason, because a third MD simulation, with the Ypt7p-Rab3A chimera,
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having Phe78 mutated to Val did not behave significantly different: the helix was still
disorganized.
Therefore, in addition to amino acids of the RabF2/RabF4 epitope, the amino acids of
the RabF3 epitope display significantly different orientations. These described structural
differences contribute to a substantial difference in charge distribution and surface topology of
Ypt7p, and most probably of Rab7, in view of the sequence identity between Ypt7p and Rab7.
In the structure of Ypt7p bound to GDP, the electron density in this area is poor and
does not allow confident tracing of some of the amino acids of the switch I (residues 38 to 41)
and switch II regions (residues 67 to 77).  The switch II region becomes ordered at the well
defined residue Phe78 which, in concert with Tyr79, is involved in hydrophobic interactions
that include the conserved Trp63 (see also Figure III-12).
III.4.1.b. Side chain conformations
Tyr 33 and positioning of the purine base
Tyr33 is localized on top of the guanine base, forming an edge-to-face interaction with
it. In most members of the ras superfamily, this residue is a phenylalanine (residue Phe28 in H-
Ras p21). Comparison with Ypt51p, Sec4p, Rab3a and Rab5c reveals that the aromatic rings
of phenylalanine and the corresponding tyrosine overlap. However, the guanine base and the
ribose sugar moiety of the bound nucleotide are slightly shifted and turned in the case of
Ypt7p (see Figure 5), whilst keeping the β- and γ-phosphate at the same positions. The side
chain hydroxyl group of Tyr33 forms a hydrogen bond with the nucleotide sugar oxygen O2’
(d=2.8 Å) and with the side chain OE1/NE2 (d=2.9 Å) of Gln35. Both side chain atoms of
Gln35, OE1/NE2, are also involved in hydrogen bonding with Lys160-NZ (d=3.1 Å). The
same interactions are seen in the GDP-form of Ypt7p. In both structures, the GXP base plane
is tilted by about 11.3 ° compared to the position of the guanine-nucleotide base in other well-
defined structures.
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Figure III-11: Tilting of the purine base due to the Phe32Tyr33 substitution in Ypt7p•GppNHp
(green), shown versus Ypt51p•GppNHp (red).  The oxygens O1A and O2A were
removed for the sake of clarity.  In the left image, the base is seen “edge on”.   The Cα
atoms are represented like blobs.
Tyr 37
Tyr37 of Ypt7p (equivalent to Tyr32 of H-Ras p21) is oriented away from the bound
nucleotide, similar to Lys36 of Ypt51p (Esters et al., 2000) and Gln50 in Rab5c (Merithew et
al., 2001). Thus, it does not interact with GTP, but forms a hydrogen bond between its side
chain hydroxyl group and the side chain of His26, creating part of a hydrophobic surface
patch. However, the corresponding pair in Ypt51p and Rab5c (Leu25/Lys36 and
Leu39/Gln50, respectively) contains a hydrophobic and a charged residue. Tyr37 does not
adopt a conformation facing the solvent and covering the nucleotide binding pocket, as
observed for Phe51 in Rab3a and Phe49 in Sec4p (see Figure 6). This might indicate a
conformational difference between Ypt/Rab proteins of the endocytic pathway and those of
the exocytic pathway. Following this rationale, we expect the above described conformational
difference in the switch I region to be shared with Ypt1p and Rab1a, since both these proteins
have tyrosines at the same position.
The above-described aromatic residues at positions 33 and 37 determine a significant
variation in the surface topology when compared with Ypt51p. In addition, the three isoforms
of Ypt5p (Ypt51p, Ypt52p and Ypt53p) have a positively charged residue at position 37 and
therefore the charge distribution of this surface patch is significantly changed. These two
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features might form an important determinant for specificity of binding partners for Ypt5Xp
versus Ypt7p, enabling specific effectors to discriminate between Ypt7p and Ypt5Xp.
III.4.2. Differences between the GDP and GppNHp forms
As was already mentioned at the beginning of this work, one of the reasons for trying
to crystallize both the GTP and GDP forms of Ypt7p was to gain a better understanding of
exactly what changes take place after GTP hydrolysis.  Although the generic differences
between the GTP- and GDP-bound states are known for Ras p21 and now even for Sec4p
(Stroupe & Brunger, 2000), small variations among several Rab/Ypt proteins in the same
nucleotide-bound state are crucial for their function. Therefore, the determination of their
individual structures with high resolution is needed for a detailed understanding.
GTP to GDP hydrolysis leads to the loss of the γ-phosphate group and, as a direct
consequence, two hydrogen bonds, between O1G and the amide hydrogen atom of Thr40
(part of loop L2) and between O2G and the amide hydrogen atom of Gly67, part of loop L4,
are lost (see Figure I-3).  This changes lead to large structural changes localized in the loops L2
and L4 (which, as discussed above, is unusually long and is followed directly by sheet β4).
III.4.2.a. Switch I region
As a direct consequence of the loss of the hydrogen bond between the γ-phosphate
and residue Thr40, the whole loop L2 is not fixed anymore, and residues Glu36 to Phe45
undergo displacements larger than 1Å.  Furthermore, residues 38, 39 and 40 could not be
traced in the electron density at all.  We can confidently define the “switch I” region in Ypt7p
as the region between residues 36 and 45.  This is also in accordance with the Ras definition of
“switch  I” region, which spans residues 30-38 and with Sec4p (residues 48 to 56, equivalent
to 48-57 in Ypt7p).
The biggest displacement, of 8.7Å, is seen for Ile41; this is almost three time as large as
the one observed in the case of Ras p21, where Ile36 is moved away by 3.1Å only.
III.4.2.b. Switch II region
The second region which undergoes serious rearrangements upon GTP hydrolysis is
the extended loop L4.  Residues 67-77 could not be traced at all in the electron density in the
GDP state, whereas residues Thr65, Ala66 and Phe78 to Gly81 have RMSDs above 1.0Å
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when comparing the GDP structure with the GTP one.  The switch II region appears to be
slightly smaller than the corresponding region in Sec4p (equivalent residues would have been
Thr65 to Ala82).  Further more, the loop regions of the two forms come “in register” earlier in
the Ypt7p sequence than in the Sec4p case.  This is mostly due to a hydrophobic interaction
between Trp63 and Phe78, which pack in an “edge-to-face” manner in the GTP state and in a
“face-to-face” mode in the GDP case.  The corresponding residues in Sec4p (Trp74 and
Tyr89) are too far apart to interact.  This difference can be easily explained if one notes the
fact that Tyr89 of Sec4p is part of an α helix with a defined structure, whereas Phe78 of Ypt7p
is part of a loop able to adopt virtually any conformation admitted by the Ramachandran plot.
Figure III-12: Comparison between the changes in the switch II region of Ypt7p (left) and Sec4p
(right) upon GTP hydrolysis.  In the GppNHp form, the conserved Trp and the Phe/Tyr
(respectively) are colored according to the CPK coloring scheme.  In the GDP form, the
loop L4 (Ypt7p) and L5 (Sec4p) are gradient-colored, in accordance with the
displacement from corresponding atoms of the GppNHp structure.  Colors range from
dark blue to light blue, cyan, green and yellow for displacements less than 1Å, 2Å, 3Å,
5Å, 6Å to red for more than 6Å.  The displayed residues are colored according to the
same scheme.  The semitransparent surfaces represent spacefilling models of the residues
in the GDP form.  Note the edge-to-face interaction in the Ypt7p case and the far bigger
distance between equivalent residues in Sec4p.
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III.5. Conclusions
The high-resolution crystal structures of Ypt7p in the GTP- and the GDP-bound
conformations have been determined and described.  The first engineering of Ypt7p yielded
well-diffracting crystals of Ypt7p in the GTP form, but later it was shown that the switch
regions, responsible for the conformational differences between the GDP and GTP
conformations, were not visible in the electron density due to unfortunate crystal packing.  In
addition, the end of the C-terminal helix was not visible in the electron density.  A second
construct was designed with the hope that these problems would be circumvented.  The
strategy proved successful: the protein could be crystallized and the structures of both the
GTP and the GDP conformations solved to very high resolution (1.6Å in the GppNHp-bound
case and 1.3Å in the case of the GDP structure).  Although it was postulated that the
differences between the GDP and GTP state are similar to the ones observed in Ras, only
recently the structure of Sec4p (Stroupe & Brunger, 2000) in the GTP and GDP states
showed that qualitatively the same differences can be seen in the Ypt family as well.  Different
Ypt proteins have to be, nevertheless, distinguished from each other in either the GDP- or
GTP-bound states. Small variations among several Ypt/Rab-proteins in the different
nucleotide-bound states are crucial for their specific function. Therefore, the determination of
their individual structures with high resolution are needed for a comprehensive understanding
of effector binding specificity.
The presented differences in main-chain and side-chain conformations of Ypt7p
compared to Ypt51p, Sec4p, Rab3a and Rab5c, in addition to the sequence differences,
contribute to structural plasticity and variations in both the surface charge distribution and
surface topology within the Ypt/Rab-family of proteins. The observed structural differences are
clustered in areas which were recently highlighted as Rab-specific or Rab-subfamily specific
regions (Pereira-Leal & Seabra, 2000). For the RabSF2 region (part of the switch I region)
Ypt7p displays, in the GTP-bound form, a shifted conformation when compared with other
Ypt/Rab structures and a different surface topology, mainly as a consequence of the two
tyrosine residues Tyr33 and Tyr37. In the structure of Ypt7p•GppNHp, helix α2 is unwound,
which results in an extended loop spanning from β-strand β3 to β4, including the RabF3
region. Molecular dynamics simulations revealed that the intrinsic sequence of Ypt7p within
this region determines this feature. These two conformational changes associated with the
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switch I and the switch II region are likely to contribute to Ypt7p specific binding of effector
proteins and presumably help to discriminate between Ypt7p and Ypt51p when they are
located on the same membrane. Furthermore, due to insertions in loops L3 and L7, the
neighboring RabSF1 and RabSF4 regions are different in their conformation compared with
other Ypt/Rab proteins. Therefore, it is probable that this surface patch can serve as an
additional binding site for Ypt7p-specific effector proteins. These variations, each taken in
part, are small, but they add up and most probably become a specificity tag allowing
differentiation between the otherwise sequence- and fold-similar Ypt/Rab proteins.
It is a common feature that the GDP-bound form of Ras-related small GTP-binding
proteins has a less well-defined structure than the GTP-bound form. In particular, the
important switch I and switch II regions are very flexible when the protein is in complex with
GDP, lacking the γ-phosphate group which fixes these regions. This higher conformational
mobility in the GDP-bound form might help proteins which interact promiscuously with
Ypt/Rab proteins in the GDP-bound form to overcome variations in the amino acid sequence
and topology at the interaction surface (e.g. GDP dissociation inhibitor, GDI, (Garrett et al.,
1994)).
With the structure in hand, the results of kinetic characterization of different Ypt7p
mutants can be more easily understood. The GTPase activity of Ypt7p is most effectively
enhanced (8×105 fold) in vitro by the GAP Gyp7p  (Vollmer et al., 1999) and to a lesser
extent by the GAPs Gyp6p and Gyp1p  (Tickle et al., 1998). This acceleration of the GTPase
activity by Gyp7p is reduced about 5 times when Ypt7p-I41M, Ypt7p-D44N and Ypt7p-Q68L
mutant proteins are used as substrates  (Vollmer et al., 1999). The reduced activity of the
Ypt7p-Q68L mutant can be rationalized by the fact that this glutamine is supposed to be an
essential part of the active site for the GTP-hydrolysis reaction in analogy to the Gln61 of H-
Ras p21  (Frech et al., 1994). It is worth mentioning that activity is not completely abolished
in the Ypt7p-Q68L mutant, as it is observed for the similar H-Ras p21-Q61L mutant. It can be
hypothesized that in the binary complex between Ypt7p and its cognate GAP, the glutamine
68 might not take the same crucial role as Gln61 does in H-Ras p21. The other two positions
(41 and 44) of Ypt7p are in the postulated interface between the Ypt protein and GAP  (Rak
et al., 2000) and perturbation  of the surface topology might be responsible for the weakened
interaction between the two proteins.
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It would have been more rewarding and instructive to gain a structural insight on the
complex between Ypt7p and Mrs6p or even the ternary complex between the GGTase II,
Ypt7p and Mrs6p.  Unfortunately, neither of the complexes was amenable to crystallization.
No crystals could be obtained for the ternary complex (A. Rak, personal communication),
while the Ypt7p-Mrs6p complex yielded only two types of crystallization results: precipitates or
phase separations.  However, to gain a better understanding of this complex system, I set out
to investigate the interactions between different Ypt proteins and Mrs6p, using steady-state
and pre steady-state methods.  The results of these experiments are described in the next
chapter.
Chapter IV.
Kinetic analysis of interaction




Although much is known, at the molecular level, about the prenylation machinery and
how it works, the quantitative description of the system is still missing.  More exactly, the
control steps involved in this process are far from being understood.  Characterizing the
system at the level of the interaction between its components might shed more light on the
way it is regulated.
To this end, I tried to use various techniques in order to understand and characterize
the system.  Equilibrium titrations were used in the first place, since they can provide
information about the affinity between the components of the system.  The different
combinations used showed that, concerning the interaction with Mrs6p, Saccharomyces
cerevisiae Ypt proteins can be divided into two groups: a set of Ypt proteins binding tightly (in
the low nM range) and a second set with affinities lower by ca. one order of magnitude.  It was
also shown that this difference applies only to the GDP form and not to the GTP form.  Trying
to understand better where this difference arises from, I performed pre steady state analysis to
learn about the differences in the association and dissociation rates.  Last, but not least, a
recently developed method was used in a trial to structurally characterize the interaction
interface between Mrs6p and one Ypt protein.
IV.2. Equilibrium relationships
IV.2.1. Equilibrium titrations: the principle1
Taken a system consisting of a ligand, L, and its receptor, R.  The following reaction
will take place:
L + R LR
k12
k21
                                                
1 Most of the theory presented in this chapter is based on  (Gutfreund, 1995)
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During an equilibrium titration experiment, the researcher tries to find out how much
receptor is bound to ligand at certain ligand and receptor concentrations.  This will give
information about how tight the interaction between the two binding partners is, namely the
dissociation constant kD of the equilibrium.  Two mass action rate constants will describe the
system: k12 will be named the association rate constant, while k21 will be referred to as the
dissociation rate constant.  The mass action law states that the rate of reaction is directly
proportional to the product of the concentrations of the reactants and the proportionality constant
is the rate constant.  If we denote the concentration of free ligand by cL and the one of free
receptor by cR, then we can write the following equations:









dcLR = k12cLcR  (IV.1)








dcLR = k21cLR. (IV.2)
Summing up the dissociation and association rates, we obtain the rate by which the






dcLR = k12cLcR – k21cLR. (IV.3)
It is important to note that, at equilibrium, this rate of change equals zero, that is: the amount
of LR complexes formed in the time unit equals the amount of LR complexes that dissociate
in the same time period.  It is easier to use the fraction (or proportion) of LR which is formed
at a certain moment (and the fraction of free R at that moment), such that











Applying this substitution in equation (IV.3), and taking into the account that the
equilibration proceeds over time and that concentrations of ligand and receptor will vary






















)(dpLR = k12cL(t)(1-pLR(t)) –  k21pLR(t) = –(k12cL(t) +k21)pLR(t) +k12cL(t) (IV.6)
so that the dependency of the concentrations and bound fractions with time is explicitly
written.  At equilibrium (t= ∞ ), the rate of change of the concentration of LR (and of the
proportion of LR) equals zero, so that:
k12cL(t)(1–pLR(t)) –  k21pLR(t) = 0   for t= ∞ (IV.7).
It is usual to perform measurements using a vast excess of ligand over receptor.  In this
case, the variation of the free ligand concentration over time is insignificant (since just a very
small amount of ligand can be bound by the receptor, even at full saturation of the receptor)
and the reaction, albeit a second order one, seems to behave like a first order reaction, with an
exponential decay for the free receptor concentration and, consequently, with an exponential
rise for the RL complex concentration.  Because of this, it is said that the experiment is
performed under pseudo first order conditions.  If this is the case, then cL(t) at any time can be
approximated to cL(0) and, for simplification, it will be noted as cL.  Equation (IV.7) can be
written as
k12cL(1–pLR(t)) –  k21pLR(t) = 0    for t= ∞ (IV.8)
which leads to













where kD is called the dissociation constant of the equilibrium (or the equilibrium dissociation








Inspection of equation (IV.9) reveals that kD, under these pseudo first order conditions,
can be defined as the concentration of ligand at which half of the receptors are in complex
with the ligand.  The graphical representation of the equation (IV.9) yields a part of a limb of a
rectangular hyperbola.
It is important to note that the definitions above consider that cL( ∞ ) = cL(0) (noted
by cL), which is the case only if the experiment is performed under pseudo first order
conditions.  Unfortunately, in practice this is not easy to acquire, hence the need for deriving
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a more robust calculation for the fraction of receptor involved in receptor-ligand complexes.












The problem is that, usually, one does not know the amounts of free ligand and receptor, but
only the total amounts of L and R and the concentration of the complex LR (for which a
proportional signal is read out).  Using the  pLR  notation and the mass conservation rules
(cL + cLR =cL total=cL0 etc.), the following substitutions can be made: cL = cL0(1–pLR) and
cR=cR0(1–pLR).  But the concentration of  bound L equals the one of bound R and this is the
concentration of the LR complex, so we can write:
cLR = pLR·cR0 ;   cL=cL0(1–cR0·pLR) ;   cR=cR0(1–pR) (IV.12)


















It is easy to realize that only the quadratic equation solution in which the radical is subtracted
has physical meaning (0≤pR≤1).  The other one, with the radical preceded by the plus sign,
will always yield values bigger than 1.
The advantage of calculating the proportion of receptor participating in ligand-
receptor complexes according to formula in (IV.14) is that the calculation is valid for any
concentrations of L and R and for any kD.
In a practical situation, one starts with a certain quantity of receptor, adds ligand
stepwise and determines the concentration of the LR complex at that particular ligand
concentration.  The obtained values are fitted to equation (IV.14), resulting in the
determination of the value of kD.
In the cases presented in the next sections, the concentration of the LR complex was
determined using fluorescence as a readout. The use of fluorescence as a signal has several
advantages: usually the signal over noise ratio is high and the fluorescence undergoes
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significant changes upon binding of the ligand to the receptor.  In a fluorescence experiment,
samples are illuminated (excited) by light at a certain wavelength and the emitted fluorescent
light is detected at right angle to the exciting light.  This means that the (usually faint)
emitted light will be read against a practically dark background; in contrast, when using
transmittance readings, a small variation has to be read against the high background of the
sample, resulting in a poorer signal-to-noise ratio.
A second advantage of fluorescence is that it can easily be used as an interaction
reporter.   This arises from two different reasons: first, fluorescence of some dyes might change
dramatically upon changing the environment of that dye; secondly, there can be a
fluorescence resonance energy transfer between a donor on one molecule and an acceptor on
a second molecule.
Fluorescence resonance energy transfer (FRET) is a distance-dependent interaction
between the electronic excited states of two dye molecules in which excitation is transferred
from a donor molecule to an acceptor molecule without emission of a photon.  For this reason
is also known as non-radiative energy transfer.









where R0 is the Förster distance (or radius), which is specific for each donor/acceptor pair and
depends on the properties of the donor and the acceptor, like the dipole orientation of the
two, the fluorescence quantum yield of the donor, the refractive index of the media and the
spectral overlap of the two species.  Usually, the Förster radius is around 30-60Å.  This means
that with a well-chosen pair of donor (on one interaction partner) and acceptor (on the
second interaction partner), a situation can be achieved in which, upon binding, either the
appearance of sensitized fluorescence of the acceptor or the quenching of donor fluorescence
can be monitored.  Proteins have natural fluorophores, namely tryptophan and phenylalanine
residues, which, both, absorb in the range 275-295nm and emit in the range of 310-340nm,
but the tryptophan residues absorb about five times more strongly than tyrosine residues,
making them the most important ones.
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The choice of using a fluorescence signal for the kinetic experiments was made also
because this kind of signal is able to report in real time on the interactions between the
proteins, making it the most useful tool for fast kinetics experiments.
In this work, the following strategy was employed for equilibrium titrations: a small
amount of Ypt protein, fluorescently labeled, was diluted in 1ml of buffer solution (25mM
HEPES Na pH 7.2, 50mM NaCl, 5mM DTT, 1mM MgCl2 and 10µM GDP) and set up in a
stirred fluorescence cuvette, thermostated at 25˚C.  The final concentration was in the range
of  30-500nM.  Mrs6p was subsequently added in small aliquots and fluorescence was read out
during the whole experiment.  The recorded values were plotted against the total
concentration of Mrs6p and a least squares fitting routine as implemented in the program
Grafit was used to derive the kD for the reactions.  In the case of a competitive titration, a
different approach was employed (see SectionIV.2.3.a).
IV.2.2. Interaction between Mrs6p and Ypt7p and Rab7, GDP
form
As a continuation of the structural work done, the first Ypt protein to be characterized
for its ability to bind Mrs6p was Ypt7p.  Two different fluorophores were used in equilibrium
titrations: rhodamine and dansyl, both as haloalkyl reagents, which react readily, in a selective
manner, with thiol groups of proteins, yielding thioether-coupled products.  The two
fluorophores used were naphthylamine-5-sulfonic acid (DANS) and tetramethylrhodamine
(TMR or rhodamine) (Figure IV-1).  The fluorescently labeled proteins obtained will be
referred to as YptX dans and YptX rhodamine.
It is known that the C-terminal tail of Ypt/Rab proteins is not structured in solution
( (Neu et al., 1997) and discussion in Section III.2.1).  However, since the tail contains two
cysteine residues which subject to geranylgeranylation, large structural rearrangements are
required before and during the prenylation reaction (see also the discussion about the GGTase
II in Section I.2.2.b).  Hence, a label placed in this part of the protein should be able to report
on the environment changes and thus on the interactions with other proteins, in particular if
these proteins are able to bind the C terminus of Ypt, for example Mrs6p or GGTase II.  Ypt7p
contains four cysteine residues.  Two of them were seen in the electron density map and are
buried in the hydrophobic core.  The other two are placed at the C terminus, so are the only
ones likely to be labeled with a water-soluble reagent capable of reacting with free cysteines.
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This is also in accordance with other results, showing that in Rab7 only two cysteines (C205
and C207) were likely to be labeled when challenged with a water-soluble reagent (P. Metcalf,
unpublished data).  For this aim, Ypt7 was incubated with 1,5-IAEDANS or 5-TMRIA for 2
hours at 4°C.  After this, the buffer was exchanged and the excess label removed by passing
the reaction mixture over a PD-10 column preequilibrated with 20mM HEPES pH 7.2, 10mM
NaCl and 2mM DTE, 10µM GDP; the resulted protein was concentrated and stored in
aliquots at –80°C.  Incorporation of the label was assessed by ESI-MS and fluorescence yield
measurements, revealing that both cysteines were quantitatively labeled.
a b
Figure IV-1: Two reagents used for fluorescently labeling different Ypt proteins
a– N-(Iodoacetaminoethyl)-1-naphthylamine-5-sulfonic acid (1,5 I-A-EDANS)
b– tetramethylrhodamine-5-iodoacetamide dihydroiodide (5-TMRIA)
For the Ypt7p-dans•GDP interaction with Mrs6p, two different types of signals were
used: the direct signal (exciting the dansyl fluorophore at 346nm and reading out the
fluorescence signal at 490nm) and the FRET signal, using tryptophan as donor and dansyl as
acceptor and monitoring the increase in dansyl fluorescence (the monochromator for
excitation was set at 280nm, while the one for emission was set at 490nm).  The result of this
titration was somehow unexpected: the obtained kD, of about 480nM (Figure IV-2) was far
above the kD of the mammalian homologous system (Rab7 against Rep1), which displayed
affinities in the order of 1-2nM (Alexandrov et al., 1998).  In order to test whether this result
was correct, a second experiment was performed, in which the FRET signal was used.
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Using FRET with tryptophan as donor involves a problem: at every step in the
titration, the excitation background is raised, since the added protein also contains
tryptophans.  Due to this, the titration curve will not reach an obvious plateau.  This behavior
can be corrected in the following manner: if enough points have been recorded after the real
saturation of the receptor (Ypt7p dansyl in this case), they will reflect only the contribution of
the tryptophans added.  A linear fit can be performed on this region of the plot, deducing the
amount by which the recorded fluorescence increases during each titration step, and
subtracting it from the recorded values.  Such an approach proved efficient when titrating
Ypt7p dansyl against Mrs6p using FRET from Trp to dansyl, as can be seen in Figure IV-3,
where the corrected data reaches a plateau.  The result obtained from this experiment was in
agreement with the one obtained from the first experiment, suggesting a kD value in the range
of 300-500nM.
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Figure IV-2: Titration of Ypt7 dansyl with Mrs6p, using direct fluorescence signal.  The fitted curve
corresponds to a kD of 480±40nM.  Concentration of Ypt7p•GDP dansyl was 136nM.
To be more confident about the results obtained, a third titration was performed, this
time with Ypt7p labeled with tetramethylrhodamine.  The fit to this titration curve indicated a
kD value of 350±33nM, also in agreement with the previously obtained values.
These first results suggested that the affinity between the components of the yeast
prenylation system were about two orders of magnitude lower than the ones of the mammalian
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system.  In order to clarify this, an experiment was performed which, at a first glance, might
seem strange: assessing the interaction between Rab7 and Mrs6p, a “molecular chimera”.
To this end, a strategy similar to that used in the case of Ypt7p was used: Rab7 was
labeled with dansyl and the interaction was characterized by reading the increase in the
fluorescence of dansyl following FRET from tryptophan.  Much to our surprise, the data
obtained showed that the hybrid system has a kD of about 13nM (Figure IV-4 a).
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Figure IV-3: Titration of Ypt7p•GDP with Mrs6p.  The squares represent the data corrected for the
contribution of the intrinsic tryptophan fluorescence.  The red curve corresponds to a fit
for kD=300±25nM.  Concentration of Ypt7p•GDP dansyl was 136nM.
Mrs6p














Figure IV-4: Titration of Rab7dans•GDP with Mrs6p.  In the fitted curve corresponds to a kD of
13.5±3.2nM.  Concentration of Rab7dansyl was 50nM.
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From these experiments, the conclusion which could be drawn was that Mrs6p per se is
able to bind Ypt / Rab proteins strongly, but Ypt7p is not able to bind tightly to Mrs6p.  If
Mrs6p was able to bind substrates with affinities of about 10-15nM. It was therefore
interesting to see if there are, in yeast, binding partners able to take advantage of this binding
capacity.
IV.2.3. The yeast tight binders: Ypt1p and Sec4p
One such substrate proved to be Ypt1.  Titration of Ypt1 dansyl with Mrs6p yielded a
titration curve which suggested a kD of about 11nM.  Preliminary data suggested that Sec4p
was also able to bind Mrs6p very tightly, but the exact affinity could not be measured using
this approach.  The problem when doing equilibrium titrations is that the concentration of the
labeled partner (which is kept constant during the whole experiment) should not be too much
higher than the kD of the system.  If this condition is not satisfied, in the sense that the
concentration is much higher than kD, the titration curve will rise linearly to the endpoint,
exhibit a sharp kink at a ligand concentration equal with that of the receptor and then
plateau; the only information which can be derived from such a curve is the stoichiometry of
the reaction.  The kD obtained from such a curve is prone to large errors.
This condition could not be satisfied in the case of Ypt1p and not even reached in the
Sec4p case.  In principle, since the titration signal is fluorescence, read against a black
background, the concentration of the label can be lowered as much as desired, in order to
reach the condition cR < kD.  In practice, however, a problem arises: the solvent scatters light
by two mechanisms: one is the Rayleigh scattering, which occurs at a wavelength equal to that
of the excitation and the other one is the Raman scattering at wavelengths longer that the
one of the exciting light.  If the concentration of the labeled compound is very low, the
fluorescent light emitted is very faint and can become swamped by the background noise.  The
intensity of the excitation light cannot be increased without limits, since too intense light will
result in “photobleaching”, the destruction of the fluorophore.  A possible solution for such a
situation is to use a competitive titration strategy.
IV.2.3.a.  Competitive titrations: the principle
In cases when one cannot lower the concentration of the label in such a manner that
will be able to have a readout and still be at a concentration low enough compared with kD,
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the competitive titration might prove to be a very good solution.  In principle, for a
competitive titration, one mixes a labeled ligand, an unlabeled one and their (common)
binding partner.  One of the ways of performing such an experiment (and which was employed
in this study) consists in mixing together the labeled and the unlabeled ligands and titrating
them with the binding partner.
Generally speaking, if a competition titration experiment is to be performed, the
following equilibria have to be considered (U is the unlabeled ligand, while L is the labeled
one):
E + U EU
kDU
E + L EL
kDL







The mass conservation equations
 [Eo]= [E] + [EU] + [EL] (IV.17)
 [Uo]= [EU] + [U] (IV.18)
 [Lo]= [EL] + [L] (IV.19)















Writing [EL] as a function of kDU, kDL, [Eo], [Uo] and [Lo] one obtains the three solutions of a
cubic equation, out of which only one has a physical meaning.  The simulations in Figure IV-5
show what happens in different situations, when the ratio between the affinities of the
receptor for the unlabeled ligand and labeled ligand varies by four orders of magnitude.  When
the kD of the labeled ligand is lower than the one of the unlabeled, the curve appears
hyperbolic.  In the other cases (and especially when kDU is lower than kDL) the curve has a
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sigmoidal aspect.  This is because at the start of the titration the receptor will bind
preferentially the ligand with a higher affinity.  If the ligand with higher affinity is not labeled,
at the beginning of the titration there will be a “lag” phase with no signal.  The curves
depicted in A and B possess more information content than the one in C and, especially, the
one in D.  Fitting data to a sigmoidal titration curve will result in better defined and more











































Figure IV-5: Simulated competitive titration curves. In all cases 10nM of receptor in the presence of
100nM fluorescently labeled ligand were titrated against increasing concentrations of
unlabeled ligand. The kD of labeled ligand for binding to the protein was fixed at 10nM.
The kD for the non labeled ligand was 100nM (A), 10nM (B), 1nM (C) and 0.1nM (D).
Although there are analytical solutions for equations (IV.20) and (IV.21), they are
difficult to introduce in many data fitting programs, using their equation editors.  A more
simple approach is to use for this purpose a program in which equations (IV.15) to (IV.19) can
be introduced in their explicit form, such as Scientist.  In such a program, the equations are
introduced exactly in the form presented above.  The fluorescence is defined as being
proportional with the concentration of the EL species.  An input script for the program
Scientist dealing with such a competitive titration is presented below
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/ Competitive Titration
// L (fluorescent substrate)
// U (non fluorescent)
// Reactions E+L <>EL : KdL -dans fluorescence
// E+U <>EU : KdU
// Signal on EL
IndVars: E0
DepVars: L, U, F, EL, EU, E




















IV.2.3.b. Results of the competitive titrations for Ypt1p and Sec4p
Based on this system, the following experiment was performed: Sec4p was mixed with
Ypt7p dansyl labeled, yielding 250nM of each.  This mixture was titrated with Mrs6p.  The
result of the fitting procedure, performed as described above, suggested that the kD for the
Sec4p – Mrs6p interaction is 26nM and the one between Ypt7p dansyl and Mrs6p is 500nM.
A similar approach yielded a kD of 10nM for the Ypt1p – Mrs6p interaction in the presence of
Ypt7p dansyl labeled, value in very good agreement with the one determined by titrating
Ypt1p dansyl labeled with Mrs6p (Section IV.2.3 at page 85).  This result proved also that the
dansyl labels attached to the C terminus of different proteins did not affect the affinities
between the Ypt protein and Mrs6p, since Ypt1p used in this case was not labeled.
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Figure IV-6: Competitive titration between Sec4p, Ypt7p dansyl and Mrs6p.  The inset is a blow-up
of the “lag” region from which the kD between Sec4p and Mrs6p was determined.
270nM of Ypt7p•GDP-dansyl and 270nM Sec4p•GDP were used.
The results obtained so far (and the ones obtained from the pre steady state kinetic
determinations, see next section) suggested the fact that the members of the Ypt family can be
divided in two categories, based on their interaction with Mrs6p: loose binders and tight
binders.  All the results presented so far were obtained with the proteins in the GDP form.
Although it is generally believed that prenylation takes place with the Ypt proteins in the
GDP form, it was interesting to see what happens in the case of GTP-loaded Ypt proteins.
Since GTP is, even at the low GTPase rates of the Ypt proteins, hydrolyzed in time, a non-
hydrolyzable analogue was used, the same one used in the crystallography part of this work:
GppNHp.
IV.2.4. Interaction between Ypt1p•GppNHp and Mrs6p
Different titration strategies were tried, with different Ypt proteins in the GTP state,
labeled with different fluorophores.  Unfortunately, no usable signal could be detected during
these equilibrium titration experiments.  Two techniques were used to obtain, however, the
information.  One was competitive titration.  The other one consisted in employing pre steady
state kinetics in order to derive the binding affinities.
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For the case of Ypt1•GppNHp, two competitive titration experiments were performed,
both having Ypt7 dansyl labeled as competitor for the Mrs6p binding site.  Each of them,
separately, could not yield the information desired, because the shape of the titration curves
was approaching a hyperbola, looking much like the curve in Figure IV-5 D.  The power of the
method consisted in using the information from both titration curves simultaneously, in a
procedure known as global fitting.  Owing to the easy way in which explicit equations can be
implemented in the program Scientist, the following model was used:
// Competitive Titration
// L (fluorescent substrate)
// U (non fluorescent)
// Reaction E+L <>EL : KdL-dans
// E+U <>EU : KdU
// Signal on EL
IndVars: E0
DepVars: EL1, EU1, L1, U1, F1, E1, EL2, EU2, L2, U2, F2, E2




































As can be seen, the two equilibrium titrations are treated separately, but there is a
single set of kDA and kDB which ties the systems together.  The kD that was deduced from this
experiment for the interaction between Mrs6p and Ypt1•GppNHp is 1100nM (compared
with 10nM for Ypt1•GDP), which is also surprising, compared to the mammalian system,
where the affinity difference between the GDP and the GppNHp forms of Rab7 and Rep1 is


























Figure IV-7: Global fitting of the data obtained from two competition experiments.  200nM
Ypt7p•GDP-dansyl and the indicated amount of Ypt1p•GppNHp were titrated with
Mrs6p, yielding a kD of 1100nM for the interaction between Ypt1p•GppNHp and
Mrs6p.
Having gained some data about the interaction between Mrs6p and different Ypt
proteins from the equilibrium titrations, next step was characterisation of the interaction in
the pre-equilibrium step, by employing pre steady-state kinetics methods, such as stopped flow.
IV.3. Pre steady-state kinetics of interaction between
Mrs6p and different Ypt proteins
IV.3.1. Stopped flow measurements: the principle
Performing steady state kinetic measurements, it is possible to obtain information
about the affinities between two (or more) interacting partners and about the kcat, which can
correspond to a single rate constant, but might be, as well, the result of the combination of
multiple rate constants, too fast to be perceived individually.   In order to examine the
intermediate steps and the rate constants linking them, as well as to detect the transient
intermediates, the kineticist has to perform measurements which give information about the
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rate of approach to the steady state.  Since, usually, the steady state is attained in time periods
of less than a second, the use of specialized apparatus is required.
One way of observing pre steady state events involves usage of a stopped flow machine.
Such a machine (which is schematically represented in Figure IV-8) is usually able to measure
pre steady state events for reactions as fast as 700s-1.  The two driving syringes (A and B) are
pushed by the drive and express a defined volume (during this work, the volume was set to
75µl for each syringe).  The reactants flow from each syringe through the mixing chamber to
the observation chamber.  At the beginning, they start “aging” and still travel to the stop
syringe, such that in the optical cell there is always a “new” mixture of a constant age, dictated
by the linear velocity of the flow.  Once the stopping syringe is pushed far enough, it reaches a
position where it stops.  In the same moment a microswitch is activated and data recording
starts.  Thus, the data will be recorded for a mixture which was mixed a certain time period
before and is now aging, providing in this way information about the reactions taking place at
short time intervals after the mixing moment.  In this work, the readout is a fluorescence













Figure IV-8: Schematic representation of a stopped flow machine.
Two types of experiments were performed and will be described in this work.  The first
one consisted in studying the association kinetics between Mrs6p and different Ypt / Rab
substrates, whereas the other one studied the dissociation of the Rab proteins from Mrs6p.
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IV.3.1.a. Association kinetics
In an association kinetics determination, the two interacting partners are in the two
different syringes and mixed together in the mixing chamber.  At this moment they start to
associate and (hopefully) an optical signal can be read out.  The experimental conditions are
often chosen such that one reagent is in large excess over the other one.  Imposing such a
condition results in linear rate equations describing the kinetic behavior of the system.  If we
consider a reaction of the form:
L+R LR
k








(see also (IV.1) and the mass action law).  However, if  L is in large excess over R (usually ten
fold or more), cL(t) will be, to a first approximation, constant and will equal cL(0).  Under
these pseudo first order conditions, the apparent rate constant is kcL(0)=kobs which has the
dimensions of a first order rate constant (s-1).  Equation (IV.15) can be integrated to yield
])0(cexp[)0(c)(c LRR tkt ⋅−= (IV.16)
which is an exponential time-dependence.  A set of measurements can be carried out at
different cL concentrations.  A least square fit to the experimental data will yield, for each
case, the value of the observed pseudo first order rate constant, namely kcL(0).  Plotting the
obtained values against cL(0), a straight line should be fitted through these values.  The slope
of this line will be exactly the k value, the second order rate constant.




equation (IV.3) can be used to calculate the amount of LR at any time:
td
dcLR = k12cL(t)cR(t) – k21cLR(t) (IV.17)
which, keeping in mind that for pseudo first order conditions, cR(t)=cR(0)–cLR(t) and dcL/dt=0,
can be rewritten as:
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td
dcLR =k12cL(cR(0) –cLR(t)) –cLR(t)k21  =  k12cLcR(0) –cLR(t)(k12cL+k21) (IV.18).
This can be regarded as a first order differential equation with constant coefficients, which was




where τ = 1/(k12cA+k21) is called the time constant of the reaction.   To find out the value of
cLR( ∞ ),  it is enough to note that at equilibrium (t= ∞ ) dcLR/dt = 0.  Hence:








































Hence, it can be said that recording the time course of a complex formation we will obtain an
exponential whose observed rate constant will be
kobs = k12cL+k21 (IV.22).
If the mechanism involves a single step, then a plot of kobs against cL for different cL(0) will
result in a straight line.  Its slope will be the second order rate constant k12(or the association
rate constant, kon) and the intercept with the y axis (kobs) will represent the value of k21,
namely the dissociation rate constant, koff.
Since kD is defined by the ratio between k21 and k12 (IV.11), the ratio between these two
values should be in accordance with the value of kD obtained from equilibrium titrations,
providing a self-consistency check and showing whether the presumed model is or not a
correct one.
IV.3.1.b. Dissociation kinetics
A second approach was used in a trial to obtain a better defined koff, since deducing the
value of koff from the intercept of the linear fit of variation of the observed rate constants with
ligand concentration (equation (IV.22)) is not always extremely accurate, due to experimental
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The idea of the experiment is to find out k21, the dissociation constant of X from the RX
complex, by measuring the decay of RX or the rise of RY.  To this end, two rate equations can
be written:
td
dcRX = k12cX(t)cR(t) – k21cXR(t) (IV.23)
td
dcRY = k13cY(t)cR(t) – k31cYR(t) (IV.24).
In order to solve these equations analytically, several conditions are required:
a) cX and cY should he high enough such that it can be assumed that cX(t)=constant
and cY(t)=constant
b) cR will be low enough (the free ligand binding sites), and it can be assumed that
cR(0)= cRX(t)+ cRY(t), which means that at any time there is no free receptor, but





c) The displacing ligand (Y) is in large excess over the other one (more correctly,
k13cY(0)k12cX(0)) .
If these conditions are fulfilled, then it can be shown that the first order rate constant
for the dissociation of X from the XR complex will be given by a single exponential showing




Analyzing equations (IV.25) and (IV.26), an important idea arises: one can monitor
either the signal of the dissociation between X and R or the signal resulted from the
association between Y and R.  Both approaches were used in the determinations of the
dissociation constants between different Ypt proteins and Mrs6p.  When possible, it was tried
to monitor the rise in the signal from the YR association.  This was done with the belief that
the results obtained in this way will be free from any artifacts induced by the existence of a
fluorescent reporter group.  Two of the three fluorescent reporter groups used in these assays
(dansyl and rhodamine) are highly hydrophobic and placed on the C-terminal part of the Ypt
proteins, on the same cysteine residues to which the geranylgeranyl is normally attached.  The
possibility that these hydrophobic compounds would preferentially bind to the presumed
hydrophobic pocket of Mrs6p should have been taken into account.  By using an unlabeled
Ypt protein as the ligand whose koff was assessed, and using a labeled Ypt protein as the
displacement agent, one could be sure to avoid any influence from the fluorescence reporter
group.
The experiment consisted in mixing together, in one syringe, Mrs6p with the Ypt
protein whose koff was to be determined.  In the second syringe was the displacing agent (also a
Ypt protein, preferably with a kD lower than that of the unlabeled one) bearing a fluorophore.
The concentrations were chosen such that, after mixing, the labeled compound was in large
excess over the unlabeled one.
IV.3.2. Interaction of Ypt51p and Ypt7p with Mrs6p
Since no information could be gained from equilibrium titrations between Ypt51p and
Mrs6p, I hoped that using pre steady state kinetics measurements would yield the information
needed.  To this end, a series of stopped flow experiments were performed, using Ypt51
labeled with mantGDP.  The fluorescent group 3'-O-(N-methylanthraniloyl) is bound to the 2’ and
the 3’ OH of the guanosine diphosphate and can be excited either directly (λex=356nm, λem=440nm)
or by using tryptophan quenching (λex=280nm, λem=440nm).
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Figure IV-9: 3'-O-(N-methylanthraniloyl)-2'(3')-guanosine diphosphate (mantGDP)
For the association kinetics, constant amounts of Ypt51p•mantGDP (300nM) were
mixed with increasing quantities of Mrs6p (1000, 1500, 2000, 2500, 3000 and 5000nM) and
the fluorescent trace due to complex formation was recorded.  Multiple traces were averaged
and exponential fits gave the values for the observed rate constant for each concentration.
The linear fit (Figure IV-10 A) yielded values of  0.0017s-1nM-1 for kon and 0.7s-1 for koff.  Thus,
the kD for the Mrs6p – Ypt51p•GDP was calculated  as 386nM.  Although, in this particular
case, the linear fit was excellent, a displacement reaction was monitored to measure the
dissociation rate directly.  In this reaction, Ypt51•mantGDP was mixed with Mrs6 in one
syringe of the stopped flow machine.  In the other one, Ypt51•GDP was used, in excess over
Mrs6p and Ypt51p.  The exponential fit to the observed transient (Figure IV-10 B) indicated
that koff = 0.565s
-1, in very good agreement with the one previously determined.  Increasing
the concentration of the unlabeled Ypt51p did not lead to an increase in the observed rate,
proving that the observed rate was the real dissociation rate. Based on this, a value of 315nM
could be calculated for the kD of the Ypt51p-Mrs6p complex.
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Figure IV-10: Pre steady state kinetics results from the interaction of Ypt51p with Mrs6p.  In the
results from the association kinetics are presented, whereas in B the stopped flow trace
from a displacement reaction and the exponential fit are depicted.  The lower panel in
B shows the residuals of the fit.  In A, 300nM Ypt51p•GDP-mant were mixed with
increasing concentrations of Mrs6p. In A, 300nM Ypt51p•GDP-mant and 300nM
Mrs6p were mixed in one syringe, while the other contained 1800nM Ypt51•GDP
IV.3.3. Interaction between Ypt1p and Rab7 and Mrs6p
Based on similar approaches, the interaction between Ypt1p and Mrs6p and Rab7 and
Mrs6p were characterized.
For the interaction between Rab7 and Mrs6p, two labels were used: dansyl labels
attached to the C-terminal cysteines and the mant label attached to GDP.  The kon values
obtained with these two approaches were in very good agreement (0.003015nM-1s-1 and,
respectively, 4.196µM-1s-1).  The experimentally determined koffs were also in good agreement
(0.0993s-1 and 0.1127s-1).  The calculated kD value for this interaction was in the range of
35±2nM, close to the value of 15nM determined by equilibrium titrations (Section IV.2.2,
page 81).
The pre steady state interaction between Ypt1p and Mrs6p was characterized also by
using a dansyl label attached to the C terminus of Ypt1p.  The on and off rates for this
interaction were found to be, respectively, 0.00365nM-1s-1 and 0.331s-1, resulting in a kD value
of 90nM, somewhat higher than the one obtained by equilibrium titrations either directly or
by using a competitive titration approach (Section IV.2.3).
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IV.3.4. Mrs6p versus Ypt7p•GppNHp
It is known that in Saccharomyces cerevisiae the ratio between GTP and GDP varies
from 3.9 to 1.7 (mid-exponential growth phase and, respectively, late exponential growth)
(Rudoni et al., 2001), but GTP is always in excess over GDP.  In this context, it is possible
that, after synthesis, Ypt proteins will be loaded with GTP and not GDP.  Thinking that it
would be interesting to find out whether Mrs6p makes any differences based on the status of
nucleotide loading, I tried to characterize the interaction between Mrs6p and Ypt proteins
loaded with the non-hydrolyzable GTP analogue 5'-[β,γ-imido]-guanosintriphosphate
(GppNHp).  A global fit analysis for the case of Ypt1p•GppNHp revealed that its affinity
towards Mrs6p was very low (kD=1100nM).
I wanted also to characterise the interaction between a Ypt family member which, in
the GDP form, binds less tightly to Mrs6p.  To this end, Ypt7p was again chosen.  Using
dansyl as fluorescent reporter group, the rates of association and dissociation between
Ypt7p•GppNHp and Mrs6p were found to be 0.273µM-1s-1 and 0.085s-1, leading to a
calculated kD value of 310nM.
IV.4. Proton/Deuteron exchange experiments and
mapping the Mrs6p–Sec4 interaction interface
The results obtained thus far are somewhat puzzling: it appears that, with respect to
their interaction with Mrs6p, there are two classes of Ypt proteins: some are able to bind
Mrs6p with affinities in the range of 10 to 20nM, whereas the others bind by an order of
magnitude less tightly.  These results are especially difficult to explain, since the sequence
homology and identity between the members of the family is high and analysis of the crystal
structures of three members (Ypt51p (Esters et al., 2000), Sec4p (Stroupe & Brunger, 2000)
and Ypt7p (this work)), two of which had the structure solved both for the GDP and the GTP
conformations, did not reveal any obvious reason for this behavior.
Unfortunately, the efforts to crystallize Ypt7p in complex with Mrs6p were
unsuccessful, the crystallization trial drops exhibiting only precipitates or phase separations.
Attempts to crystallize the ternary prenylation complex between the yeast geranylgeranyl
transferase II, Mrs6p and various Ypt proteins were also unsuccessful (Alexey Rak, personal
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communication).  Due to the size of Mrs6p (66kDa) the problem would also not be amenable
to magnetic nuclear resonance spectroscopy (NMR) methods.
Under these circumstances, a different approach was tried.  It was based on a method
developed at the University of California, San Diego (Mandell et al., 1998b; Mandell et al.,
1998a).   The method showed that protein-protein interfaces could be identified by decreased
amide proton solvent accessibility and the use of a matrix-assisted laser desorption/ionization
time-of-flight(MALDI-TOF) mass spectrometer.  The principle is that amides exhibiting slow
proton/deuteron exchange rates when the proteins are in complex and fast exchange rates in
the uncomplexed state are positioned at the protein-ligand interface.  The rate of amide
proton/deuteron (H/D) exchange is temperature- and pH- dependent and a change of pH
from 7 to 2.5 lowers the exchange rate by three to four orders of magnitude (depending on the
peptide studied); this leads to a half-life of 30..120 minutes at 0˚C.
In order to map the protein-protein interface of the Mrs6p/Ypt complex, two types of
determinations were performed: in one series of experiments, each member of the complex
(lyophilized protein) was incubated in buffered D2O at pD 7.25.  Subsequently, the protein-
protein complex was diluted ten fold in H2O and allowed to back-exchange for various time
periods and subsequently quenched by lowering the pH to 2.5 and the temperature to 0˚C.
The samples were subjected to digestion with pepsin and the resulting peptide mixture was
analyzed by MALDI-TOF.  The second series of experiments started also by incubating each
member of the complex in D2O.  After a defined time, the proteins were mixed, enabling them
to build the complex, and the complex was diluted in H2O and subjected to the same
treatment as the individual components.  Mass spectra were acquired and the mass shift for
each peak was assessed (see below).
IV.4.1. The method
IV.4.1.a. Sample preparation
Information about the affinity between members of the Ypt family and Mrs6p proved
to be very important, since it enabled me to choose the right interacting partner (Sec4p in this
case, since its three dimensional structure is also known) and calculate (using the equation
(IV.14) and the kDs previously determined) protein concentrations at which more than 95% of
the protein is involved in the complex.  Also, since the proteins had to be, at the beginning,
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lyophilized, it was useful to know whether this process had a negative influence on one (or
both) members of the complex.  In order to examine this, competitive titrations were
performed with the protein before and after lyophilization.  The affinity constants determined
in both cases were equal, showing that lyophilization did not have any adverse effect.
The buffer in which Mrs6p and Sec4p were dissolved was exchanged for one consisting
of 30mM potassium phosphate, pH 7.5; after that, the proteins were lyophilized in aliquots of
750pmoles (Sec4p) and 1875pmoles (Mrs6p). For the experiment, each aliquot was
redissolved in 10µl of D2O and allowed to exchange the amide proton for deuterons for 10
minutes.  After this time period, the sample was diluted 10 fold with H2O and allowed to
exchange back the deuterons for protons for 0, 1, 2, 3, 5 and 10 minutes.  The H/D exchange
was quenched by addition of 7.5µl TFA 0.05% (pH 2.5), transferred to ice and incubated for
10 minutes with an equimolar amount of pepsin.  At the end of the digestion period, samples
were snap-frozen in liquid nitrogen and kept at –80˚C until further analysis.  For the complex,
each protein was dissolved separately in 10µl D2O, allowed to exchange the protons for
deuterons for eight minutes only and then the two aliquots mixed together.  After an extra
two minutes, the complex was diluted with H2O and all the subsequent steps were carried out
as indicated above.
IV.4.1.b. Data collection and analysis
In order to minimize the loss of deuterons during data recording, each sample was
analyzed separately.  Each sample was thawed as fast as possible, mixed with cold MALDI
matrix (5mg/ml α-cyano-4-hydroxycinnamic acid in 1:1:1 acetonitrile:ethanol: 0.05%TFA)
and spotted onto a chilled MALDI target.  To accelerate the drying process, the MALDI
target was placed in an exicator and a moderate vacuum was applied.  The time span for
acquiring each sample was very carefully kept constant.
Spectra were acquired with a Voyager DE-PRO workstation using delayed extraction
with a 100ns pulse delay, the guide wire was set at 0.02% and the grid voltage at 70%.
The acquired spectra were calibrated once with an external calibration and then a
second, internal, calibration was performed.  A typical spectra is shown in Figure IV-11. The
mass centroid of each isotopic peak cluster was calculated using a Microsoft Excel worksheet.
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Figure IV-11: A typical mass spectra obtained after digesting a mixture of Mrs6p and Sec4p with
pepsin
For each isotopic peak cluster investigated, the variation of the centroid position with
the back-exchange time was plotted and fitted to the exponential
D = Dmax + (Dmax –D0) · exp(–k ·t).
where D is the number of deuterons retained in a particular sample, Dmax is the number of
deuterons retained in the sample corresponding to the timepoint zero and t is the time elapsed
before quenching the analyzed sample.  The number of deuterons was calculated as the
difference between the centroid of the isotopic peak cluster for the deuterated sample and the
centroid of the undeuterated control.  Two spectra displaying such a shift can be seen in
Figure IV-12 and two exponential fits in the Figure IV-13.
Based on the exchange rates obtained from the exponential fits, a protection factor was
defined, as the ratio between the decay rate in the uncomplexed case and the rate in the
complexed case.  Thus, the higher the protection factor, more efficient was the observed
“protection” of the corresponding peptide.
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Figure IV-12: Shift of the isotopic peak cluster for the peptide of monoisotopic mass 1927.91 occurring
after 5 minutes of back-exchange, compared with the isotopic peak cluster obtained for
the undeuterated protein.
Figure IV-13: Exponential fits for data acquired for two different peptides.  Red is for the protein
digested uncomplexed and green is for the protein digested in complex.  The spectra in
a corresponds to the peptide of monoisotopic mass 1927.9159 and the spectra in b






IV.4.1.c. Assigning the peaks
An important problem was assigning the peaks.  The method used for assigning the
peaks was the following: the mass spectrum of each protein digested separately was subjected
to the deisotoping process.  During this process, the Voyager software calculates the
monoisotopic mass of each isotopic peak cluster found and outputs a list containing only the
deisotoped masses.   The Protein Prospector web server at http://prospector.ucsf.edu/ performs
an in silico enzymatic digestion of a protein sequence and calculates the mass of each peptide,
reporting also the monoisotopic masses.  The two lists were compared and, for each match,
the corresponding peptide was mapped on the sequence of the protein.
The accuracy of the MALDI machine used is about 0.2 atomic mass units for a sample
with the mass of 2000 atomic mass units.  In other words, a sample with the mass 2000.0000
could be reported as having the mass anywhere between 1999.9000 and 2000.1000 atomic
mass units.  Thus, if a peak matched more than one putative peptide in the list output from
Protein Prospector, there was, in a first run, no way of deciding which peptide it really is,
leading to ambiguities in the assignments.  However, a significant region of each of the two
interaction partners could be covered.
1 MS GL RT VS AS S GN GK SY DS I MK IL LI GD SG V GKS CL LV RF V ED KF NP SF I
51 TT IG ID FK IK T VD IN GK KV K LQ LW DT AG QE R FRT IT TA YY R GA MG II LV Y
1 01 DV TD ER TF TN I KQ WF KT VN E HA ND EA QL LL V GNK SD ME TR V VT AD QG EA L
1 51 AK EL GI PF IE S SA KN DD NV N EI FF TL AK LI Q EKI DS NK LV G VG NG KE GN I
2 01 SI NS GS GN SS K SN CC
1 7 5 2 .8 6 6 9
1 7 5 2 .8 5 5 7
3 6 1 1 .7 4 0 7
2 3 4 6 .1 9 7 5
2 6 8 5 .6 2 8 2
2 4 7 8 .2 2 0 0
1 9 1 5 .9 3 0 2
1 8 9 9 .9 2 4 1
1 5 9 7 .8 3 7 9
1 4 8 4 .7 5 3 8
1 1 5 6 .6 1 8 9
1 1 5 6 .7 3 0 5
1 1 0 9 .5 0 1 6
Figure IV-14: Amino acid sequence of Sec4p indicating the position of each peptic fragment that was
identified in the mass spectrum of undeurated Sec4p digest.  The colored arrows
indicate peptides which could not be unambiguously identified.
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IV.4.2. Results
Each protein was digested undeuterated, in order to assign the peaks and then the time
course of deuterium loss for each peptide was recorded. The same determinations were done
for the digest originating from the complex between Sec4p and Mrs6p.  An unfortunate
situation appeared: many of the peaks found in the digest of separate proteins could not be
found in the spectra acquired using the digest of the Sec4p–Mrs6p complex.  It is known that
some peptide peaks are suppressed in digest mixtures (Mandell et al., 1998b), but the basis of
this effect is not clear, especially because the physics of the matrix desorption is not totally
understood.  In a trial to circumvent this problem, different dilutions of the sample were
tested.  I found that diluting the sample as much as 60 fold with matrix could yield spectra
displaying some of the peaks which were previously not observed.
In an attempt to resolve some of the ambiguously assigned peaks, two methods of
sequencing were tried.  In the first one, named MS/MS, the digested sample was analyzed in a
nanospray ionization mass spectrometer.  During an MS/MS experiment, ions of a certain
mass (more correctly m/z ratio) are trapped in an ion trap filled with helium.  A
radiofrequency signal is used to drive the ions in a circular motion.  Under certain conditions,
the energy can be set in such a manner that, after colliding with the He ions in the ion trap,
the peptides will break exactly at a peptide bond, yielding two subfragments.  Because these
subfragments have a different m/z ratio, they will escape from the ion trap and will be
detected.  Since, in general, any peptide bond has almost the same chance of be broken, the
method allows one, in principle, to  determine the sequence of the peptide.
The second method used was post source decay (PSD).  The method allows obtaining
structural information about a sample by analyzing the fragment ions generated from the
original ions in the flight tube.
Regrettably, none of the methods could yield sequence information about the peaks
which could not be assigned previously due to ambiguities.  However, the number of peptides
that could be assigned and characterized for both the digest of the single protein and the
digest of the complex allowed some information to be extracted.
In order to obtain structural information, a model of the two interacting partners was
necessary.  Coordinates of Sec4p were already available (Stroupe & Brunger, 2000), but for
Mrs6p there was no crystal structure, nor a model.  The closest relative of Mrs6p for which
structural information was available was bovine Gdiα (Schalk et al., 1996).  Unfortunately, the
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degree of identity between these two proteins is less than 20%, which is a serious problem for
today’s homology modeling programs.  It is today generally accepted that models based on less
than 30% sequence identity have significant alignment errors, resulting in large errors in main
chain positions (Vitkup et al., 2001).  Modeling was attempted with two homology modeling
programs: Modeller (Sali & Blundell, 1993) and Swiss-Model (Peitsch, 1996).  Both programs
use as input coordinates of the template (bovine Gdiα in this case) and a sequence alignment.
The sequence alignment was generated with T-Coffee (Notredame et al., 2000), an algorithm
which uses a combination of local and global pair-wise alignments to generate a library of
alignment information which will be then used for generating the alignment.  The algorithm is
especially recommended for difficult cases, i.e. cases in which the sequence homology/identity
is very low.  This obtained alignment was further improved manually, by attempting to align
the insertions/deletions with flexible structural elements (loops) in Gdiα.  However, neither of
the modeling programs used succeeded in modeling the N terminal extension of Mrs6p and
the long insertions in the Mrs6p sequence in a satisfactory manner.  These regions will be
referred to  as “untrusted regions”.
The peptides arising from Mrs6p which could be assigned with certainty were mapped
on the surface of the models obtained.  The following peptides could be mapped on the
surface of Mrs6p:





For the case of Sec4p, only one peptide could be unambiguously assigned; that was the
peptide of mass 1597.8379, which maps to the switch I region of Sec4p.  The “protection
factor” for this peptide was 3.35.
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Figure IV-15: Model of Mrs6p.  In the left panel, the known peptides are mapped on the surface.
The color scale indicates the “protection factor”, with red being high (good protection)
and blue being low (no protection).  In the right panel the untrusted areas are marked
in red.  Note that the mapped peptides do not fall in untrusted areas of the model.
IV.5. Conclusions
The kinetic experiments performed with different members of the Ypt family showed
that they can be divided in two categories, with respect to their interaction with Mrs6p.
Members of the first category are able to bind Mrs6p tightly, with affinities in the range of 10
to 30nM.  Although not as strong as that in the mammalian system, this interaction can still
be considered tight, especially when compared with the affinity of the members of the second
category, which is lower by an order of magnitude.  The pre steady state experiments showed
that this effect arises from differences in both the association and dissociation rates, but the
variation in the association rates is more significant than the one in dissociation rates.  The
data obtained from the pre steady state and steady state kinetic determinations is summarized
in Table IV-1 and Table IV-2.
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Protein kon koff koff intercept kD calc kD exp
Ypt7p•GDP 0.000314 0.164 0.154 521.0 354.0
Rab7•GDP 0.004196 0.099 0.309 23.7 13.0
Ypt51p•GDP 0.001790 0.565 0.691 315.7 N.D.
Sec4p•GDP N.D. N.D. N.D. N.D. 4.2
Ypt1p•GDP 0.00365 0.331 0.488 90.7 11.2
Table IV-1: Overview of the data obtained from kinetic determinations for the
interaction between different Ypt / Rab•GDP proteins and Mrs6p.    N.D. –
the values could not be determined; koff intercept – dissociation rate
obtained from the intercept between the liniar fit of the observed rate-
versus-concentration plot and the Y (observed rate) axis of the graph; this
value is usually susceptible to large errors; koff  – experimentally determined
dissociation rate; kD calc – affinity between the interaction partners
calculated as the ratio between kon and koff; kD exp – affinity experimentally
determined from equilibrium titration experiments.  Units: [kon] = s-1nM-1,
[koff] = s-1, [kD] = nM
Protein kon koff koff intercept kD calc kD exp
Ypt1p •GppNHp N.D. N.D. N.D. N.D. 1100.0
Ypt7p •GppNHp 0.000273 0.085 0.010 311.5 N.D.
Table IV-2: Overview of the data obtained from kinetic determinations for the
interaction between different Ypt / Rab•GppNHp proteins and Mrs6p.
Notations as in Table IV-1
It is interesting to note that the only tight binders are those encoded by vital genes.
Different studies showed that Sec4p and Ypt1p are vital (Schmitt et al., 1986; Walworth et al.,
1989), whereas Ypt7p, Ypt51p and Ypt31p are not (Gallwitz et al., 1983; Wichmann et al.,
1992; Singer-Kruger et al., 1994; Benli et al., 1996).  It is known that Ypt proteins are normally
prenylated in the cell (Alory & Balch, 2000; Miaczynska et al., 2001) in ideal growth
conditions.  However, under less favorable conditions, it is possible that the cell has to decide
which are the most important proteins to be prenylated.  Recently (Alory & Balch, 2000), it
was shown that Mrs6pts mutants were able to sustain growth if the cells were shifted at hourly
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intervals for less than two minutes from the non-permisive temperature (37˚C) to the
permisive (30˚C) temperature.  It was also shown that, in cells overexpressing the MRS6
gene, Ypt proteins accumulate and remain partially unprenylated (Alory & Balch, 2000).
Under stress conditions, like the ones described above, it is conceivable that the
prenylation machinery has to make critical decisions in terms of which Ypt family members
will be prenylated first.  It is possible that, in this context, the ability to discern between the
vital members of the family and the less important ones starts playing an important role.  The
results of the kinetic determinations would provide a good explanation for such a behavior.
The above-mentioned discrimination does not hold for the GTP state of the proteins.
On the contrary, in the GTP state the vital Ypt proteins are bound at least three times less
tightly than the non-essential ones.  This might be also part of a regulatory system, by which
the cell avoids the delivery of GTP-loaded, active, Ypt proteins with essential roles in the
membrane.  In this way, the most important Ypt proteins have less chances of evading the
tight regulatory system functioning in the cell.
In an attempt to understand the molecular and structural basis of this behavior, the
interaction interface between Mrs6p and Sec4p was partially mapped.  Although the coverage
is not extensive, the results are in accordance with previous results and also bring new
information.
Out of the four peptides that could be identified and mapped with certainty on the
protein surface of Mrs6p, three were shown to be implicated in the Mrs6p–Sec4p interface.
Peptide 149-159, one of the two most-protected peptides, maps on Gdiα to residues 96-106.
These residues are part of a loop in contact with helix α9; it was shown (Schalk et al., 1996)
that residues 248,249,250 of Gdiα, part of this helix, when mutated, induce a lowering of the
affinity between Gdiα and Rab3A by about 25 times.
Residues 352-367 are less protected in Mrs6p and map to region 296-310 in Gdiα.
The study mentioned above showed that mutation of residue 309 had a minor effect in
altering the affinity between Rab3A and Gdiα, suggesting that this area participates in the
interaction, but is less important.
Mutation of R195 and K199 in Mrs6p to alanine reduces the growth rate of a MRS6∆
strain (Alory & Balch, 2000).  Consistent with this, residues 184-209 were shown to have the
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highest protection factor, suggesting that the mutations described affect the interaction
interface with the Ypt proteins.
Unfortunately only one peptide could be mapped on the structure of Sec4p.  However,
this peptide (region 38-50, the blue arrow in Figure IV-14) is part of the switch I region and
exhibits a relatively high protection factor (3.35), an indication that the switch regions are
important for the interaction with Mrs6p and offering an explanation for the discrimination
between the GDP and the GTP states.
Taken together, all these data provide extra information on the system controlling the
prenylation of the members of the Ypt family and, thus, controlling the whole vesicular traffic





Ypt / Rab proteins are small Ras-related GTPases involved in intracellular traffic.  The
current data suggest a model in which Ypt proteins (in yeast) and Rab proteins (in higher
eukaryotes) play a major role in the catalysis/specificity of the intracellular traffic, from vesicle
budding to vesicle transport, docking and fusion (Segev, 2001).  However, the exact
subreactions in which Ypt / Rab proteins are required and the exact role they play remain
unknown.  Also, we do not know much about how the specificity is achieved and which are
the molecular mechanisms that control the very complex endomembraneous system within
the cell.  Neither do we know what makes these Ypt proteins, structurally so much alike, the
key players in a specificity process which requires the differentiation between different
compartments.  Another question which was unanswered at the beginning of this work was
how big are the structural differences between the GTP- and the GDP- bound forms of the
members of the family and if defining the “switch” regions based solely on the homology with
Ras was a correct decision or not.
This work was done with the points outlined above in mind and with the hope of
gaining some insight into the molecular basis of this specificity.  To answer these questions,
crystallographic analysis was combined with extensive kinetic characterization of different Ypt
family members.
For the crystallographic analysis, Ypt7p was C-terminally truncated by 10 residues.
This Ypt7p truncation mutant yielded well-diffracting crystals in the GTP form, but later it
was shown that the switch regions, responsible for the conformational differences between the
GDP and GTP conformations, were not visible in the electron density due to unfortunate
crystal packing.  In addition, the end of the C-terminal helix was not visible in the electron
density and crystal-packing analysis suggested that it interacts with the switch regions of two
other molecules.  A second construct, lacking the last 26 aminoacid residues of Ypt7p was
designed with the hope that these problems would be circumvented.  The strategy proved
successful: the protein could be crystallized and the structures of both the GTP and the GDP
conformations solved to very high resolution (1.6Å in the case of the GTP-bound form and
1.3Å in the case of the GDP structure).  Although it was postulated that the differences
between the GDP and GTP state are similar to the ones observed in Ras, only recently the
structure of Sec4p (Stroupe & Brunger, 2000) in the GTP and GDP states showed that
qualitatively the same differences can be seen in the Ypt family as well.  Different Ypt proteins
have to be, nevertheless, distinguished from each other in either the GDP- or GTP-bound
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states. Small variations among several Ypt/Rab-proteins in the different nucleotide-bound
states are crucial for their specific function. Therefore, the determination of their individual
structures with high resolution is needed for a comprehensive understanding of effector
binding specificity.
The presented differences in main-chain and side-chain conformations of Ypt7p
compared to Ypt51p, Sec4p, Rab3a and Rab5c, in addition to the sequence differences,
contribute to structural plasticity and variations in both the surface charge distribution and
surface topology within the Ypt/Rab-family of proteins. The observed structural differences are
clustered in areas which were recently highlighted as Rab-specific (RabF) or Rab-subfamily
specific (RabSF) regions (Pereira-Leal & Seabra, 2000). For the RabSF2 region (part of the
switch I region) Ypt7p displays, in the GTP-bound form, a shifted conformation when
compared with other Ypt/Rab structures and a different surface topology. In the structure of
Ypt7p•GppNHp, helix α2 is unwound, which results in an extended loop spanning from β-
strand β3 to β4, including the RabF3 region. Molecular dynamics simulations were performed
and revealed that the intrinsic sequence of Ypt7p determines this feature, proving that it is
not induced by crystal-packing interactions. These two conformational changes associated
with the switch I and the switch II region are likely to contribute to Ypt7p specific binding of
effector proteins and presumably help to discriminate between Ypt7p and Ypt51p when they
are located on the same membrane. Furthermore, due to insertions in loops L3 and L7, the
neighboring RabSF1 and RabSF4 regions are different in their conformation compared with
other Ypt/Rab proteins. Therefore, it is probable that this surface patch can serve as an
additional binding site for Ypt7p-specific effector proteins. These variations, each taken in
part, are small, but they add up and most probably become a specificity tag allowing
differentiation between the otherwise sequence- and fold- similar Ypt/Rab proteins.
It is a common feature that the GDP-bound form of Ras-related small GTP-binding
proteins has a less well-defined structure than the GTP-bound form. In particular, the
important switch I and switch II regions are very flexible when the protein is in complex with
GDP, lacking the γ-phosphate group which fixes these regions. This higher conformational
mobility in the GDP-bound form might help proteins which interact promiscuously with
Ypt/Rab proteins in the GDP-bound form to overcome variations in the amino acid sequence
and topology at the interaction surface (e.g. GDP dissociation inhibitor, GDI, (Garrett et al.,
1994)).
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The purpose of the kinetic analysis was to gain a better understanding of the way
prenylation is controlled.  To this end, equilibrium titrations as well as pre steady state kinetics
methods were employed.  By making use of a large array of techniques, the characterization of
the interaction between the escort protein Mrs6p and a variety of members of the
Saccharomyces cerevisiae Ypt family was achieved.  The results obtained helped us to suggest a
mechanism by which cells differentiate between the more and the less important members of
the family.
The kinetic experiments performed with different members of the Ypt family showed
that they can be divided in two categories, with respect to their interaction with Mrs6p.
Members of the first category are able to bind Mrs6p tightly, with affinities in the range of 10
to 30nM.  Although not as strong as that in the mammalian system, this interaction can still
be considered tight, especially when compared with the affinity of the members of the second
category, which is lower by an order of magnitude. It is interesting to note that the only tight
binders are those encoded by vital genes.
It is known that Ypt proteins are normally prenylated in the cell (Alory & Balch, 2000;
Miaczynska et al., 2001) in ideal growth conditions.  However, under less favorable conditions,
it is possible that the cell has to decide which are the most important proteins to be
prenylated.  Recently (Alory & Balch, 2000), it was shown that Mrs6pts mutants were able to
sustain growth if the cells were shifted at hourly intervals for less than two minutes from the
non-permisive temperature (37˚C) to the permisive (30˚C) temperature.  It was also shown
that, in cells overexpressing the MRS6 gene, Ypt proteins accumulate and remain partially
unprenylated (Alory & Balch, 2000).
Under stress conditions, like the ones described above, it is conceivable that the
prenylation machinery has to make critical decisions in terms of which Ypt family members
will be prenylated first.  It is possible that, in this context, the ability to discern between the
vital members of the family and the less important ones starts playing an important role.  The
results of the kinetic determinations would provide a good explanation for such a behavior.
The above-mentioned discrimination does not hold for the GTP state of the proteins.
On the contrary, in the GTP state the vital Ypt proteins are bound at least three times less
tightly than the non-essential ones.  This might be also part of a regulatory system, by which
the cell avoids the delivery of GTP-loaded, active, Ypt proteins with essential roles in the
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membrane.  In this way, the most important Ypt proteins have less chances of evading the
tight regulatory system functioning in the cell.
In an attempt to understand the molecular and structural basis of this behavior, the
interaction interface between Mrs6p and Sec4p was partially mapped using variations in amide
proton solvent accessibility as monitored by proton-deuteron exchange and MALDI-TOF
analysis.  Although the coverage is not extensive, the results are in accordance with previous
results and also bring new information.
Only one peptide could be mapped on the structure of Sec4p.  However, this peptide is
part of the switch I region and is relatively highly protected, an indication that the switch
regions are important for the interaction with Mrs6p.  This results offers an explanation for
the discrimination between the GDP and the GTP states.
Out of the four peptides that could be identified and mapped with certainty on the
protein surface of Mrs6p, three were shown to be implicated in the Mrs6p–Sec4p interface.
Peptide spanning residues 149-159, one of the two most-protected peptides, maps on Gdiα to
residues 96-106.  These residues are part of a loop in contact with helix α9; it was shown
(Schalk et al., 1996) that residues 248,249,250 of Gdiα, part of this helix, when mutated,
induce a lowering of the affinity between Gdiα and Rab3A by about 25 times.
Residues 352-367 are less protected in Mrs6p and map to region 296-310 in Gdiα.
The study mentioned above showed that mutation of residue 309 had a minor effect in
altering the affinity between Rab3A and Gdiα, suggesting that this area participates in the
interaction, but is less important.
Mutation of R195 and K199 in Mrs6p to alanine reduces the growth rate of a MRS6∆
strain (Alory & Balch, 2000).  Consistent with this, residues 184-209 were shown to have the
highest protection factor, suggesting that the mutations described affect the interaction
interface with the Ypt proteins.
Taken together, the data presented in this work provide extra structural and kinetic
information on the system controlling the prenylation of the members of the Ypt family and,
thus, controlling the whole vesicular traffic machinery of the cell.
116
Publications resulted from this
work
H. Esters, K. Alexandrov, A. T. Constantinescu, R. S. Goody and A. J. Scheidig.
“High-resolution Crystal Structure of S. cerevisiae Ypt51∆C15-GppNHp, a Small GTP-
binding Protein Involved in Regulation of Endocytosis”. J.Mol.Biol. 298 (1):111-121, 2000.
A. Kalinin, N. H. Thoma, A. Iakovenko, I. Heinemann, E. Rostkova, A. T.
Constantinescu and K. Alexandrov. “Expression of Mammalian Geranylgeranyltransferase
Type-II in Escherichia coli and Its Application for in vitro Prenylation of Rab Proteins”. Protein
Expr.Purif. 22 (1):84-91, 2001.
A. T. Constantinescu, A. Rak, K. Alexandrov, R. S. Goody and A. J. Scheidig.“Rab-
subfamily specific regions of Ypt7p are structurally different from other RabGTPases”.
Submitted to Structure with Folding and Design.
Chapter VI.
References
Adams PD, Pannu NS, Read RJ, Brunger AT: Cross-validated maximum likelihood
enhances crystallographic simulated annealing refinement. Proc.Natl.Acad.Sci.U.S.A
1997, 94:5018-5023.
Albert S, Will E, Gallwitz D: Identification of the catalytic domains and their functionally
critical arginine residues of two yeast GTPase-activating proteins specific for Ypt/Rab
transport GTPases. EMBO J. 1999, 18:5216-5225.
Alexandrov K, Simon I, Iakovenko A, Holz B, Goody RS, Scheidig AJ: Moderate
discrimination of REP-1 between Rab7 x GDP and Rab7 x GTP arises from a
difference of an order of magnitude in dissociation rates. FEBS Lett. 1998, 425: 460-
464.
Alory C, Balch WE: Molecular Basis for Rab Prenylation. J.Cell Biol. 2000, 150:89-104.
Bacon RA, Salminen A, Ruohola H, Novick P, Ferro-Novick S: The GTP-binding protein
Ypt1 is required for transport in vitro: the Golgi apparatus is defective in ypt1
mutants. J.Cell Biol. 1989, 109:1015-1022.
Ban N, Nissen P, Hansen J, Moore PB, Steitz TA: The complete atomic structure of the
large ribosomal subunit at 2.4 A resolution. Science 2000, 289:905-920.
Benli M, Doring F, Robinson DG, Yang X, Gallwitz D: Two GTPase isoforms, Ypt31p and
Ypt32p, are essential for Golgi function in yeast. EMBO J. 1996, 15: 6460-6475.
Berchtold H, Reshetnikova L, Reiser CO, Schirmer NK, Sprinzl M, Hilgenfeld R: Crystal
structure of active elongation factor Tu reveals major domain rearrangements. Nature
1993, 365:126-132.
Berendsen HJC, van der Spoel D, van Drunen R: GROMACS: A message-passing parallel
molecular dynamics implementation. Comp.Phys.Comm 1995, 91:43-56.
119
Bourne HR, Sanders DA, McCormick F: The GTPase superfamily: a conserved switch for
diverse cell functions. Nature 1990, 348:125-132.
Bourne HR, Sanders DA, McCormick F: The GTPase superfamily: conserved structure and
molecular mechanism. Nature 1991, 349:117-127.
Bowser R, Muller H, Govindan B, Novick P: Sec8p and Sec15p are components of a plasma
membrane-associated 19.5S particle that may function downstream of Sec4p to
control exocytosis. J.Cell Biol. 1992, 118:1041-1056.
Brachvogel V, Neu M, Metcalf P: Rab7: crystallization of intact and C-terminal truncated
constructs complexed with GDP and GppNHp. Proteins 1997, 27:210-212.
Brennwald P, Novick P: Interactions of three domains distinguishing the Ras-related GTP-
binding proteins Ypt1 and Sec4. Nature 1993, 362:560-563.
Brunger AT: Free R value: a novel statistical quantity for assessing the accuracy of crystal
structures. Nature 1992, 355:472-475.
Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS,
Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL:
Crystallography & NMR system: A new software suite for macromolecular structure
determination. Acta Crystallogr.D. 1998, 54 (Pt 5):905-921.
Casey PJ, Seabra MC: Protein prenyltransferases. J.Biol.Chem. 1996, 271:5289-5292.
Chavrier P, Gorvel JP, Stelzer E, Simons K, Gruenberg J, Zerial M: Hypervariable C-terminal
domain of rab proteins acts as a targeting signal. Nature 1991, 353:769-772.
Cramer P, Bushnell DA, Kornberg RD: Structural basis of transcription: RNA polymerase
II at 2.8 angstrom resolution. Science 2001, 292:1863-1876.
120
de Vos AM, Tong L, Milburn MV, Matias PM, Jancarik J, Noguchi S, Nishimura S, Miura K,
Ohtsuka E, Kim SH: Three-dimensional structure of an oncogene protein: catalytic
domain of human c-H-ras p21. Science 1988, 239:888-893.
Desnoyers L, Seabra MC: Single prenyl-binding site on protein prenyl transferases.
Proc.Natl.Acad.Sci.U.S.A. 1998, 95:12266-12270.
Dever TE, Glynias MJ, Merrick WC: GTP-binding domain: three consensus sequence
elements with distinct spacing. Proc.Natl.Acad.Sci.U.S.A 1987, 84:1814-1818.
Doignon F, Biteau N, Crouzet M, Aigle M: The complete sequence of a 19,482 bp segment
located on the right arm of chromosome II from Saccharomyces cerevisiae. Yeast
1993, 9:189-199.
Dumas JJ, Zhu Z, Connolly JL, Lambright DG: Structural basis of activation and GTP
hydrolysis in Rab proteins. Structure.Fold.Des 1999, 7:413-423.
Dunn B, Stearns T, Botstein D: Specificity domains distinguish the Ras-related GTPases
Ypt1 and Sec4. Nature 1993, 362:563-565.
Eitzen G, Will E, Gallwitz D, Haas A, Wickner W: Sequential action of two GTPases to
promote vacuole docking and fusion. EMBO J. 2000, 19:6713-6720.
Esters H, Alexandrov K, Constantinescu AT, Goody RS, Scheidig AJ: High-resolution
Crystal Structure of S. cerevisiae Ypt51(DeltaC15)-GppNHp, a Small GTP-binding
Protein Involved in Regulation of Endocytosis. J.Mol.Biol. 2000, 298:111-121.
Esters H, Alexandrov K, Iakovenko A, Ivanova T, Thoma N, Rybin V, Zerial M, Scheidig AJ,
Goody RS: Vps9, rabex-5 and dss4: proteins with weak but distinct nucleotide-
exchange activities for rab proteins. J.Mol.Biol. 2001, 310:141-156.
Ferro-Novick S, Newman AP, Groesch M, Ruohola H, Rossi G, Graf J, Shim J: An analysis of
BET1, BET2, and BOS1. Three factors mediating ER to Golgi transport in yeast. Cell
Biophys. 1991, 19:25-33.
121
Frech M, Darden TA, Pedersen LG, Foley CK, Charifson PS, Anderson MW, Wittinghofer A:
Role of glutamine-61 in the hydrolysis of GTP by p21H-ras: an experimental and
theoretical study. Biochemistry (Mosc). 1994, 33:3237-3244.
Gallwitz D, Donath C, Sander C: A yeast gene encoding a protein homologous to the
human c-has/bas proto- oncogene product. Nature 1983, 306:704-707.
Garcia-Ranea JA, Valencia A: Distribution and functional diversification of the ras
superfamily in Saccharomyces cerevisiae. FEBS Lett. 1998, 434:219-225.
Garrett MD, Zahner JE, Cheney CM, Novick PJ: GDI1 encodes a GDP dissociation
inhibitor that plays an essential role in the yeast secretory pathway. EMBO J. 1994,
13:1718-1728.
Glomset JA, Farnsworth CC: Role of protein modification reactions in programming
interactions between ras-related GTPases and cell membranes. Annu.Rev.Cell Biol.
1994, 10:181-205.
Gotte M, Lazar T, Yoo JS, Scheglmann D, Gallwitz D: The full complement of yeast
Ypt/Rab-GTPases and their involvement in exo- and endocytic trafficking.
Subcell.Biochem. 2000, 34:133-173.
Gotte M, von Mollard GF: A new beat for the SNARE drum. Trends Cell Biol. 1998, 8:215-
218.
Goud B, Salminen A, Walworth NC, Novick PJ: A GTP-binding protein required for
secretion rapidly associates with secretory vesicles and the plasma membrane in yeast.
Cell 1988, 53:753-768.
Gutfreund H: Kinetics for the life sciences: receptors, transmitters and catalysts. Cambridge
University Press; 1995.
122
Haas A, Scheglmann D, Lazar T, Gallwitz D, Wickner W: The GTPase Ypt7p of
Saccharomyces cerevisiae is required on both partner vacuoles for the homotypic
fusion step of vacuole inheritance.  EMBO J. 1995b, 14:5258-5270.
Haas A, Scheglmann D, Lazar T, Gallwitz D, Wickner W: The GTPase Ypt7p of
Saccharomyces cerevisiae is required on both partner vacuoles for the homotypic
fusion step of vacuole inheritance.  EMBO J. 1995a, 14:5258-5270.
Hama H, Tall GG, Horazdovsky BF: Vps9p is a guanine nucleotide exchange factor
involved in vesicle- mediated vacuolar protein transport. J.Biol.Chem. 1999,
274:15284-15291.
Hengst L, Grabowski R, Gallwitz D: Ypt6p. In Guidebook to the small GTPases. Edited by M
Zerial and LA Huber. Oxford University Press; 1995:403-404.
Hoffenberg S, Nikolova L, Pan JY, Daniel DS, Wessling-Resnick M, Knoll BJ, Dickey BF:
Functional and structural interactions of the Rab5 D136N mutant with xanthine
nucleotides. Biochem.Biophys.Res.Commun. 1995, 215:241-249.
Hwang YW, Miller DL: A mutation that alters the nucleotide specificity of elongation
factor Tu, a GTP regulatory protein. J.Biol.Chem. 1987, 262:13081-13085.
Jahn R, Sudhof TC: Membrane fusion and exocytosis. Annu.Rev.Biochem. 1999, 68:863-911.
Jancarik J, Kim SH: Sparse matrix sampling: A screening method for crystallization of
proteins. J.Appl.Crystallog. 1991, 24:409.
Jedd G, Richardson C, Litt R, Segev N: The Ypt1 GTPase is essential for the first two steps
of the yeast secretory pathway. J.Cell Biol. 1995, 131:583-590.
Jiang Y, Ferro-Novick S: Identification of yeast component A: reconstitution of the
geranylgeranyltransferase that modifies Ypt1p and Sec4p. Proc.Natl.Acad.Sci.U.S.A.
1994, 91:4377-4381.
123
John J, Schlichting I, Schiltz E, Rosch P, Wittinghofer A: C-terminal truncation of p21H
preserves crucial kinetic and structural properties. J.Biol.Chem. 1989, 264:13086-
13092.
Jones T.A., Zou JY, Cowan SW, Kjeldgaard M: Improved methods for building protein
models in electron density maps and the location of errors in these models. Acta
Crystallogr.D. 1991, 47:110-119.
Jones S, Litt RJ, Richardson CJ, Segev N: Requirement of nucleotide exchange factor for
Ypt1 GTPase mediated protein transport. J.Cell Biol. 1995, 130:1051-1061.
Jordan P, Fromme P, Witt HT, Klukas O, Saenger W, Krauss N: Three-dimensional
structure of cyanobacterial photosystem I at 2.5 A resolution. Nature 2001, 411:909-
917.
Jurnak F: Structure of the GDP domain of EF-Tu and location of the amino acids
homologous to ras oncogene proteins. Science 1985, 230:32-36.
Kahn RA, Der CJ, Bokoch GM: The ras superfamily of GTP-binding proteins: guidelines
on nomenclature. FASEB J. 1992, 6:2512-2513.
Kee Y, Yoo JS, Hazuka CD, Peterson KE, Hsu SC, Scheller RH: Subunit structure of the
mammalian exocyst complex. Proc.Natl.Acad.Sci.U.S.A. 1997, 94: 14438-14443.
Kirchhausen T, Bonifacino JS, Riezman H: Linking cargo to vesicle formation: receptor tail
interactions with coat proteins. Curr.Opin.Cell Biol. 1997, 9:488-495.
Lazar T, Gotte M, Gallwitz D: Vesicular transport: how many Ypt/Rab-GTPases make a
eukaryotic cell? Trends Biochem.Sci. 1997, 22:468-472.
Mandell JG, Falick AM, Komives EA: Identification of protein-protein interfaces by
decreased amide proton solvent accessibility. Proc.Natl.Acad.Sci.U.S.A. 1998a,
95:14705-14710.
124
Mandell JG, Falick AM, Komives EA: Measurement of amide hydrogen exchange by
MALDI-TOF mass spectrometry. Anal.Chem. 1998b, 70:3987-3995.
Matthews BW: Solvent content of protein crystals. J.Mol.Biol. 1968, 33: 491.
Maurer KC, Urbanus JH, Planta RJ: Sequence analysis of a 30 kb DNA segment from yeast
chromosome XIV carrying a ribosomal protein gene cluster, the genes encoding a
plasma membrane protein and a subunit of replication factor C, and a novel putative
serine/threonine protein kinase gene. Yeast 1995, 11:1303-1310.
Merithew E, Hatherly S, Dumas JJ, Lawe DC, Heller-Harrison R, Lambright DG: Structural
Plasticity of an Invariant Hydrophobic Triad in the Switch Regions of Rab GTPases
Is a Determinant of Effector Recognition. J.Biol.Chem. 2001, 276:13982-13988.
Miaczynska M, Wagner W, Bauer BE, Schweyen RJ, Ragnini A: Ypt protein prenylation
depends on the interplay among levels of Rab escort protein and geranylgeranyl
diphosphate in yeast cells. Yeast 2001, 18:697-709.
Mikol V, Rodeau JL, Giege R: Experimental determination of water equilibration rates in
the hanging drop method of protein crystallization. Anal.Biochem. 1990, 186:332-339.
Milburn MV, Tong L, deVos AM, Brunger A, Yamaizumi Z, Nishimura S, Kim SH:
Molecular switch for signal transduction: structural differences between active and
inactive forms of protooncogenic ras proteins . Science 1990, 247:939-945.
Navaza J: AMoRe: an automaed package for molecular replacement. Acta Crystallogr.A.
1994, 50:157-163.
Neu M, Brachvogel V, Oschkinat H, Zerial M, Metcalf P: Rab7: NMR and kinetics analysis
of intact and C-terminal truncated constructs. Proteins 1997, 27:204-209.
Notredame C, Higgins DG, Heringa J: T-Coffee: A novel method for fast and accurate
multiple sequence alignment. J.Mol.Biol. 2000, 302:205-217.
125
Novick P, Field C, Schekman R: Identification of 23 complementation groups required for
post- translational events in the yeast secretory pathway. Cell 1980, 21:205-215.
Ostermeier C, Brunger AT: Structural basis of Rab effector specificity: crystal structure of
the small G protein Rab3A complexed with the effector domain of rabphilin- 3A. Cell
1999, 96:363-374.
Overmeyer JH, Wilson AL, Maltese WA: Membrane Targeting of a Rab GTPase That Fails
to Associate with Rab Escort Protein (REP) or Guanine Nucleotide Dissociation
Inhibitor (GDI)*. J.Biol.Chem. 2001, 276:20379-20386.
Pai EF, Kabsch W, Krengel U, Holmes KC, John J, Wittinghofer A: Structure of the
guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the
triphosphate conformation. Nature 1989, 341:209-214.
Pai EF, Krengel U, Petsko GA, Goody RS, Kabsch W, Wittinghofer A: Refined crystal
structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution:
implications for the mechanism of GTP hydrolysis. EMBO J. 1990, 9:2351-2359.
Palade G: Intracellular aspects of the process of protein synthesis. Science 1975, 189:347-
358.
Park HW, Boduluri SR, Moomaw JF, Casey PJ, Beese LS: Crystal structure of protein
farnesyltransferase at 2.25 angstrom resolution. Science 1997, 275:1800-1804.
Peitsch MC: ProMod and Swiss-Model: Internet-based tools for automated comparative
protein modelling. Biochem.Soc.Trans. 1996, 24:274-279.
Pereira-Leal JB, Seabra MC: The Mammalian Rab Family of Small GTPases: Definition of
Family and Subfamily Sequence Motifs Suggests a Mechanism for Functional
Specificity in the Ras Superfamily. J.Mol.Biol. 2000, 301:1077-1087.
126
Price A, Seals D, Wickner W, Ungermann C: The docking stage of yeast vacuole fusion
requires the transfer of proteins from a cis-SNARE complex to a Rab/Ypt protein.
J.Cell Biol. 2000, 148:1231-1238.
Rak A, Fedorov R, Alexandrov K, Albert S, Goody RS, Gallwitz D, Scheidig AJ: Crystal
structure of the GAP domain of Gyp1p: first insights into interaction with Ypt/Rab
proteins. EMBO J. 2000, 19:5105-5113.
Reiss Y, Goldstein JL, Seabra MC, Casey PJ, Brown MS: Inhibition of purified p21ras
farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell 1990, 62:81-88.
Reiss Y, Seabra MC, Armstrong SA, Slaughter CA, Goldstein JL, Brown MS: Nonidentical
subunits of p21H-ras farnesyltransferase. Peptide binding and farnesyl pyrophosphate
carrier functions. J.Biol.Chem. 1991, 266:10672-10677.
Rossi G, Yu JA, Newman AP, Ferro-Novick S: Dependence of Ypt1 and Sec4 membrane
attachment on Bet2. Nature 1991, 351:158-161.
Rudoni S, Colombo S, Coccetti P, Martegani E: Role of guanine nucleotides in the
regulation of the Ras/cAMP pathway in Saccharomyces cerevisiae.
Biochim.Biophys.Acta 2001, 1538:181-189.
Rybin V, Ullrich O, Rubino M, Alexandrov K, Simon I, Seabra MC, Goody R, Zerial M:
GTPase activity of Rab5 acts as a timer for endocytic membrane fusion. Nature 1996,
383:266-269.
Sacher M, Jiang Y, Barrowman J, Scarpa A, Burston J, Zhang L, Schieltz D, Yates JR, III,
Abeliovich H, Ferro-Novick S: TRAPP, a highly conserved novel complex on the cis-
Golgi that mediates vesicle docking and fusion. EMBO J. 1998, 17:2494-2503.
Sali A, Blundell TL: Comparative protein modelling by satisfaction of spatial restraints.
J.Mol.Biol. 1993, 234:779-815.
127
Sambrook J, Fritsch EF, Maniatis T: Molecular cloning, a laboratory manual, edn 2nd. Cold
Spring Harbour, New York: Cold Spring Harbour Laboratory Press; 1989.
Saraste M, Sibbald PR, Wittinghofer A: The P-loop--a common motif in ATP- and GTP-
binding proteins. Trends Biochem.Sci. 1990, 15:430-434.
Schalk I, Zeng K, Wu SK, Stura EA, Matteson J, Huang M, Tandon A, Wilson IA, Balch
WE: Structure and mutational analysis of Rab GDP-dissociation inhibitor. Nature
1996, 381:42-48.
Scheidig AJ, Burmester C, Goody RS: The pre-hydrolysis state of p21(ras) in complex with
GTP: new insights into the role of water molecules in the GTP hydrolysis reaction of
ras- like proteins. Structure.Fold.Des 1999, 7:1311-1324.
Schlichting I, Almo SC, Rapp G, Wilson K, Petratos K, Lentfer A, Wittinghofer A, Kabsch
W, Pai EF, Petsko GA, .: Time-resolved X-ray crystallographic study of the
conformational change in Ha-Ras p21 protein on GTP hydrolysis. Nature 1990,
345:309-315.
Schmidt G, Lenzen C, Simon I, Deuter R, Cool RH, Goody RS, Wittinghofer A: Biochemical
and biological consequences of changing the specificity of p21ras from guanosine to
xanthosine nucleotides. Oncogene 1996, 12:87-96.
Schmitt HD, Wagner P, Pfaff E, Gallwitz D: The ras-related YPT1 gene product in yeast: a
GTP-binding protein that might be involved in microtubule organization. Cell 1986,
47:401-412.
Seabra MC, Brown MS, Slaughter CA, Sudhof TC, Goldstein JL: Purification of component
A of Rab geranylgeranyl transferase: possible identity with the choroideremia gene
product. Cell 1992, 70:1049-1057.
Seabra MC, Reiss Y, Casey PJ, Brown MS, Goldstein JL: Protein farnesyltransferase and
geranylgeranyltransferase share a common alpha subunit. Cell 1991, 65:429-434.
128
Segev N: Ypt and Rab GTPases: insight into functions through novel interactions.
Curr.Opin.Cell Biol. 2001, 13:500-511.
Sheetz MP: Motor and cargo interactions. Eur.J.Biochem. 1999, 262:19-25.
Sheldrick GM, Schneider TR: SHELXL: high resolution refinement. Methods Enzymol. 1997,
277:319-343.
Singer-Kruger B, Stenmark H, Dusterhoft A, Philippsen P, Yoo JS, Gallwitz D, Zerial M: Role
of three rab5-like GTPases, Ypt51p, Ypt52p, and Ypt53p, in the endocytic and
vacuolar protein sorting pathways of yeast. J.Cell Biol. 1994, 125:283-298.
Sollner T, Bennett MK, Whiteheart SW, Scheller RH, Rothman JE: A protein assembly-
disassembly pathway in vitro that may correspond to sequential steps of synaptic
vesicle docking, activation, and fusion. Cell 1993, 75:409-418.
Stenmark H, Valencia A, Martinez O, Ullrich O, Goud B, Zerial M: Distinct structural
elements of rab5 define its functional specificity. EMBO J. 1994, 13:575-583.
Strom M, Vollmer P, Tan TJ, Gallwitz D: A yeast GTPase-activating protein that interacts
specifically with a member of the Ypt/Rab family. Nature 1993, 361:736-739.
Stroupe C, Brunger AT: Crystal Structures of a Rab Protein in its Inactive and Active
Conformations. J.Mol.Biol. 2000, 304:585-598.
Sutton RB, Fasshauer D, Jahn R, Brunger AT: Crystal structure of a SNARE complex
involved in synaptic exocytosis at 2.4 A resolution. Nature 1998, 395: 347-353.
Tickle IJ, Laskowski RA, Moss DS: Rfree and the rfree ratio. I. Derivation of expected
values of cross- validation residuals used in macromolecular least-squares refinement.
Acta Crystallogr.D. 1998, 54 ( Pt 4):547-557.
129
Tsao J, Chapman MS, Agbandje M, Keller W, Smith K, Wu H, Luo M, Smith TJ, Rossmann
MG, Compans RW, .: The three-dimensional structure of canine parvovirus and its
functional implications. Science 1991, 251:1456-1464.
Tsukada M, Gallwitz D: Isolation and characterization of SYS genes from yeast, multicopy
suppressors of the functional loss of the transport GTPase Ypt6p. J.Cell Sci. 1996, 109
( Pt 10):2471-2481.
Ungermann C, Price A, Wickner W: A new role for a SNARE protein as a regulator of the
Ypt7/Rab-dependent stage of docking. Proc.Natl.Acad.Sci.U.S.A. 2000, 97:8889-8891.
Ungermann C, Sato K, Wickner W: Defining the functions of trans-SNARE pairs. Nature
1998, 396:543-548.
Valencia A, Chardin P, Wittinghofer A, Sander C: The ras protein family: evolutionary tree
and role of conserved amino acids . Biochemistry (Mosc). 1991, 30:4637-4648.
Vitkup D, Melamud E, Moult J, Sander C: Completeness in structural genomics.
Nat.Struct.Biol. 2001, 8:559-566.
Vollmer P, Gallwitz D: High expression cloning, purification, and assay of Ypt-GTPase-
activating proteins. Methods Enzymol. 1995, 257:118-128.
Vollmer P, Will E, Scheglmann D, Strom M, Gallwitz D: Primary structure and biochemical
characterization of yeast GTPase- activating proteins with substrate preference for the
transport GTPase Ypt7p. Eur.J.Biochem. 1999, 260:284-290.
Wagner P, Molenaar CM, Rauh AJ, Brokel R, Schmitt HD, Gallwitz D: Biochemical
properties of the ras-related YPT protein in yeast: a mutational analysis. EMBO J.
1987, 6:2373-2379.
Walworth NC, Goud B, Kabcenell AK, Novick PJ: Mutational analysis of SEC4 suggests a
cyclical mechanism for the regulation of vesicular traffic. EMBO J. 1989, 8:1685-1693.
130
Wang W, Sacher M, Ferro-Novick S: TRAPP Stimulates Guanine Nucleotide Exchange on
Ypt1p. J.Cell Biol. 2000, 151:289-296.
Wendland B, Emr DS, Riezman H: Protein traffic in the yeast endocytic and vacuolar
protein sorting pathways. Curr.Opin.Cell Biol. 1998, 10:513-522.
Wichmann H, Hengst L, Gallwitz D: Endocytosis in yeast: evidence for the involvement of
a small GTP- binding protein (Ypt7p) . Cell 1992, 71:1131-1142.
Wickner W, Haas A: Yeast homotypic vacuole fusion: A Window on Organelle
Trafficking Mechanisms. Annu.Rev.Biochem. 2000, 69:247-275.
Wieland F, Harter C: Mechanisms of vesicle formation: insights from the COP system.
Curr.Opin.Cell Biol. 1999, 11:440-446.
Wimberly BT, Brodersen DE, Clemons WM, Jr., Morgan-Warren RJ, Carter AP, Vonrhein C,
Hartsch T, Ramakrishnan V: Structure of the 30S ribosomal subunit. Nature 2000,
407:327-339.
Wu SK, Zeng K, Wilson IA, Balch WE: Structural insights into the function of the Rab
GDI superfamily. Trends Biochem.Sci. 1996, 21:472-476.
Yoo JS, Grabowski R, Xing L, Trepte HH, Schmitt HD, Gallwitz D: Functional implications
of genetic interactions between genes encoding small GTPases involved in vesicular
transport in yeast. Mol.Gen.Genet. 1999, 261:80-91.
Zahraoui A, Joberty G, Arpin M, Fontaine JJ, Hellio R, Tavitian A, Louvard D: A small rab
GTPase is distributed in cytoplasmic vesicles in non polarized cells but colocalizes
with the tight junction marker ZO-1 in polarized epithelial cells. J.Cell Biol. 1994,
124:101-115.
Zhang FL, Casey PJ: Protein prenylation: molecular mechanisms and functional
consequences. Annu.Rev.Biochem. 1996, 65:241-269.
131
Zhang H, Seabra MC, Deisenhofer J: Crystal structure of Rab geranylgeranyltransferase at
2.0 A resolution. Structure.Fold.Des 2000, 8:241-251.
